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Since their introduction, the hydrotris(pyrazolyl)borate and the 
hydrotris(methimazolyl)borate ligands have drawn the attention of many research 
groups. These boron-centred ligand systems have been studied, modified and applied 
in different areas of chemistry from medicinal to surface chemistry and catalysis. 
The synthesis of new tripodal ligands of the type [LB(Mt)31 (L = neutral 
Lewis base; mt = methimazolyl) with boron substituted by various nitrogen donors 
(L) is the aim of the work reported in this thesis. In this work a new synthetic method 
to obtain these ligands is presented. This new method consists of the substitution of 
dimethylamine in [(I{NMe2)B(mt)3 ] by a neutral N-donor under reflux in toluene. 
The evidence that the dimethylamine in [(I{NMe 2)B(mt)3] can be substituted with N-
donors contradicts the previously proposed mechanism for the "one-pot" reactions 
with tris(dimethylamino)borane reported previously—From this synthetic work, a new 
mechanism for the formation of ligands of the type [(L)B(mt) 3 ] is proposed. 
The N-donors used in this work were mainly tertiary amines and imines but 
also a primary amine, benzylamine was successfully used. The functionalization of 
the boron central atom of these ligands with primary amines broadens the possibility 
of synthesis of new ligands. 
In order to explore an alternative to methimazole, two new boron-centred 
tripodal ligands with sulphur donors, [(HNMe2)B(1 ,4, 5-trimethylimidazolyl-2-
thione)3] and [(HNMe2)B(1-methyl-benzimidazolyl-2-thione)3], were synthesized. 
These ligands present a more protective environment around the boron bridgehead 
created by the substituents in the 4th  and 5th  position of methimazole. 
IV 
The chiral tripodal ligand, 	[(S)-(-)-a-methylbenzylamine)B(1 ,4,5- 
trimethylimida.zolyl-2-thione)3] was successfully obtained, and after its coordination 
to molybdenum trica bony! two diastereoisomeric complexes in a 1:7 ratio were 
obtained. Although, it was sought to obtain a single diastereisomer form of the 
complex this is a very promising result indicating that this system can still be 
improved in order to obtain chiral boron-centred tripodal ligand complexes. 
V 
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BORON-CENTRED LIGANDS WITH THIONE DONORS 
1.1. INTRODUCTION 
The synthesis of new boron-functionalized tripodal ligand analogues of 
hydrotris(methimazolyl)borate (Tm) is the main concern of this thesis. The efforts 
towards the synthesis of these tripodal ligands will be described and discussed in the 
next chapters. This chapter will provide an introduction to the Tin tripodal ligand 
system which is necessary to contextualize this thesis work. 
1.2. FROM HARD TO SOFT SCORPIONATE LIGANDS 
Five decades ago, Trofimenko introduced the tris(pyrazolyl)borate (Tp) 
ligand, and described it as "a creature (that) grabs its prey with two identical claws 
and then may proceed to sting it with the sharp point of the curving tail"(Fig. 1.1).' 
Following this metaphor the poly(pyrazolyl)borates were coined as scorpionate 
ligands. 
RBN . 
Fig. 1.1. Tris(pyrazolyl) borate ligand coordinated to a metal centre () mimicking a 
scorpion attack 
The anionic hydrotris(pyrazolyl)borate was synthesized by heating pyrazole 
and alkali-metal borohydrides under solvent-free conditions (Scheme 1.1).' This 
2 
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Scheme 1.1. Synthesis of the anionic hydrotris(pyrazolyl) borate ligand.' 
The tris(pyrazolyl)borate ligand is often compared to the cyclopentadienyl 
(Cp) ligand, as both systems are anionic, 6e donor face-capping ligands. However, 
there are also differences between these ligands systems such as, the relatively hard 
a-donor character of Tp and the softer character of Cp which has some it-acceptor 
ability. Other differences between these ligand systems are the topology and the 
number of possible substitutable positions. There are five possible substitutable 
positions in the Cp ligand and ten substitutable positions in the Tp ligand (one on the 
boron and three on each of the pyrazole rings). Then, the tris(pyrazolyl)borate 
ligands can be tuned sterically and electronically and this versatility is reflected in 
the number of applications of Tp ligand derivatives in various fields of study such as 
catalysis, bioinorganic models and metal extractions. 2 
It is also possible to modify the scorpionate ligands by replacing the pyrazole 
with another heterocycle, or by replacing the central boron atom by another element. 
The replacement of the pyrazole rings can affect the size of the chelate rings formed 
on metal complexation, though the negative charge of the ligand is maintained. 
3 
Furthermore, the anionic character of the ligand can be changed if the boron is 
replaced with a different atom. 2 
The possibility of changing the pyrazole rings in the Tp ligand by other 
heterocycles with different donor atoms is attractive since it can lead to scorpionate 
ligands with different donor properties. As Tp ligand complexes were used to mimic 
sulphur-donor protein complexes with biological activity, it became interesting to 
explore the introduction of sulphur donor heterocycles into tris(pyrazolyl)borate 
derivatives.' However, the choice of another molecule to use in the synthesis of new 
derivatives to replace the pyrazole was restrained to the presence of an N-H acidic 
proton to enhance the condensation with the borohydride under solvent free 
conditions. 
The first scorpionate ligand with heterocycles bearing sulphur donors was 
reported by Reglinski and Spicer in 1996 .4  They used 1-methylimidazole-2-thione 
(methima.zole) to replace the pyrazole in the Tp ligand structure and obtained the 







Fig. 1.2. Hydroiris(methimazolyl) borate (I'm) ligand and its crystal structure 
(hydrogens and the counter ion omittedfor clarity). 54 
4 
Methimazole can exist in two tautomeric forms, thiol and thione (Fig. 1.3). 
Despite being commercialized as 1-methyl-2-imidazolethiol, NMR spectroscopy 
studies proved that the thione tautomer is the more favourable structure for this 
compound  .6  In this form it presents the acidic N-H proton which allows the 
condensation with borohydride during the synthesis of 
hydrotns(methymazolyl)borate ligand. 4 
CN~~ 	 N.) I _ C 
Fig. 1.3. Thiol and thione taulomers of methimazole. 
1.3. TRIS(METHIMAZOLYL)BORATE (TM) LIGAND 
1.3.1. Synthesis 
The Tm ligand can be synthesised employing a similar method as used to 
obtain the Tp ligand, a melt reaction with an alkali-metal borohydride and 
methimazole. This synthesis does not require solvent and can be followed by 













Scheme 1.2. Synthesis of Tin ligand via melt reaction. 
This synthesis is limited by the thermal stability of the product formed since 
decomposition can occur if the reaction is heated beyond 180°C.7' 8  The thermal 
limitation of this reaction can be related to methimazole's properties, as its melting 
point is around 145°C. The Tm ligand can also be obtained when a solution of 
methimazole and sodium borohydride in toluene is heated under reflux This 
synthetic route can prevent thermal decomposition of the reactants, however it can 
take up to 36 hours to reach completion (Scheme I 3) 9 ' 
N 
0 BH4 + 3 s==IIIiI 	r.4Iux tolueno + 3H2 
Scheme 1.3. Alternative Tin ligand synthesis: healing a solution of methimazole and 
bomhydride in toluene until reflux. 
Some analogues of the Tm ligand with thioimidazole derivatives can be 
synthesised by heating a mixture of a substituted thioimidazole and sodium 
borohydride in toluene under reflux.9 
1.3.2. Tm Wand derivatives 
Derivatives of the Tin ligand can be obtained by replacing and/or 
functionali.zing the N-methyl group and the 4- and 5- positions of the methimazole 
ring, or the boron central atom. The ten possible sites which can allow modifications 
on the Tin ligand are represented m Fig. 1.4. 
ss 
[R T 	" 
Fig.1.4. Substitutable positions on the Tm ligand structure and respective 
abbreviation system. 
There are many examples of Tin ligand derivatives using methimazole 
analogues with different alkyl and aryl groups instead of the N-methyl group. Some 
of these methimazole derivatives used for the synthesis of Tin ligand analogues are 
displayed in Fig. 1.5. The common abbreviation for these analogues is TmR,  where R 
is the substituent of the thiolmidazole nitrogen atom. 
7 
Boron-centred ligands with thione donors 
R— 	 R 666&o' 
Me 	Et 	tBu 	Cy 	 Bz Ph p-ToI Mes o-An 
Ref 	4 10 11,12 13 10,9 	14 	9 	12 	15 
Fig. 1.5. Tm iigand derivatives with 1-R-imidazole-2-thiones. 
Usually, the 1-R-imidazole-2-thiones are easy to synthesize or are 
commercially available which makes them an interesting replacement for 
methimazole in the Tin ligand. The ligands synthesized with the imidazole-2-thiones 
may present different stenc properties depending on the size of the R group which 
affects the encapsulation of the metal upon complexation. The creation of a cavity 
which can accommodate the metal centre is an attractive feature explored when this 
ligand system is applied to modelling metalloenzyme sites. 
The 1-R-imidazole-2-thiones can also accommodate different groups on the 
4- and 5- positions such as 1.3 and 1.4 shown in Fig. 1.6.. 
8 








Fig.1.6. Methimazolefunctionalized in the 5-position by piperazine derivatives: 1- 
methyl-5-[4-(2 '-methoxyphenyl)-1-piperazinyl)carbonyl]-imidazole-2-thione 1.3 and 
1-methyl-5-[4-(2 '-methoxyphenyl)-1-piperazinyl)methyl]-imidazole-2-thionel.4.' 6 
As shown on Fig. 1.4, it is also possible to replace the hydride on the boron by 
alkyl or aryl groups without affecting the overall negative charge of the ligand. The 
first synthesis of a ligand with a different group on the boron instead of the hydride 
was reported by Santos and co-workers. They used methyl and phenyl groups to 
functionalize the boron atom by synthesising the ligands for precursors RB(OH)2 
(Scheme 1.4). ' 
S 
+LjAIH4 	
+ 3 N R NH 
R'B(OH)2 	 Li[RBH3] 	
- 3H2  










Scheme 1.4. Synthesis of LiRTm?e  1.5 reported by Santos and co-workers. 
17 
Other groups have been used to replace the hydride on the boron central atom 
of the Tm ligand, giving rise to ligands such as nBuTmMe and p-FC6H4Tm. 3 Other 
Boron-centred ligands with thione donors 
approaches, such as the oxidative reaction of metallaboratranes was also used to 
insert groups, such as Cl or Br or an alkoxide group on the boron central atom. 
18,3 
The functionalization of the boron atom on the Tm framework with neutral 
N-donors to form new neutral ligands was reported by Bailey's research group. 19 The 
introduction of these zwitterionic ligands also brought to light a new synthetic 
method to generate Tm ligand analogues from tris(dimethylamino)borane. With this 
new synthesis, neutral tris(methiinazolyl)borate derivatives can be obtained through 
a one-pot reaction with N-donor, B(NtvIe2)3 and methimazole in a 1:1:3 ratio in a 
toluene solution heated under reflux to obtain the product in high yield (more than 80 





Fig. 1.7. Neutral boron-centred tripodal ligand [(N- 
methylimidazole)B(methimazolyl)] 1.6 introduced by Bailey. 19 
It is also possible to obtain ligands with a similar backbone structure as Tm 
by using other five-membered ring heterocycles with thione functions such as 
thiazolidine-2-thione7 (1.7), 1 ,2,4-triazole-5-thione 2° (1.8) or 1,3 ,4-thiadiazole-2-
thione2' (1.9) and 1-methyl-5-thiotetrazole 22 (1.10) (Fig. 1.8). However, some of 
these heterocycles (1.8 and 1.9) can provide boron-centred tripodal ligands with the 
10 
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ability to coordinate through two different donor atoms (sulphur or nitrogen). More 
detail of these ligands and examples of complexes needed. 
S 






1.8 	 1.9 	 1.10 	 1.11 
R = H or Me 
Fig.1.8. Range of other heterocycles which can be used in the synthesis of Tin ligand 
derivatives. 3 
Recently, it was reported the synthesis of a new boron-centred tripodal ligand 
with thione donors using 2-mercaptopyridine. This new ligand was prepared by 
heating under reflux a xylene suspension of potassium borohydride and 2-
mercaptopyridine (Scheme 1.5). 23  
/XyIen 






Scheme 1.5. Synthesis of hydrotris(2-thiopyridone) borate (Tmp) ligand reported by 
Owen. 23 
11 
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The 2-mercaptopyridine presents two tautomeric forms, the thione and 
thio late. The thione form provides more electron density on the sulphur which can 
enhance the donor properties of the ligand (Fig 1.9). 
O < N 	S. 	 N 	S 
2-thiopyridone pyridine-2-thiolate 
Fig. 1.9. Resonance structures present on 2-mercaptopyridone. 23 
The anionic Tmp ligand can also present two resonance forms, as the 
negative charge can be on one of the sulphur donors or on the boron central atom. 
Fig.!. 1 0.23 However, Owen observed by '3C NMR and X-ray single crystal 
diffraction that K[Tmp] structure presents thione donors which shows that the 




Fig. 1.10. Resonance forms present on Tmp ligand 23 
As the negative charge of Imp ligand can be on the sulphur, the B-H bond 




1.4. COORDINATION CHEMISTRY 
1.4.1. Symmetry of metal complexes 
The [(Tm)ZnBr] was the first complex of the Tm ligand reported by 
Reglinski. 4  In this complex it was possible to observe that this tridentate ligand forms 
a C3-symmetric complex with a "propeller-like" conformation. 4 Fig. 1.11 shows a 







1.13 	 1.14 
Fig. 1.11. Structures of[zn(Th/e)B r] and [Ti (Tm) 2]  reported by Reglinski and 
Spicer 
425 
The Tm ligand differs from the Tp ligand system by the insertion of 
hexocyclic sulphur donor atoms on the methimazole ring. This results in the 
formation of eight-membered rings upon complexation instead of the six-membered 
rings formed in complexes with tris(pyrazolyl)borate (Tp) ligands. The Tm ligand 
complexes present C 3-symmetry due to twisting  of the chelate rings to minimize 
angle-strain and maximize the 7t overlaping. This contrasts with the C 3,-symmetry 
presented by the tridentate Tp ligand metal complexes (Fig. 1.12). 
13 
- Metal Center 	 N 
- Boron Central Atom 
N 16 N N 
C N 	 101, 	 MTp 





Fig. 1.12. Symmetry d ifferences between Tp and Tin metal complexes. 
The helical rotation around the H-B M axis of the tndimensional-cage 
structure present on the Tm ligand complexes generates tw) enantiomeric 
conformations (Fig. 1.13). 
CI  N ~__S ~ sj 
0 - Boron Central Atom 
4 - Metal Center 
Fig. 1. 13. Rotational enantiomers ofMTm complexes. 
The crystal structures of these complexes show the presence of the two 
enantiomers. In solution it is possible to observe the racemisation process of TmR 
complexes presenting diastereotopic CH2 protons adjacent to N in the 1-position of 
methimazole through 'H NMR analysis. The racemisation of the complexes can 
occur by two different mechanisms: a non-dissociative mechanism and a dissociative 
mechanism (Fig. 1.14). 
14 
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Non-dissociative racemization 
tB73 	 B- 
	




Fig. 1.14. Two possible racemization processes of metal complexes with TmR 
ligands.26 
The chirality of these Tm ligand systems will be discussed in more detail in 
the introduction to Chapter IV. 
1.4.2. Donor properties 
The presence of three 	sulphur donor atoms 	in the 
hydrotris(methimazolyl)borate ligand makes it a "softer" derivative of the ubiquitous 
hydrotris(pyrazolyl)borate (Tp) with its set of three hard nitrogen donors. A good 
example of the different hard-soft properties of these ligands was demonstrated by 
Reglinski and collaborators through a sequential reaction of BiC1 3 with NaTm and 
NaTp (Scheme 1.6) .27  The complex {Bi(Tm) 21[Na(Tp)2f was obtained showing the 
soft sulphur donors of Tm coordinated to the bismuth and the hard nitrogen donors of 
Tp coordinated to the sodium (Fig 1.13) showing the coordination preferences of 
both ligands. 27 
15 
B 
_ _ S:HS 
QC[/ 
Cl 	 +2NaTp 2 NaTm+ BiCI 2 Naw.  Tm2BiCI 	
NaCI sçs)/ 	'(IIIN\II)N 
H 
1.15 
Scheme 1.6. Sequential reaction with hard and soft donor ligands reported by 
Reglinski. 27 
The result of the reaction presented in Scheme 1.6 was also confirmed by ab 
initio calculations of the complexation energies for NaTp and NaTm, which showed 
a lower energy for the formation of the sodium tris(pyrazolyl)borate complex. 8 This 
confirms the softer donor character of the Tm ligand. 
1.15 
Fig.1.15. Structure of[Bi(rm) 2J[Na(4')2J reported by Reglinski. 27 
16 
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Since its introduction, the Tm ligand has been related with other 6& face- 
capping ligands, such as, the well known Tp and Cp (cyclopentadienyl) ligands. The 
donor properties of these ligands can be determined by observing the IR carbonyl 
stretching bands of similar metal carbonyl complexes of these ligands. This was 
achieved by comparison of the carbonyl stretching frequencies in tungsten carbonyl 
complexes [LW(CO)31] with the Tm, Tp and Cp ligands (Table 1.1).28 
Table 1.1. C-O stretching frequencies for /L W(CO)31] complexes with Cp, Tp and 
TM ligands. 28 
Complex u(CO) / cm' 	Ref. 
[CpW(CO)31] 2030 	1944 	1936 	
29 
[TpW(CO)31] 2021 1942 1904 	
30 
[TmW(CO)31] 2004 	1916 	1902 
Observing Table 1.1., it is possible to order the ligands in a series of 
decreasing donor strength as: Tm - Tp - Cp. In this series, Tm ligand is the 
stronger donor due to its sulphur lone pairs sr-donation to the metal centre. However, 
the it-donation from the Tp ligand to the metal centre is very small which is related to 
its strong or-donation from the pyrazole nitrogen atoms. The Cp is the worst donor of 
this series as it acts as a a-acceptor and competes with the carbonyl groups for 
electron density and therefore the C-O stretching energy for [CpW(CO)31] is high.28 
The strong -r-donation of the Tm ligand to the metal centre was also observed in 
other carbonyl complexes with metals such as, molybdenum, 31  tungsten, 31 rhemum 32 
and manganese. 33 
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Another important aspect to describe the Tm ligands is its ligand-field 
properties. The magnetic behaviour of three sandwich-type complexes of Fe(R) with 
Tm, Tp and Cp (ferrocene) showed how different these complexes can be in terms of 
ligand field splitting. For instance, [Fe"(Cp)2] (ferrocene) is a low-spin diamagnetic 
complex while [Fe"(Tp)2] shows spin crossover properties 34 and [Fe11(Tm)2] has a 
high spin paramagnetic d 6 iron (11) . 3'  This indicates that the order of these ligands in 
the spectrocheniical series is Cp > Tp> Tm. 35 ' 36 
The spectroscopic analysis of the distorted octahedral [Ni(Tm) 2] complex 
showed that hydro(trismethimazolyl)borate generates a weak ligand field with an 
estimated Dq of 816 cm'. This estimation allowed the placement of Tm ligand 
between the Cl - (Dq = 680 cm') and the H20 (Dq = 850 cm') ligands in the 
spectrochemical series. 35 ' 3 
1.4.2.1. Donor properties of neutral RTm ligands 
The synthesis of analogues of Tm ligand with replacement N-donor 
substituents on the boron is the focus of this thesis. The insertion of these groups on 
the boron neutralizes the charge of the anionic Tm and can change its donor 
properties upon coordination to a metal centre. The effect of the insertion of different 
donors in boron-centred ligands can be illustrated with the comparison of the CO 
stretching frequencies of different manganese(I)triscarbonyl complexes with anionic 
and neutral pyrazolyl tripodal ligands (Table 1.2). 
18 
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Table 1.2. CO stretching frequencies of manganese tricarbonyl complexes with 
anionic and neutral pyrazolyl tripodal ligands 
Complex 
Uco/Cm' Medium Ref. 
[HB(3,5-Me2pz)31Mn(CO)31 2023,1912 KBr 
37 
[HB(pz)3 }Mn(CO)31 2036, 1932 MeCN 
38 
[{ 1 -methy1imidazole)B(pz) 3 }Mn(CO)3} 2041, 1941 MeCN 39 
[{HC(3,5-Me2pz)3}Mn(CO)3] 4 2044, 1949 C11202 
40 
[(HC(J)z)3 )Mn(CO)3 1 2051, 1956 C11202 40 
It is possible to observe on Table 1.2. that the anionic pyrazolyl ligands 
generate neutral complexes whereas neutral ligands, such as [1-
methylimidazole)B(pz)31 forms catiomc complexes. The CO stretching frequencies 
of an anionic complex are expected to be lower than in the neutral complex, as in the 
latter the positive charge of the metal will affect directly the attached carbonyl 
ligands. This is also verified by the 1R data on Table 1.2, as the donor strength of the 
ligand decreases if its negative charge is neutralized by the insertion of another group 
on the boron tripodal central atom. Replacing the boron atom by a carbon atom on 
the tripodal ligand not only affects the electronic charge of the ligand but also its 
electron donation to the metal. By comparison of CO stretching energies of the 
complexes [(HB(pz) 3 )Mn(CO)3] and [(HC(pz)3 )Mn(CO)31 it is possible to note a 
decrease of electronic donation to the metal from the neutral complex as indicated 
by the higher CO stretching frequency. Moreover, the insertion of an N-donor, as 1-
methylimidazole, on the boron bridgehead in the Tp ligand structure also decreases 
the donor strength of this anionic ligand. This can be observed by comparison 
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between the two CO stretching frequencies on [{HB(pz)3}Mn(CO)3] and [(1-
methylimidazole)B(pz)3}Mn(CO)31. With the data on Table 1.2, it is possible to 
place the ligand [I 1 -methylimidazole)B(pz)3 } between the anionic Tp and the neutral 
[(HC(pz)3 )Mn(CO)3]4 according to its donor properties. This can be due to the 
stabilization of the positive charge on the 1 -methylimidazole ring which is located 
away from the metal. In the tris(pyrazolyl)methane ligands this charge localization is 
not possible which makes them the weakers donors than the other ligand on Table 
1.2. 
A similar situation is observed for the methimazolyl ligands, as the CO 
stretching frequencies of manganese(I)tricarbonyl complexes with the neutral ligand 
[(N-methylimidazole)B(methiniazolyl)3] was compared to the anionic Tm ligand by 
JR spectroscopy. This JR data is displayed in Table 1.3. 
Table 1.3. C-U stretching frequencies for manganese (I)triscarbonyl complexes with 
Tm and [(N-methylimidazole) Tm ligands. 
\ 
H C) I 
B- 












u(C-O) I cm' 	2003, 1905 2007, 1914 
Medium 	 Toluene Acetomtrile 
Ref. 	 41 	 39 
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Observing Table 1. 3, it is possible to see that the anionic Tm is only a slightly 
stronger donor than the neutral ligand, indicating that the interaction between the 
positive charge on N-methylimidazole and the metal centre is very small. This is 
possibly caused by the delocalisation of the azole charge within the ring as shown on 








Fig.1.16. Localization of the charge on N-methylimidazole in the neutral boron- 
centred tripodal ligand.39 
1.4.3. Coordination modes 
The tris(methimazolyl)borates have shown great flexibility of coordination 
and have been found to adopt six different coordination modes (Fig. 1.17). This 
versatility of coordination gives this ligand system a range of alternative steric and 
electronic properties which can be explored for different applications. 
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Fig.1.17. Possible coordination modes of boron-centred tripodal ligands with thi one 
donors ligand. 
There is a wide range of complexes reported where these boron-centred 
ligands present these different types of coordination and it is interesting to consider 
the possible metal geometries that can be found in some of these metal complexes. 
1.4.3.1. ic3-S,S,S coordination mode 
The most common complexes of the RTm ligand present the three sulphur 
atoms coordinated to the metal centre in a x'-S,S,S coordination. The coordination 
through three sulphur donors is the most expected pre-organization of these ligands. 3 
The tris(methimazolyl)borates can form bis-ligand complexes, when two Tin 
units coordinate in a k-3-SAS fashion to a metal centre in an octahedral S6 
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coordination sphere. In the literature, it is possible to find [M(TM)21' -  complexes 
With In(ffl)'42,fl(UI)'21  Sn(IV),43 As(ffl), Bi(ffl), 42 Fe(ll)," and Ni(ll). 35 A bismuth 
complex of this type was displayed on the Fig.!. 15. It is also common to find 
octahedral complexes were one tris(methimazolyl)borate occupies three positions of 
the coordination sphere. [Mn(Tm)(CO)3], [Ru(Tm)(p-cymene)]Cl and [Ru(Tm)(Cp)] 
are some examples of complexes that were previously reported and Studied.  '°' 45' 33 It 
was observed that complexes of these tridentate ligands with tungsten can form a 
seven coordinate complex, [W(Tm)(CO) 31] (Fig. 1.1 8).28 
Tetrahedral complexes of zinc bearing the tridentate Tm' ligands have also 
been reported as they have been shown to have some applications as metallo enzyme 
mimics. 46 
1.18 
Fig. 1.18. Structure of the seven coordinate complex [W(Tm,('CO) 3
11 28 
1.4.3.2. x2-SS coordination mode 
The tris(methimazolyl)borate also can coordinate by two sulphur donors as a 
4e donor ligand, an example of this coordination mode is the tellurium complex 
[Te(Ic2-S,S-Tm)21. This complex has a distorted square-planar geometry as shown in 
Fig. 1.19. This geometry has previously been observed in other Te(ll) complexes with 
thione donors. 47 
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1.19 
Fig. 1. 19. Structure of[Te(r?-S,S-Tm)2]. 47 
The square-pyramidal antimony complex, [Sb(x-S, S, S-Tm)(K2-S, S-Tm)]Tm, 
has two Tm ligands coordinated in K2 and i< modes and a third Tm unit is present a 
the counter anion (Fig.l.2O). 
01 
1.20 
Fig. 1.20. Structure [Sb(r-S, S, S-Tm) (?-S, S-Tm)]Tm. 48 
1.4.3.3. ic1 - S coordination mode 
The tris(methimazolyl)borates can also bind to a metal centre by only one 
sulphur donor in a x'-S fashion. This coordination mode is not very common 
amongst these ligands and the tetra coordinated tin complex [Ph 3 Sn(K 1 -S-Tm)] and 
[Ag(PhTm)(PPh3)] are the few examples that can be found in the literature. 49,50 
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1.4.3.4. 10-H,S,S and x2-HS coordination modes 
The B-H in hydrotris(methimazolyl)borates can be close to the metal centres 
creating aM ... H-B interaction. It is difficult to evaluate the nature of this "bond" and 
it is many times referred as an agostic bond. Although, agostic is a term that is 
generally used to describe M H-C interactions, it may not be most appropriate to 
describe the M" H-B interaction. Recently, Spicer and Reglmski 3 introduced a 
classification system where these interactions are classified into three types. These 
classes are defined by & which is the difference between the observed M H 
distance (d(M" H)) and the sum of the metal and hydrogen covalent radii (r) 
(Equation 1.1). 
& = d(M• 'H) - (r(M) + r(H)) 
	
Equation 1.1 
The first type of M' H interaction is when the metal and the hydride are 
close (& < 0.25 A). When, Ar is between 0.25 A and 0.75 A the interaction M . 
is of the second type and finally all other complexes that present longer interactions 
(0.75 <Ar) belong to the third type .3  This classification system quantifies the M 
B interaction and allows the understanding of the nature of this "bond" as resultant 
from 3-centre 2 electron bond or dependant of electrostatic or stenc factors. 3 Fig. 1.21 




1.21 	 1.22 	 1.23 
Ru(Tm)(PPh3)(CO)H] 	[Ag(TmXPCy3)] 	 [Fe(Tm")] 
Fig. 1.21. Complexes with tris(methimazoly!)borates presenting is-H, S, S 
coordination. 51-5-3  
From the complexes showed in Fig.1.21, the octahedral complex 
[Ru(Tm)(PPh3 )(CO)H] presents a M H-B interaction of the first category with 
short distance between the ruthenium and the hydride. 5 ' The other to complexes in 
Fig. 1.21 display M" H-B interaction of the second type. ' 3' 53 The Tm' ligands can 
also coordinate in a ic 2-H,S mode however complexes with this type of coordination 
are rare. 
1.4.3.5. k3-BSS and k4-B,S,S,S coordination modes 
The formation of complexes with tris(methimazolyl)borane coordinated in a 
K3-B,S,S or a ic4-B,S,S,S mode can occur when the boron loses the hydride during the 
complex synthesis. This has been shown to occur during the reaction of 
[Ir(PPh3)2(CO)CI] with KTm' generating { [(ic3 -B, S, S-B(mt)3]Ir(PPh3)(CO)H} . 
The synthesis of this complex involves the metathesis of Cl by the 
tris(methimazolyl)borate and the cleavage of the B-H bond to allow the formation 
the M—*B interaction. The type of structure formed has been named as 
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metallaboratranes. 54 
A metallaboratrane is formed by the coordination of the three sulphur atoms 
of the t ris(methimazolyl)borateS and a dative bond between the boron and the metal 
centre and presents a structure with three five membered chelate rings. These types 
of complexes with Rh(1),55' 14 Ir(I), 5 Ru(ll), 56  Os(0) " and other platinum group 
elements have been reported and studied. An example of a ruthenaboratrane structure 
is displayed in Fig. 1.22. 
1.23 
Fig. 1.22. Structure of[Rufr4-B(m(3) (PPh3) (C0)].58 
The nature of the M—B interaction was investigated using computational 
methods and it was observed that in a metallaboratrane the metal has a d 6 
configuration instead of the expected d 8  configuration according to the metal 
oxidation number. Parkin's studies of M—B bonding in the metallaboratrane 
1[(,K4_ 
B(Mt)3]lr(PPh3)CI) showed that there is a 3-centre 4-electron interaction between Cl-
Ir-B orbitals resulting in decrease of 2 electrons in the metal d 8 electron orbital 
configuration. 14 
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1.5. CONCLUSION 
Since it was introduced the  tris(methimazolyl)borates have been used to 
model sulphur-rich metalloenzyme sites. 59' 46  Technetium complexes with this ligand 
system have been studied and applied as radiopharmaceutical drugs. 17326o The 
application of the Tm ligand in surface coatings has also been reported. 6 ' Other 
applications of this ligand in mass spectrometry of organometallic analytes 62 and in 
catalysis have as well been investigated. 63 
Due to the particularly large variety of coordination modes, 
tris(methimazolyl)borate ligands have the ability to "tune" the metal centre in terms 
of geometry and/or electronic and stenc properties. Thus, its uses are very diverse 
making this system attractive and applicable in different areas of chemistry. 
28 
Boron-centred ligands with thione donors 
REFERENCES 
S. Trofirnenko, .1. Am. Chem. Soc., 1966, 88, 1842. 
S. Trofimenko, Scorpionates: The Coordinational Chemistry of 
Polypyrazolylborate Ligands, Imperial College Press, London, 1999. 
Ni D. Spicer and J. Reglinski, Eur. I Inorg. Chem., 2009, 1553. 
M. Garner, J. Reglinski, I. Cassidy, Ni D. Spicer and A. R Kennedy, Chem. 
Commun., 1996, 16, 1975. 
A. Biemat, M Schwalbe, D. Wallace, J. Reglinski and M D. Spicer, Dalton 
Trans., 2007, 2242. 
Ni Garner, D. R- Armstrong, j. Reglinski, W. E. Smith, R- Wilson and J. R 
McKillop, Bioorg. Med. Chem. Lett., 1994, 4, 1357. 
J. F. Ojo, P. A. Slavin, J. Reglinski, M. Garner, Ni D. Spicer, A. it Kennedy 
and S. J. Teat, Inorg. Chim. Acta, 2001, 313, 15. 
J. Reglinski, MI. Garner, I. D. Cassidy, P. A. Slavin, IVL D. Spicer and D. it 
Armstrong, J. Chem. Soc., Dalton Trans., 1999, 2119. 
S. Bakbak, V. K Bhatia, C. D. Incarvito, A L. Rhemgold and D. Rabinovich, 
Polyhedron, 2001, 20, 3343. 
P. J. Bailey, A. Dawson, C. McCormack, S. A. Moggach, D. H Oswald, S. 
Parsons, D. W. H Rankin and A. Turner, Inorg. Chem., 2005, 44, 8884. 
D. J. Mihalcik, J. L. White, J. Ni Tanski, L. N. Zakharov, G. P. A. Yap, C. D. 
Incarvito, A. L. Rheingold and D. Rabinovich, Dalton Trans., 2004, 1626. 
M Tesmer, MI. Shu and HI. Vahrenkamp, Inorg. Chem., 2001, 40, 4022. 
M Ni Ibrahim, MI. Shu and H. Vabrenkanip, Eur. J. Inorg. Chem., 2005, 
2005, 1388. 
29 
Boron-centred ligands with thione donors 
C. Kimblin, B. M Bridgewater, D. G. Churchill and G. Parkin, Chem. 
Commun., 1999, 2301. 
J. Seebacher, M. Shu and H Vahrenkamp, Chem. Commun., 2001, 1026. 
it Garcia, Y. H Xing, A. Paulo, A. Dommgos and I. Santos, J. Chem. Soc., 
Dalton Trans., 2002, 4236. 
it Garcia, A. Paulo, A. Domingos and I. Santos, Dalton Trans., 2003, 2757. 
J. S. Figueroa, J. G. Melnick and G. Parkin, Inoi. Chem., 2006, 45, 7056. 
P. J. Bailey, D. Lorono-Gonzales, C. McCormack, F. Milhican, S. Parsons, R. 
Pfeifer, P. Pinho, F. Rudoiphi and A. S. Perucha, Chem. Eur. J., 2006, 12, 
5293. 
P. J. Bailey, M Lanfranchi, L. Marchio and S. Parsons, Inorg. Chem., 2001, 
40, 5030. 
it lvi. Silva, C. Gwengo, S. V. Lindeman, M D. Smith and J. it Gardinier, 
Inorg. Chem., 2006, 45, 10998. 
Y. -L. Wang, R. Can and W. -H Bi, Polyhedron, 2005, 24, 585. 
G. Dyson, A. Hamilton, B. Mitchell and G. it Owen, Dalton Trans., 2009, 
6120. 
G. it Owen, P. H Gould, J. P. H. Charmant, A. Hamilton and S. Saithong, 
Dalton Trans., 2010, 39, 392. 
P. A. Slavin, J. Reglinski, M. D. Spicer and A. it Kennedy, .1. Chem. Soc., 
Dalton Trans., 2000, 239. 
P. J. Bailey, D. Lorono-Gonzales, C. McCormack, F. Milhican, S. Parsons, it 
Pfeifer, P. P. Pinho, F. Rudoiphi and A. S. Perucha, Chem. Eur. J., 2006, 12, 
5293. 
30 
Boron-centred ligands with thione donors 
J. Reglinski, M. D. Spicer, M. Gamer and A. R. Kennedy, J. Am. Chem. Soc., 
1999, 121, 2317. 
M Garner, M. -A- Lehmann, J. Reglinski and M D. Spicer, Organometallics, 
2001, 20, 5233. 
K H Hill, A. Becaiska and N. Chiem, Organometallics, 1991, 10, 2104. 
H P. Kim, S. Kim, K A. Jacobson and K J. Angelici, Organometallics, 
1986, 5, 2481. 
M. K Foreman, A. F. Hill, A. J. White and D. J. Williams, Organometallics, 
2003, 22, 3831. 
K Garcia, A. Paulo, A. Domingos and!. Santos, I Organomet. Chem., 2001, 
632, 41. 
L. A. Graham, A. K Fout, K it Kuehne, J. L. White, B. Mookheiji, F. M. 
Marks, G. P. A. Yap, L. N. Zakharov, A. L. Rhemgold and D. Rabinovich, 
Dalton Trans., 2005, 171. 
J. P. Jesson, S. Trofimenko and D. K Eaton, I Am Chem. Soc., 1967, 89, 
3158. 
M. Garner, K Lewmski, A. Pattek-Janczyk, J. Reglinski, B. Siekiucka, M D. 
Spicer and M. Szaleniec, Dalton Trans., 2003, 1181. 
M. Schwalbe, P. C. Andrikopoulos, D. K Armstrong, J. Reglinski and M D. 
Spicer, Eur. I Inorg. Chem., 2007, 1351. 
J. E. Joachim, C. Apostolidis, B. Kanellakopulos, K Maier, N. Marques, D. 
Meyer, J. Muller, A. Pires de Matos, B. Nuber, J. Rebizant and M. L. Ziegler, 
.1. Organometal. Chem., 1993, 448, 119. 
31 
Boron-centred ligands with thione donors 
J. Ii MacNeil, A. W. Roszak, M C. Baird, K F. Preston and A. L. 
Rheingold, Organometallics, 1993, 12, 4402. 
P. J. Bailey, L. Budd, F.A. Cavaco, S. Parsons, A. Sanchez-Perucha and F. 
White, Chem. Eur. J., 2010, 16, 2819. 
D. L. Reger, T. C. Grattan, K J. Brown, C. A. Little, J. J. S. Lamba, A. L. 
Rheingold and R. D. Sommer, I Organometal. Chem, 2000,607, 120. 
P. J. Bailey, D. J. Lorono-Gonzales, C. McCormack, S. Parsons and M Price, 
Inorg. Chim. Acta, 2003,354, 61. 
C. A. Dodds, J. Reglinski and M. D. Spicer, Chem. Eur. J., 2006, 12, 931. 
C. Kimblin, B. M. Bridgewater, D. G. Churchill, T. Hascall and G. Parkin, 
Inorg. Chem., 2000, 39, 4240. 
C. A. Dodds, M. Jagoda, J. Reglinski and M D. Spicer, Polyhedron, 2004, 
23,445. 
P. J. Bailey, D. J. Lorono-Gonzales, C. McCormack, S. Parsons and M Price, 
Inorg. Chim. Acta, 2003, 354, 61. 
G. Parkin, New J. Chem., 2007, 31, 1996-2014. 
C. A. Dodds, A. R. Kennedy, J. Reglinski and M. D. Spicer, Inorg. Chem., 
2003, 43, 394. 
C. A. Dodds, J. Reglinski and M. D. Spicer, Chem. Eur. J., 2006, 12, 931. 
A. F. Hill and M. K Smith, Chem. Commun., 2005, 1920. 
D. Wallace, E. J. Quinn, D. R. Armstrong, J. Reglinski, M. D. Spicer and W. 
E. Smith, Inorg. Chem., 49, 1420. 
M. R Foreman, A. F. Hill, G. K Owen, A J. P. White and D. J. Williams, 
Organometallics, 2003, 22, 4446. 
32 
Boron-centred ligands with thione donors 
C. Kimblin, D. G. Churchill, B. Ni Bridgewater, J. N. Girard, D. A Quarless 
and G. Parkin, Polyhedron, 2001, 20, 1891. 
C. Santini, C. Pettinari, G Gioia Lobbia, R. Spagna, M Pellei and F. 
Vallorani, Inorg. Chim. Ada, 1999, 285, 81. 
V. Landry, J. G. Melnick, D. Buccella, K Pang, J. C. Ulichny and G. Parkin, 
Inorg. Chem., 2006, 45, 2588. 
I. it Crossley, Ni it Foreman, A. F. Hill, A. J. P. White and D. J. Williams, 
Chem. Commun., 2005, 221. 
MitS.J. Foreman, AF. Hill, G.R Owen, AJ.P. White and DJ 
Williams, Organometallics, 2003, 22, 4446. 
Ni it Foreman, A F. Hill, A J. P. White and D. J. Williams, 
Organometallics, 2004, 23, 913. 
A F. Hill, G. it Owen, A. J. P. White and D. J. Williams, Angew. Chem. mt. 
Ed., 1999, 38, 2759. 
J. G. Melnick and G. Parkin, Science, 2007,317, 225. 
it Garcia, A. Paulo, A. Domingos, I. Santos, K. Ortner and it Alberto, J Am. 
Chem. Soc., 2000, 122, 11240. 
J. Reglinski, M. D. Spicer, J. F. Ojo, G. D. McAnally, A. Skorska, S. J. Smith 
and W. E. Smith, Langmuir, 2003, 19, 6336. 
Ni F. Wyatt, B. K Stein and A G. Brenton, Anal. Chem., 2005, 78, 199. 




STUDIES INTO THE SYNTHESIS OF BORON-CENTRED TRIPODAL 
LIGANDS FROM TRIS(DIMEThYLAMINO)BORANE 
Studies into synthesis of boron centred tripodal ligands from tris(dimethylamiflO)borafle 
2.1. INTRODUCTION 
The synthesis of new tripodal ligands of the type [LB(Mt)31 (L = neutral 
Lewis base; mt = methimazolyl) with boron substituted by various nitrogen donors 
(L) is the aim of this work. These ligands can be synthesized via a "one-pot" 
reaction with tris(dimethylanhino)bOrafle, as mentioned in the previous chapter, or 
through substitution of the dimethylarnine in [(HNMe2)B(mt)3]. In this chapter, the 
results towards the study and development of the latter synthetic method will be 
presented and discussed. To support the understanding of this work, an introduction 
to the reactivity of tris(dimethylamino)borane and the synthesis of these ligands via a 
"one-pot" reaction will be presented. The application of a similar synthetic route to 
obtain [(L)B(pz)3] (pz = pyrazole) will also be included in this chapter. 
2.2. TRIS(DIMETHYLAMINO)BORANE 
The source of boron of the majority of the ligands synthesized and studied in 
this work was tns(dimethylamino)borane. In order to understand the [LB(mt)3] 
ligand system synthesis it is important to consider some structural features and 
reactivity of B(NMe2)3. 
X-ray diffraction and gas phase electron diffraction studies have shown that 
tris(dimethylamino)borane has 1)3 symmetry in which B-N3 is planar (Fig.2.1). 
Although, it was observed that two of the three diinethylamino groups of this 
compound can twist through a variable angle between 28 to 
350 (N(CH3)2 twist 
35 
angle)."2  This twist is due to the stenc strain relief of the amine groupes. The B-N 
bond lengths were found to be between 1.43-1.44(8) A, which is shorter than in 
tetrahedral borane compounds, such as H 3BNH3 where the B-N distance is 1.56 A." 3 
The short distance between the vacant p-orbital of the boron and the delocalized lone 
pairs of the nitrogen atoms creates a n-interaction. 
2.1 
Fig. 2.1. Structure of ,ris(dimethylamino)borafle 2.1. 
2 
NMR studies by Beckett and co-workers demonstrated that this B-N ir-
interaction decreases the Lewis acidity of tris(dimethylamino)bOrane relative to 
tris(methoxy)borane and trifluoroborane, and this can be understood in terms of the 
relative electronegativities of nitrogen, oxygen and fluor. 4 
Tris(dimethylamino)bOrafle can easily react with primary and secondary 
amines by transamination reactions to form tris(amino)boranes. 5  These reactions are 
facilitated by the fact that liberated dimethylamine gas is readily lost from the 
reaction, thus driving the equilibrium to the transamination product (Eq. 2.1 
)6 
B(NMe2)3 + 3 RNH 	B(NHR)3 + 3 HNMe2 (g) Eq. 2.1. 
36 
Other heterocyclic aminoboranes, such as that formed with 3,3,2-
diaminodipropylamlfle, can be obtained via the reaction with triamines, as 






H2N NH2 + N 	N 	3HNMe 
Scheme 2.1. Synthesis of]. 5, 7-iriaza-6-borabicyclo[4. 4. OJdecane from 
tris(dimethylamino)borane. 6 
Interesting work on the reactivity of B(NMe2)3 with pyridines and anilines 
was developed by Braun and NOth. They reported the synthesis of three 
tris(amino)boranes synthesized via transamination of tris(dimethylamino)bOrane with 
aniline, 2-aniinopyridine and 8-quinohnamine. For all these reactions the respective 
amine was reacted with tris(dimethylamino)borafle under reflux in toluene . 7' The 
structures of tris(anilino)borane 2.2, tris(2-pyridylamino)bOrafle 2.3, and tris(8- 
quinolinoamino)borane 2.4 are represented on Fig. 2.2.8 
08 
.c 
O N 2.2 	 2.3 	 2.4 
Tñs(anilino)boiwe 	Tris(2-p,Tidlarflino)bOfafle 	Tns(8-quino1nmifl0)b0raflO 
Fig.2.2. Trisaminoboranes synthesizedfrom trzs(dimethylamino)borafle(hydrOgefls 
are not shown). 8 
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Braun and NOth also investigated the reactivity of B(NMe2)3 with di(pyrid-2-
yl)amme 2.5 expecting to obtain bis(dimethylamino)di(PyridYl-2-Yl)borane 2.6 
(Scheme 2.3). This reaction was unsuccessful and the product formed was the 
heterocyclic 2aminopyridine(dimethy1aflhIflo)b0rafle 2.7 (Scheme 2.3). 
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Scheme 2.3. Product obtained and expected of the reaction of 
tris(dimethylamino)borane with di (pyrid-2-yl) amine. ' 
According to Braun and NOth, the mechanism of this reaction was different 
from the previous reactions with pryridines and anilines. In this case, the boron 
coordinates first with one of the pyridine nitrogen atoms instead of reacting with the 
nitrogen bearing the acidic N-H proton, which is less accessible sterically. 
Dimethylannne gas is formed and eliminated due to the formation of an N-H 
hydrogen bridge bond. The rotation of the C-N bond of the non-coordinated pyridyl 
moiety allows the cyclization and consequently formation of the six-membered ring 
anion. The electron delocalization of di(pyrid-2-yl)amine 2.5 also affects strongly 
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Scheme 2.4. Mechanism of the synthesis of the 2- 
aminopyridine(dimethylamino)borafle and the electron delocalization of di(pyrid-2- 
yl)amine reported by Braun and Nöth. 
When this 2aminopyridine(dimethylamiflO)bOrane reacts with aluminium 
trichioride one of the dimethylamine groups is easily removed. This may be due to 
the disparity of the B-N bond lengths of the dimethylamino groups which are 
different (1.63(8) A and 1.45(9) A), which may indicate a weaker B-N bond. This is 
observed in the structure of 2aminopyridine(dimethy1amiflO)bOrafle 2.7, also 
reported by Braun and NOth (Fig.2.3.). 7 
Sc 
Fig.2.3. Structure of 2aminopyridine(dimethylamiflO)borafle 2.7 reported by Braun 
and NOth (hydrogens not shown for clarity). 
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Niedenzu also investigated the reactivity of tris(dimethylamino)borane with 
pyrazole in the synthesis of pyrazaboles. In this work, B(NMe2)3 was reacted with 
different equivalents of pyrazole under benzene or toluene reflux where some 
dimethylamine gas evolution was observed. In the case of pyrazabole formation, the 
mixture was left reacting at room temperature until dimerization occured. The 
conditions of these reactions and the products obtained, dimethylamine-
tris(J)yrazolyl)borate 2.8 and two different pyrazaboles (2.9 and 2.10), are displayed 
in Scheme 2.5. 
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Scheme 2.5. Niedenzu reactions with B(NIVIe&3 and pyrazole. 9 
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According to Niedenzu, the driving force for these reactions is the formation 
of a very reactive tetrahedral intermediate, [(}{NMe2)(NMe2)B(PZ)2], that reacts 
readily with pyrazole in solution releasing dimethylamine gas. Niedenzu's work 
showed that it was possible to synthesize a tris(pyrazolyl)borate analogue from 
tris(dimethylaminO)bOrane. 
9,10 
2.3. SYNTHESIS OF LIGANDS OF THE TYPE [LB(MT)3] 
2.3.1. Ligand synthesis via a "one-pot" reaction: genesis and 
mechanism 
Tris(pyrazolyl)borate ligand derivatives with functionalized boron can be 
synthesized from boronic acids and boron trihalides." As mentioned previously, 
tris(dimethylamino)borane was used in the synthesis of [(HINMe 2)B(pz)3] 2.8 as 
reported by Niedenzu (Scheme 2.5). 9  It was observed in the low temperature 'H 
NMR spectrum that the dimethylamine N-H proton can interchange site between the 
NMe2 group and pyrazole nitrogen atoms, and the ligand can be represented as 
[(HNMe2)B(pz)3] or 1ff(NMe2)B(pz)3]. This is reinforced by its easy deprotonation, 
so when this ligand reacts with MeLi the lithium salt, Li[(NMe2)B(pz)3], is formed 
(Scheme 2.6). 12 
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Scheme 2.6. Synthesis of [(RNMe2)B(p43] 2.8 from B(NMe2,)3 and respective 
lithium salt reported by Niedenzu. 9"2 
This route was exploited by Bailey to obtain derivatives of the 
hydrotris(methimazolyl)borate (rm) ligand in which the boron bound hydride is 
replaced by alternative groups, [(L)B(Mt)31, as the synthesis of these ligands could 
not be achieved directly from [(H)B(mt)3] due to the strong covalent character of the 
B-H bond.'3' '' After establishing that [(HNMe 2)B(mt)31 could also be obtained by 
heating a solution of tris(dimethylamino)borafle and methimazole in toluene under 
reflux, Bailey and co-workers first attempted to prepare these derivatives of Tm was 
via N-H deprotonation of [(HNMe 2)B(mt)3] with a strong base followed by the 
addition of an electrophile in order to convert HNMe2 into a good leaving group 
which could be substituted by the desired groups (L) (Scheme 2.7). Despite the use 
of different bases (BuLi, MeLi, NaH, NaOMe, LDA) and electrophiles (Mel, 
Me3OBF4, MeCOC1, PhCOC1), this method failed as only methimazole and/or its 
derivative resulting from electrophilic addition could be isolated. The attempts to 
isolate the anion [(NMe2)B(mt)31 -  were also unsuccessful possibly due to product 
decomposition during the deprotonation step. 14 
—/ 
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Scheme 2.7. Synthetic approach attempted by Bailey and co-workers to obtain Tin 
ligand derivatives via deprotonation of the dimethylamine group in 
[(HNMe2)B(mt)3]. 14 
The ligand decomposition and consequent formation of the methimazolyl 
anion in the presence of a strong base suggests a weaker coordination of the 
methimazole rings to the boron than pyrazole under these conditions. This disparity 
is likely to be related to the stability of the anionic heterocycles anions and can be 
expressed by the acidic pK.1  which is a measure of its Brønsted acidity and therefore 
stability of conjugate base (heterocycle anion). Thus, methimazole (pKa = 12)' is 
expected to provide a more stable anion than pyrazole (pL= 14 in EtOHIH20).' 6 
Following these observations, Bailey and co-workers sought the reactivity of 
tris(dimethylamino)borane with a range of imidazoles. The different imidazoles used 
to react with the borane under toluene reflux are displayed in Table 2. 
1.14 
These reactions lead to the isolation of two different types of product: 
[(HNMe2)B(azolyl)3] 2.12 and H[B(azolyl)4] 2.13 (Scheme 2.8). The basic pKa of 
the heterocycles appeared to be the main feature which determines the outcome of 
these reactions. It was observed that azoles with basic pK a higher than -3 give the 
H[B(azolyl)4] 2.13 system and azoles with basic pK3 lower than -3 form 
[(HNMe2)B(azolyl)3] 2.12 (Scheme 2.8). 
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Table 2.1. Range of azoles reacted with B(NMe2)3 by Bailey and co-workers. 
14 
Azole Basic piCa Acidic pKa 
/ 
N 1 -methylimidazole-2-thione 
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Scheme 2.8. Influence of azole basic pKa and its reactivity with 
tris(dimethylamino)borane. 25 
44 
Studies into synthesis of boron centred tripodal ligands from tris(dimethylamino)bOrafle 
Bailey and co-workers initially explained these observations as resulting from 
a two step mechanism via a reactive intermediate. The first step in the formation of 
H[B(azolyl)4] 2.13 was proposed to be the formation a tetrahedral reactive 
intermediate [(azzle)B(NMe2)3] 2.14 (Scheme 2.9) by coordination of the azole to 
tris(dimethylamino)borafle. It was suggested that, despite the weak Lewis acidity of 
B(NMe2)3, the strong basicity of the azole (basic pKa higher than -3) enables its 
coordination. The formation of this tetrahedral intermediate [(aznie)B(NMe2)3] 2.14 
(Scheme 2.9) removes the N-B n-bonding within B(NMe2)3 and substantially 
increases the basicity of the NMe2 groups bound to the boron and these then react 
with the remaining azole heterocycle in solution through a transainination reaction to 
form the tetra(azolyl) system 2.13 (Scheme 2.9). This is analogous to the initial 
formation of [(HINMe2)(NMe2)B(PZ)2] proposed by Niezendu during the formation of 
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Scheme 2.9. Bailey and co-workers proposed mechanism for the reaction of strongly 
basic azoles with tris(dimethylamino)borane to afford a tetrasubstituted borane.' 4 
If the azole was not basic enough (basic pKa lower than —3, e.g. methimazole 
or pyrazole) it cannot coordinate to the borane to form the [(azole)B(NMe2)3] 2.14 
(Scheme 2.10) intermediate. In this case, transamination directly from B(NMe2)3 
proceeds to provide initially [(azolyl)B(NHMe2)(NMe2)2] and subsequently 
45 
Studies into synthesis of boron centred tripodal ligands from fris (dim ethylamino)borafle 
[(HNMe2)B(azolyl)3] 2.12 via subsequent transamination steps (Scheme 2.10); this 
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Scheme 2.10. Transamination reaction between methimazole and 
tris(dimethylamino)borane. 
In all of these reactions the reactivity of tris(dimethylamino)borafle with the 
basic azole heterocycles is affected by its weak Lewis acidity, as the boron p-orbital 
in the planar B(NMe2)3 is stabilized by B-N ir-bonding by donation of the nitrogen 
lone pairs to the boron. In this view of the mechanism, the strongly basic 
heterocycles may be regarded as activating the B(NMe2)3, as they form the reactive 
tetrahedral borane species to promote the reaction with the azoles. 
As a result of this interpretation, Bailey and his collaborators reported a new 
method to synthesize ligands of the type [LB(Mt)31 via a "one-pot" reaction. Through 
this method [(N-methylimidazole)B(methimazOlYl)31 could be obtained in high yield 
(yield> 80 %) from a mixture of tris(dimethylamino)borane, N-methylimidazole and 
methimazole in a 1:1:3 ratio in a toluene solution under reflux (Scheme 2.11). 
14 
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Scheme 2.11. The proposed two step mechanism of [(N-methylimidazOle)B(Fflt) 3] 
synthesis in a "one-pot" reaction reported by Bailey. 
14 
The idea behind this approach was that one equivalent of the strongly basic N-
methylimidazole would coordinate to B(NMe2)3 to form a more reactive 
intermediate, [(N-methylimidazole)B(NMe2)3] 2.15 (Scheme 2.11). Since N-
methylimidazole lacks an acidic proton, the transamination reaction only occurs 
when this intermediate reacts with the acidic N-H proton of methimazole to form 
[(N-methylimidazole)B(mt)3] 2.16. As dimethylamine was released from the 
reaction, the concentration of [(N-methylimidazOle)B(NMe2)31 2.15 in the mixture 
was very low and it was never possible to observe its presence by NMR analysis. 
The scope of this reaction with some different basic activators other than N-
methylimidazole was also studied by Bailey and Perucha, and further investigated 
through the work presented in this thesis. Perucha's results on the scope of basic 
activators of borane using this synthetic method are presented on Table 2.2.25 
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Table 2.2. Work developed by Perucha on the scope of neutral N donor heterocycles 
(L) as borane activators in the synthesis of fLB(mt)31! 
Heterocycles 
Pyridine I 8diazabicyc1o[5 4 0]undec-7-ene 	Triethylamine 
mhoxypyiidine 	4Y1ainmPY 	
(DBU) 
Basic 5.14 26 	6.2 	 9.2 	 12.0 29 	9.07 30 
 
)K 	(1120) 	(1120) (1420) (DM50) (DM50) 
Reactio 16h 	8h 	 6h 	 I 	
* 
n time 
No reaction due to steric effects 
In all these reactions the three components were combined in toluene solution 
and heated to reflux. The time until dimethylamine ceases to be evolved marks the 
time to reaction completion, at which point the product has generally precipitated 
from the reaction mixture. At first glance, these results indicate a correlation between 
the heterocycle basicity and reaction time, but this is not conclusive since no further 
kinetic studies with a wider range of borane activators were done. The reaction with 
triethylamine was not successful as only [(HNMe 2)B(mt)3] could be isolated in the 
end, despite its high basic pKa. This indicates that steric effects also affect the 
synthesis of these ligands through this route. It should be noted that in the absence of 
an "activating base" the reaction between B(NMe2)3 and methimazole proceeds to 
form [(HNMe2)B(mt)3] in 2 h. 
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2.3.2. Ligand synthesis via I(HNMe2)B(m031 
The aim of this work is the synthesis of chiral boron-centred tripodal ligands 
type [(L*)B(mt) 3] following the previous work of Perucha. However a more 
extensive study of the influence of the basic pKa of the bases used to activate 
tris(dimethylamino)borane and the outcome of these "one-pot" reactions showed that 
the mechanism explained above cannot be correct. As mentioned before, there is a 
correlation between the basicity of the borane activator and the reaction time, as 
stronger bases react readily with the borane decreasing the overall ligand synthesis 
reaction time. Consequently, the formation of the tetrahedral borane species with a 
strongly basic activator base appears to be the rate-determining step of this reaction. 
Comparing, the basic pKa of dimethylamine (pKa = 10•7)26 with some other borane 
activators, as 4-dimethylaminopyridifle (pL = showed that it could also 
activate the borane while it is present in solution during reaction. Besides, it was seen 
that when pyridine (pK3  = 5.14)3 ' acts as borane activator it takes around sixteen 
hours until no dimethylamine evolution ceases. In reactions with all other activating 
bases the products LB(mt)3 are obtained in a pure state, however the product of this 
reaction with pyridine is contaminated with [(HNMe 2)B(mt)3], which can be 
obtained after just a few hours of reaction. This was intriguing and the hypothesis 
that [(HNMe2)B(mt)3] could react with strong neutral N-donors (L) to afford the 
desired ligand type [(L)B(Mt)31 by direct substitution of its HNMe2 group was raised. 
Since [(HNMe2)B(mt)3] is formed in just 2 hours in the absence of an "activating 
base", the question arises as to why the slower reactions with activating base do not 
form products contaminated with this species. 
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In order to investigate this hypothesis, a series of ligands were synthesized 
by both methods: the "one-pot" reaction and from the reaction of [(HNMe 2)B(mt)3] 
with a strong base. An analysis of both synthetic methods and the discussion of the 
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Scheme 2.12. Proposed mechanism for the synthesis of these ligands. 
This investigation proved that it is possible to substitute the dimethylamme in 
[(HNMe2)B(mt)3] 2.11 with neutral nitrogen donors to obtain the desired neutral 
boron substituted ligand, [(L)B(Mt)31. Therefore, the previously reported mechanism 
has been shown to be erroneous and the proposed mechanism for this synthesis is 
represented in Scheme 2.12. 
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According to the results obtained, the first step of the synthesis of [(L)B(Mt)31 
from [(HNMe2)B(mt)3] is the formation of a neutral tetrahedral species 2.17, 
[(HNMe2)(NMe2)2B(methimaZolYl)] (Scheme 2.12) from a reaction between 
methimazole's acidic proton with one of the borane dimethylammo groups with 
coordination of the resulting methimazolyl group to boron. The borane thus loses its 
B-N it-bonding and changes its hybridization from sp2 to sp3. In the absence of an 
added base (L), this more reactive tetrahedral borane species reacts with two more 
equivalents of methimazole to affbrd the ligand [(HNMe 2)B(mt)3] by transamination 
reactions. In the presence of an added base, the dimethylamine group of one of the 
three tetrahedral borane intermediates (2.17, 218 or 2.11 on Scheme 2.12) can be 
replaced. Although this base substituted borane intermediate could not be isolated, 
the outcome of this reaction was the desired substituted neutral ligand. Whether the 
substitution of HNMe 2  can occur in the intermediates 2.17 or 2.18 could not be 
determined, however it was established that it can be achieved in [(HNMe 2)B(rnt)31 




Fig.2.4. Structure of dimethylamino-tris(melhimazolyl) borate 2.11 reported by 
Bailey (hydrogens atoms are hidden for clarity). ' 4 
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It has therefore been established that it is possible to substitute the HNMe2 in 
[(H1NMe2)B(mt)3] by another basic N-donor, providing a new route to obtain ligands 
of the type [(L)B(mt)3]. The substitution of HINMe2 of [(HNMe2)B(pz)3] has also 
been investigated and this is discussed in Section 2.7. 
2.4. ANALYSIS OF BOTH SYNTHETIC METHODS 
Both synthetic methods, the "one-pot" reaction (method 1) and the reaction of 
[(H1NMe2)B(mt)3] with added N-donor (method 2), are effective for the synthesis of 
[LB(Mt)31. The procedures are quite similar, as the products are obtained by heating 
the starting materials under reflux in a high boiling point solvent, usually toluene. 
Generally, the final product precipitates while the mixture is still heated under reflux 
or after cooling and can be recovered in high yield (more than 80%) and purity after 
filtration. 
Another common feature of these syntheses is their irreversibility due to the 
evolution of dimethylamine gas. This characteristic is important because it favours 
the formation of the boron functionalized Tm ligand analogue. During the reaction 
[(HNMe2)B(mt)3] and the final product are in equilibrium (Scheme 2.13). This 
equilibrium is shifted if dimethylamine gas is released from the reaction vessel, 
allowing the formation of the desired final product. It was observed that these 
reactions are faster when nitrogen is bubbled into the reaction vessel to sweep the 
HNMe2 away. This procedure assures the irreversibility of this reaction as it allows a 
better degasification of the mixture. The release of dimethylarnine facilitates the 
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monitoring of this reaction by testing the pH of the gases exhausted while the 
mixture is heated. 
NMe2 
/(C N >N 
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L = neutral N-donor 
Scheme 2.13. Species in equilibrium during the reaction of [(IINMe 2)B(mt) ] with a 
neutral N-donor (L). 
The position of the equilibrium represented on Scheme 2.13 will be 
determined by the nature of the added donor L, and may be correlated with its basic 
pKa as the reaction is favoured by the stronger donors (higher pKa). The basic pL of 
}INMe2 is 10.826 and thus its substitution with weaker bases (e.g. pyridine, pKa 5.14 
31)  would be unfavourable and provide a small value of K (Scheme 2.13). However, 
the loss of HNMe2 as a gas drives the reaction to completion. Since these reactions 
can be quantitative, the measure of accurate stoichiometric amount of starting 
materials favours the high purity of the final product, which can be obtained just by 
solvent removal or after washing the precipitated product with an inert solvent. 
2.4.1. Llaands synthesized by both methods 
In order to study and understand the synthetic methods a series of ligands was 
synthesized via both routes (Fig.2.5). This study started with the synthesis of 
previously reported ligands obtained by the "one-pot" reaction (method 1), [(N- 
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methylimidazole)B(metlUmarOlYD31 	2.16 	and 	[(4- 
dimethylaminopyridme)B(meth1maz0tYD31 2.20, but using 
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Fig. 2.5. Series of ligands synthesized 
Following Bailey's methods, [(dimethylamine)B(methllTlaZOlYD31 was 
obtained by heating under reflux a 1:3 mixture of tris(dimethylammo)borafle and 
methimazole in toluene. After a few hours, the product precipitated from the mixture 
and isolated by filtration, washed with diethylether, dried under vacuum and used as 
starting material for this work. 
The procedure used for both methods was very similar: heating under refiux a 
suspension of reactants in toluene. Although, during these reactions 
[(dimethylamine)B(methimazOlyl)3] never completely dissolves in the toluene, this 
solvent has been chosen for the base exchange reactions (method 2). Tetrahydrofuran 
and dichioromethane were also tried for method 2. Although 
[(dimethylamine)B(methimazOlyD31 is soluble in these solvents, the reactions were 
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very slow due to their lower boiling points and sometimes the final product was 
contaminated with starting materials. The results obtained with both synthetic 
methods are displayed on Table 2.3. 
For this study, the basicity was the main feature for selecting N-donors other 
than N-methylimidazole or 4-dimethylaminopyridine, but the possibility to use a 
chiral analogue of these bases was also important. 
The choice of 1,5-diazabicyclo[4,3,O]nOn-5-efle (DBN) for this work was 
based on previous work done by Perucha with 1,8diazabicyc1o[5.4.0]undeC-7-efle 
(DBU) and with a perspective to functionalize the boron with a chiral DBN 
analogue. 
Table 2.3. Results obtained for the synthesis of ligands of type [LB (mt) ] via 
method 1 ("one-pot" reaction) or by method 2 05 ,om a reaction of a base with 
[(HNMe2)B(mt)3]). 
Ligand Method 1 Method 2 
(product 




7.818 2.16 2 	71 3 	75 
DMF/H2O)________________________________________ 
1,5-diazabicyclo[4,3,O]non-5-me (DBN) 12.032 2.19 4 78 5 72 
4-dimethylammopyridine (DMAP) 9 . 2028 2.20 4 87 4 76 
Benzylamine 	 8.74 
33
2.21 	9 	54 	12 	40 
(McON/H 20) 
1,4-diazabicyclo[2.2.2]octane (DABCO) 	9.06 0 	2.22 	48 	83 	36 	78 
* As measured by the time of cessation of HNMe 2 formation. 
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The successful ligand synthesis with benzylamine (ligand 2.21) showed that 
primary amines can also be used to functionalize the borane; all previous work had 
been done with tertiary amines or imines. 
The DABCO (1,4diazabicyclo[2.2.2]OCta11e) was selected for this work as an 
alternative to triethylamine, since its nitrogen lone pairs of electrons are more 
accessible. It was also interesting to investigate the reactivity of a diamine in these 
ligand syntheses. An interesting result was obtained from a "one-pot" reaction with 
tris(dimethylamino)borafle, metbimazole and 1,4-diazabicyclo[2.2.2]Octane, in 1:3:1 
proportion respectively. This reaction was stopped before all dimethylamine gas was 
released and a solid was isolated after solvent removal under vacuum. The analysis 
through electro-spray mass spectrometry (Fig. 2.6.) and 'H NMR (Fig.2.7) showed 
that this powder was a mixture of three different species. 
\ 
H 
S o il 










MS (ES-) 	 I ,%?S.(S  
- 	 395.-94 
394.93 417.69 	
1 ' 	50 
114.18 	281.98 
.-,i-(_ 	 ' ( 	
698.83 	812.80 
o t 	A 	 . . "'I' 
200.00 	 400.00 600.00 	 800.00 
Fig.2.6. Positive electro-spray mass spectrum of the mixture obtainedfrom the "one- 
pot" ligand synthesis with DABCO. 
The 'H NUR of this mixture of products shows five different signals between 
3.65 and 2.9 ppm which correspond to the DABCO protons and to the methyl groups 
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of the methimazole moieties of the ligands (Fig. 2.7). There are two different signals 
for the DABCO protons; one at 2.91 ppm which corresponds to the mono substituted 
product and another signal of small intensity at 3.56 ppm for the bis substituted 
ligand. The 'H NUR of this mixture also shows three different signals at 3.49, 3.58 
and 3.61 ppm which were assigned to the three different methimazole methyl groups 
of the species present in the mixture, [(1,4- 
diazabicyclo[2.2.2]octafle) {B(methimazolyl)3} 21, 	 (1,4- 
diazabicyclo [2.2. 2]octane) {B(methimaz.olyl)3 	 and 
[(dimethylamine)B(methimaZolYl)31 (Fig. 2.7). 
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Fig. 2. 7 'HNMR of the mixture obtainedfrom the "one-pot" ligand synthesis with 
DABCO in CDCI3 (detail over region between 3.65-3.45 ppm where are the different 
proton signals of the three products). 
The presence of [(dimethylamine)B(methirflazOlYl)3] in this mixture indicates 
that this ligand was an intermediate formed during a "one-pot" reaction. Also, it is 
interesting to note that the mixture contains the bis-substituted DABCO species, 
[(1 ,4-diazabicyclo[2. 2. 2]octane) {B(methimazolyl)3 } 21 (Fig. 2.7). The formation of 
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this product indicates that the basicity of the 2' DABCO nitrogen atom in 
[(DABCO)B(mt)3] is sufficiently high to substitute HNMe2 in [(HNMe 2)B(mt)3]. 
Many attempts were made to separate this mixture or to synthesise [(1,4-
diazabicyclo[2.2.2]octane)21 exclusively but all of them failed due to product 
decomposition or inefficient  separation. The synthetic approaches attempted for this 
synthesis are displayed on Scheme 2.14. 
2 B(NMe2)3 + 6 Hmt 	AlToluene 2.23+ 2.22 + 2.11 
HNMO r B(NMe3]3 + 3 Hmt I. A I Totuene 2.23 + 2.11 	+ B(NMe 	+ 3 H 1/ 	Product Decomposition 
N 2.cooling AlToluene 
- HNMe2 - HNMS2 / M + 
B(NMe3]3 + 3 Hmt A I Toluene 2.23 
N2 purge / - HNMe2 
= Hmt 	
L
(HNMe3]B(mt) H 	J A /Totuene 2.23  - HNMe2 
.-t 
S 	N 	 N--4S 




2.23 	' 	' 2.11 	
I 
Scheme 2.14. Attemped synthetic apporoaches to obtain ra 4- 
diazabicyclo[2. 2. 2]octane) {B(methimazolyl)3}2J 
The [(1,4diazabicyclo[2.2.2]oCtafle){B(methlm0lY')3}2] seems to be an 
unstable product thus, it was not possible to isolate. Analysis of the decomposition 
product obtained by 'H NMR show that small quantities of [(HNMe 2)B(mt)3] (one 
singlet at 3.58 ppm) and [(DABCO)B(mt)3] (two singlet signals at 3.50 and 2.90 
ppm) were also present within the mixture. This indicates that there is an equilibrium 
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between [(DABC0)B(mt)3] and [(DABCO){B(mt)3}2] that depends on the presence 
of [(HNMe2)B(mt)3] and dimethylamine dissolved in solution. The instability of 
[(DABC0){B(mt)3}21 favours the equilibrium towards the formation of 
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Scheme 2.15. Equilibrium that can occur during the reaction of[(HNMe2)B(m03] 
and DABCO. 
2.5. METAL COMPLEXES 
As mentioned in Chapter I, the Tm ligand and its derivatives synthesized in 
this work give metal complexes with C3 symmetry. In this chapter the synthesized 
ruthenium and molybdenum complexes will be introduced and discussed. 
2.5.1. Structural Parameters 
The structures of the C3 - symmetric complexes of T mMC ligand have been 
described by Hill in terms of two parameters 8° and co° (Fig. 
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c> 	cLrc 
0 	 CD 
. (0<0°) 
8 (9>00) 
Fig 2.8. Parameters introduced by Hill and co-workers to characterize the C3- 
symmetric metal complexes of Tin ligand or its derivatives. 34 
These parameters are used to describe the rotational deformation that the 
metal complexes of the Tm ligand and its derivatives (including ligands of the type 
[(L)B(mt)31) metal complexes exhibit. When coordinated to a metal this type of 
ligand forms a bicyclo[3,3,3] cage that twists due to its inherent angle strain. The 
formation of two rotational enantiomers, LU and 666, is a consequence of the helical 
twist of this cage. Hill introduced the 0 parameter to describe the absolute 
configuration of the rotational enantiomers. This parameter is the measure of the 
tortional angle N-B-M-S (Fig.2.8.). 34  Therefore, for a complex with 1 enantiomeric 
configuration the parameter 0 is <00  and if 0 is> 0° the enantiomeric configuration 
of the complex is ö (Fig. 2.8). The measure of the three 0 angles (9") in a complex 
allows the determination of the absolute rotational enantiomeric configuration of the 
complex, since 1 and ö configurations cannot coexist in the same complex, though 
the two enantiomers can coexist in the same unit cell of the whole crystal structure 
lattice. 34 
The angle between the normal to the plane of the methimazole ring, which 
makes with the B-)M vector is the second parameter, co, defined by Hill (Fig. 
.).34 
 
This angle measures the displacement of the metal (M) from the methimazole planes 
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and is related to the flexibility of hybridization of the sulphur atoms. This parameter 
is usually presented as wm, which is the mean of all the three w angles. 
14 
2.5.1. Complexation to Ruthenium (II) 
In this work, some of the ligands were coordinated to the [Ru(p-cymene)] 2 
fragment. Ruthenium was used for this work due to its properties and its potential 
applications in catalysis. Ruthenium (II) forms low spin diamagnetic complexes, and 
it easily coordinates to molecules containing heteroatoms (e.g. nitrogen, oxygen, 
phosphorus... The complexes of arene Ru(ll) are usually stable to hydrolysis 
and the metal not easily oxidized to Ru(ffl) due to the strong 7r interaction between 
the metal and the arene. 36  Moreover, ruthenium complexes have shown good 
catalytic activity in hydrogenations and transfer hydrogenation2 7 and on olefin 
metathesis. 38  The potential catalytic applications of ligands of the type [(L*)B(mt) 3], 
(with chiral groups attached to the boron) coordinated to rutheninum (II) can also be 
interesting in a further investigation as future work 
The synthesis of the Ru(ll) complexes described in this work followed a 
similar method which was previously reported by Bailey and Perucha for the 
synthesis of [Ru(pcymene)(Nmethylimidazole)B(methiIflaZOlyl)3] [Cl] 2 (Scheme 
2.16).' 
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Scheme 2.16. Synthetic mute used to obtain the ruthenium complexes 2.25 and 2.26 
A 	ruthenium 	(II) 	complex of [(1,5-diaza-bicylo-(4.3.0)non-5- 
ene)B(methimazolyl) 3] 2.25 was formed by reaction of the ligand with dichloro(p-
cymene)ruthenium dimer in ethanol followed by a salt metathesis with NH4PF6 to 
exchange the chloride counter-ions (Scheme 2.16). Generally, this last procedure 
facilitate the purification of the complex, since the hexa.fluorophosphate anions 
usually make the complex precipitate, thus render it easy to isolate via filtration. 
Compared to that of the free ligand, the 'H NMR spectrum of the complex 
shows a shift upfield of the proton signals of 1,5-diaza-bicylo-(4.3.0)non-5-ene 
which indicates that the complex was formed. The other signals of the 'H and 13 C 
NMR for 2.25 confirm the solid state structure found by X-Ray anaysis. 
The complex was crystallized by slow diffusion of ether into a concentrated 
acetonitrile solution. The structure of the obtained crystals contains both AL and ööö 
enantiomers within the unit cell. One of the rotational enantiomers of this crystal 









Fig.2.9. Crystal stuclure of A enantiomer of [((1, 5-diaza -hi cylo-(4. 3. O)non-5- 
ene)B(me!himazolyl) 3)Ru(p-cymene)][PF6]2 2.25 (hexafluorophosphale  counter-ions 
and hydrogens not shown for clarity). The selected bond lengths and angles for this 
complex are presented on Table 2.4. 
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Table 2.4. Selected angles () and bond lengths (A) of [{(1,5-diaza-bicylo-
(4.3. O)non-5-ene)B(methimazolyl)3)Ru(p-cymene)][PF6J2 2.25 
B-N(13) 1.538(5) Ru-S(2) 2.403(9) 
B-N(1 1) 1.553(4) Ru-S(3) 2.425(8) 
B-N(12) 1.561(4) Ru-S(1) 2.454(9) 
B-ND(14) 1.569(5) N(1 3)-B-N(1 1) 109.6(3) 
S(1)-C(21) 1.721(3) N(13)-B-N(12) 116.7(3) 
S(2)- C(22) 1.729(3) N(1 1)-B-N(12) 105.0(3) 
S(3)-C(23) 1.719(3) N(1 3)-B-N(14) 104.5(3) 
RUC,,m (55) 2.183(4) N(11)BN(14) 111.5(3) 
Ru-C. (3 5) 2.185(3) N(12)-B-N (14) 109.6(3) 
Ru-C,,m (65) 2.196(4) S(2)-Ru-S(1) 90.90(3) 
(25) 2.196(4) S(3)-Ru-S(1) 95.69(3) 
Ru-C, m (45) 2.213(4) S(2)-Ru-S(3) 87.08(3) 
Ru-C,,y. 2.226(4)  
The ruthenium (II) complex of [(DMAP)B(methimazolyl) 3] was obtained by 
an analogous method (Scheme 2.16.) as the previously presented complex 
Compared to the free ligand, the 'H NMR of 2.25 shows a shift downfield of the two 
doublet signals of the DMAP pyridine moiety and the olefinic protons of the 
methimazole rings. The analysis of 2.25 by FAB-MS, showed the molecular peak of 
the complex with loss of the counterions (M = 708.7). This complex was 
crystallized by slow diffusion of diethyl ether in acetonitrile. These crystals were 
analysed by X-ray crystallography, however its structure could not be refined as the 
crystal lattice was not regular due to solvent loss and decomposition of the complex 
The structure presented on this chapter shows only the relative position of the atoms. 
The crystals analysed showed to have the ALX and 885 enatiomers present in the 
crystal unit cell as seen in Fig. 2. 10. 
AX) 
Fig.2.10. Crystal structure of[[(DMAP)B(methimazolyl)3]Ru(p-.cymene)][PF6]2 
2.26 showing the axial enantiomers LU and 65Ô (hydrogen atoms and counter-ions 






Fig.2. 11. Crystal stuclure of 558 enantiomer of[((DMAP)B(methimazolyl)3JRu(p- 
cymene)J[PF6]2 226 showing the atomic numbering scheme 
(hexafluorophosphate counter-ions and hydrogens not shown for clarity). The 
selected bond lengths and angles for this complex are presented on Table 2.4. 
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Table 2.5. Selected angles () and bond lengths (A) of A enantiomer of 
[{(DMAP)B(methimazolyl) 3)Ru(p-cymene)J[PF6]2 2.26 (this structure could not be 
refined due loss of solvent)) 
B-N,,(18) 1.592 Ru-S(2) 2.414 
B-N,,(7) 1.541 Ru-S(3) 2.432 
B-N,(25) 1.538 Ru-S(1) 2.412 
B-NDp(9) 1.584 N(18)-B-N(7) 111.92 
S(1)-C(21) 1.713 N(7)-B-N(25) 105.91 
S(2)- C(22) 1.728 N(25)-B-N(18) 115.78 
S(3)-C(23) 1.718 N(1 3)-B-N(9) 103.50 
(55) 2.177 N(1 1)-B-N(9) 109.28 
Ru- C..,.,, (35) 2.189 N(12)-B-N(9) 110.46 
Ru- C,,,m (65) 2.206 S(2)-Ru-S(1) 92.59 
Ru-C,,(15) 2.220 S(3)-Ru-S(1) 87.11 
Ru- C,,. m (25) 2.203 S(2)-Ru-S(3) 92.54 
Ru-C,,,m (45) 2.213 
The structure of complex 2.26 was not fully solved as the R-factor was above 
30%, thus the measurements on this crystal do not present any standard deviations. 
The structures presented on Fig. 2.10 and Fig. 2.1 1 were based on the atomic position 
assigned for the crystals obtained. 
The structure of complexes 2.25 and 2.26 show that the ligand is coordinated 
in a facial c3-S,S,S mode to the metal centre. The average S-Ru distances and S-Ru-
S angles are 2.42 A and 91.23° for 2.25 and 2.41 A and 90.74° for 2.26. The 
distances and angles present on 2.25 are very similar to the ones found in [{(N-
methylminidazole)B(methimazolyl)3}Ru(p-cymene)][PF6]2 (Ru-S 2.42 A and S-Ru-
S 90.77°) reported by Bailey and Perucha.' 4' 25 In both of the complexes the 
ruthenium is r bonded to the p-cymene ligand with an average Ru-C bond distance 
of 2.19 A for 2.25 and 2.20 A for 2.26. The separation between the metal centre and 
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the arene ligand centroid is 1.68 A 2.25 and 1.70 A 2.26. The average BNmt bond 
length is 1.55 A 2.25 and 1.56 A 2.26 of the nitrogen atoms of the methimazole rings 
coordinated to the boron. The mean NmrB-Nmt angle of complex 2.26 is 111.20°. For 
complex 2.25 the flfl NmrBNmt angle is 110.43° which is close to 109.450  found 
in {(N-methylminidazole)B(methimazolyl)3}Ru(p-cymene)] [PF6]2 (The structural 
parameter (I" for 2.25 and 2.26 is respectively, -49.23° and 49.3 and -49.0° for the 
displayed structures. The a!" tortional parameter is -56.22° (AU enantiomer of 2.25) 
and -56.34° and 56.33° for 122 and 65ö enantiomers of 2.26, respectively. The value 
of 9" and wm value for complex 2.25 is in the range for octahedral Tm ligand 
complexes (042.8-49.8° and cv 50.6-61.70). " 
The complexation of [(benzylamine)B(methimazolyl)3] with ruthenium (11) 
by a similar procedure as presented on Scheme 2.16 was attempted. Before 
reciystallization, the 'H NMR analysis of this complex indicated the presence of 
[{(benzylamine)B(methima.zo1y1)3)Ru(p-cymene)] 2 , since the four aromatic protons 
of the benzylamine appeared as a multiplet between 7.60 and 7.54 ppm and the 
correspondent singlet signals at 3.91 ppm for the CH 2 group and at 5.90 ppm for the 
NH2 moiety. Recrystallization of the product was performed by slow diffusion of 
diethyl ether in acetonitrile and yielded crystals suitable for X-Ray analysis. 
However, this analysis showed that these crystals presented an unexpected structure 
containing only three methimazole ligands coordinated to ruthenium p-cymene 
(Fig.2. 12). This may be due to complex decomposition by moisture/air or light 
during crystallization or it is also possible that the previously analysed complex was 







Fig.2. 12. Crystal structure of [(methimazole)3Ru(p-cymene)J[PF6]2 2.27 (some 
hydrogen atoms and counter-ions were hidden for clarity). The selected bond lengths 
and angles for this complex are presented on Table 2.6 
Table 2.6. Selected angles () and bond lengths (A) [(methimazo1e) 3Ru(p-
cymene)J[PF6]2 2.27. 
S(1)-C(11) 1.707(6) Ru-C,,,(5) 2.260(6) 
S(2)-C(12) 1.716(6) Ru- C,,..m (6) 2.226(5) 
S(3)-C(13) 1.700(6) Ru- C,,..,,. (7) 2.189(6) 
Ru-S(1) 2.401(15) N(21)-C(11)-S(1) 129.1(4) 
Ru-S(2) 2.427(16) N(22)-C(12)-S(2) 127.4(4) 
Ru-S(3) 2.408(14) N(23)-C(13)-S(3) 130.1(4) 
Ru-C,,., (2) 2.24 1(6) S(1)-Ru-S(3) 83.60(5) 
Ru-C,,.,,(3) 2.204(5) S(1)-Ru-S(2) 88.40(5) 
Ru- 	(4) 2.201(6) S(2)-Ru-S(3) 87.51(5) 
The structure of complex 2.27 shows three independent methimazole rings 
and a p-cymene ring coordinated to ruthenium. The arene ligand is 'r bonded to the 
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metal centre with an average Ru-C bond distance 2.20 A which is very close to the 
Ru-C average bond found in [TmRu(p-cymene)] (2.21 A) reported by Bailey. 39 The 
separation between the arene centroid and the metal centre is 1.71 A. The average S-
Ru bond distances in complex 2.27 is 2.43 A which are similar to the Ru-S average 
bonds found for the cationic [TmRu(p-cymene)] (average S-Ru bonds 2.41 A). 
Unexpectedly, these values are similar to the ones found in the previously presented 
structures 2.25 and 2.26 and for the ones found in [TmRu(p-cymene)], despite the 
absence of the boron centre. This may indicate that the coordination of the 
methimazole to boron does not significantly influence the donor properties of the 
sulphur atoms in the tripodal ligands. An interesting feature of this complex is the 
S' 'H-N hydrogen bond present between two of the three methimazole rings 
coordinated to the ruthenium. For this interaction, the S"'H distance is 2.73 A and 
the S ... H-N angle is 123.73°, which fall on the range of typical sulphur containing 
hydrogen bonds. 40 These hydrogen bonds, which are commonly present amongst 
proteins, are relatively weaker and generally are related to the stabilization of the 
sulphur atom by an acidic proton. 40 In the case of the complex 2.27 this hydrogen-
sulphur interaction affects the position of the Ru coordinated methimazole rings. 
This is reflected on the average S-Ru-S angles for complex 2.27 (average S-Ru-S 
angle 86.5°) relatively to the ones found in [TmRu(p-cymene)] (average S-Ru-S 
angle 91.7°). 39 
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2.5.2. Complexation to Molvdenum(0) 
The ligand [(HNMe2)B(methimazolyl)3] was reacted with molybdenum 
hexacarbonyl under reflux of tetrahydrofuran, to obtain 
{ [(HNMe2)B(methiinazolyl)3]Mo(CO)3 } (Scheme2. 17). 
H 	 Be 
I 	co 	/THF 
lv Co 
$ + 
,N S (N Co 
\ MO 
N 	s 	 oc'" !co 
2.11 CO 2.28 
Scheme 2.17. Synthesis of[{(dimethylamine)B(methimazolyl) 3JMo(CO)3]. 
The synthesis of 2.28 was followed by JR spectroscopy until the molybdenum 
hexacarbonyl characteristic C=O frequency band (2004 cm') could no longer be 
observed. The appearance of two new C=O frequency bands at 1982 and 1921 cm 1 
indicated the reaction was complete and the complex 2.28 was formed. The product 
2.28 was recovered as a white solid after washing the crude product with diethyl 
ether and removing the remaining solvent under high vacuum. The 'H and 13C NMR 
and electrospray mass spectroscopy analysis confirmed the presence of 2.28. The "B 
NIvIR of this compound presented a single peak at 5.98 ppm which is in the range for 
tetrahedral boron compounds . 41 This diamagnetic stable complex allowed the study 
of the ligand properties by comparing the Infra-Red C=O stretching frequencies with 
those observed for complexes with other tridentate sulphur donor ligands (Table 2.7). 
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Table 2.7. Infra-red C=O stretching frequencies of [{(HI"[Me 2)B(mt) 3}Mo(CO)3] and 
other three tridentate sulphur donor molybdenum (0) triscarbonyl complexes. 
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The C=O frequencies observed are higher in 2.28 that in the previously 
reported complexes. This indicates that the C=O bonds in this complex are stronger 
that in the other three complexes, which means that [(HNMe 2)B(mt)3 ] is the weakest 
donor of this group. The lower carbonyl stretching frequencies observed for the other 
three complexes indicate weaker C=O bonds. This is due a stronger Mo-CO 2t 
backbondmg that is influenced by the higher electronic donation of the sulphur atoms 
coordinated to the metal. This difference may be attributed to the sp2 hybridization of 
the methimazolyl sulphur atom resulting in a 2V donation to the metal in comparison 
to the sp3 hybridization of the sulphur donors in the other three complexes which are 
or donors. 
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2.6. FURTHER INVESTIGATION OF THE LIGAND SYNTHESIS 
MECHANISM 
Since the dimethylamine could be substituted in [(I{NMe 2)B(mt)3], its 
substitution in metal complexes of this ligand was investigated. The aim of this study 
was to attempt to identify if the HNMe2 substitution in [(HNMe 2)B(mt)3] follows a 
SN1 or SN2 type of process. If this substitution follows a dissociative mechanism type 
SN!, the reaction occurs in two steps. The first step is the formation of a 3-coordinate 
borane species after the dimethylamine is release. Then this reactive borane species 
reacts with the added N-donor to produce the substituted complex (Scheme 2.18). If 
this substitution follows a SN2 process the release of the dimethylamine and the 
coordination with an N-donor will be simultaneous. This process cannot occur within 
a complex since the hindrance created by the coordinated metal to the ligand would 
not allow the N-donor backside attack and the evolution of I{NMe2 will not be 
observed. Although a bimolecular substitution is possible to occur within the free 
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Scheme 2.18. Possible mechanisms for the substitution of I-INMe2 in metal 
complexes of[(HNMe2)B(mt)3]. 
For this study, [{(dimethylamine)B(methimazolyl)3)Mo(CO)3] was dissolved 
in toluene and 4-dimethylaminopyndine was added. The mixture was heated under 
reflux for one hour and after cooling  it was stirred at room temperature until no 
evolution of dimethylamine gas was observed. The isolated off-white solid obtained 
was analysed by infra-red and "B NMR spectroscopy to seek, respectively, the 
presence of carbonyl characteristic vibration bands and boron isotope nuclei. Despite 
the fact that dimethylamine gas was released during the reaction, this product has 
been shown to be a complex mixture of decomposition products without any boron 
or carbonyl groups. 
73 











6toluene 	 N 
/ 	/ 
N—<f h_N N 	
s N...t...  
VS 
MO 
OC' 	 CO 
2.32 Co  
Scheme 2.19. Attempted substituition of dimethyleanine for 4-dimethylaminopyridine 
within a molybdenum complex. 
The results from this study are therefore inconclusive since this reaction was 
performed only once, and lead to the decomposition of the product. Further 
investigation of this type of reactions with different metal complexes and different 
N-donors may indicate the which mechanism type can occur when the ligand 
[LB(mt) 3] is synthesized from [(HNMe 2)B(mt)3]. 
2.6.1. Functionalization of boron by N-donors within complexes: 
reactivity of metal laboratranes 
Nickel complexes with tris(2-mercapto- 1 -tert-butylimidazolyl)borate with the 
boron functionalized on the 4 th position by a N-donor have been obtained from the 
reaction of the respective metallaboratrane. This observation was made by Parkin 
and co-workers who reacted a nickel metallaboratrane complex, [i 4-B(mtt ')3]NiCl 
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with potassium thiocyanate or sodium azide in the presence of iodine (Scheme 
2.2O). 41 
+12 	1. 
R = C(CH3)3 
Scheme 2.20. Synthesis of[(SCN)B(mt&t)3]NiI  by reaction of ([K4-B(mt t 
Bu)]Ni(NCS)) with iodine. 45 
More investigation of this route may lead to an alternative route to synthesize 
boron functionalized complexes. However, the mechanism of this synthesis is still 
uncertain and more investigation is required to provide a better understanding of the 
reactivity of metallaboratranes. 45 
2.7. SYNTHESIS OF [RB(PZ)3] TYPE OF LIGANDS 
The chemistry of hydrotris(pyrazolyl)borate or scorpionate ligand and its 
analogues has been under investigation since their introduction by Trofimenko. 46  
Many analogues of Tp ligand have been reported and used for a broad range of 
applications, from catalysis to radiopharmaceutical drugs. 
Due to its importance, the synthesis of Tp ligand analogues in which the B-H 
is replaced by a neutral N-donor was also investigated in this work. The 
dimethylamine substituition on [(HNMe 2)B(pz)3] was also investigated to afford the 
respective boron substituted Tp ligands analogues of the type [LB(pz)3}. 
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2.7.1 Synthesis of 1(HNMe2)B(Dz)1 
As discussed on Section 2.2, Niedenzu studied the reactivity of 
tris(diinethylamino)borane and pyrazole under various conditions (e.g. reflux time, 
further stirring time at room temperature) and solvents (benzene or toluene) and the 
different products that could be obtained (Scheme 2.5). The reaction of pyrazole 
reaction with B(NMe2)3 is exothermic with immediate evolution of dimethylamine, 
and a range of boranes from [(HNMe2)B(pz)3] to pyrazaboles can be obtained 
depending on the reactional conditions. 9 For this work it was necessary to improve 
and modify these conditions in order to obtain exclusively [(HNMe 2)B(pz)3]. Many 
attempts were made until the desired product was obtained in relatively high yield 
and good purity. The product was obtained by a slow addition of B(NMe 2)3 to a 
solution of pyrazole in cyclohexane followed by heating under reflux for one hour. 
This procedure slows the reaction of tris(dimethylamino)borane with pyrazole and 
avoids the formation of dimers and/or pyrazaboles, favouring the formation of 
[(HNMe2)B(pz)3]. 
2.7.2. Synthesis of 1LB(z)1 lipands from I(HNMe2)B(pz)1 
Since the substitution of dimethylamine in [(HNMe 2)B(pz) 3 } 2.8 by neutral 
N-donors could be achieved it was investigated whether this method could be applied 
to tns(pyrazolyl)borate analogues. 
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The ligands 2.33 and 2.34 were synthesized by heating a solution of 
[(HNMe2)B(pz)3] under reflux with a neutral N-donor (Fig. 2.13). The loss of 
HNMe2 during these reactions was observed with damp pH paper. The 'H NMR 
analysis of the crude product of these reactions showed the absence of the 
characteristic singlet for the HNMe2 group at 2.26 ppm of 2.8, indicating the 
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Fig.2.13. Ligands synthesized by substituition ofHNMe 2 in 
[(dimethylamine)B(pyrazolyl) 31. 
The ligand [(N-methylimidazole)B(pyrazolyl)3] had been previously 
synthesized by Perucha via a "one-pot" reaction of tris(dimethylamino)borane, 
pyrazole and N-methylimidazole, and it was reproduced via a base exchange reaction 
to compare the efficiency of both methods in the synthesis of this compound. The 'H 
NMIR characterization of this compound was very similar to the analysis of the same 
ligand obtained by Perucha . 25  
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This base exchange method was also used to obtain [(DMAP)B(pyrazolyl)3] 
which is an analogue of one of the ligands previously obtained from 
[(HNMe2)B(mt)3]. The analysis of this product by 'H and ' 3C NUR are consistent 
with the proposed ligand structure. 
2.7.3. ComDlexatlon to Ruthenium (II) 
Ruthenium complexes of poly(pyrazolyl)borates ligands have been shown to 
have many interesting applications in catalysis, such as C-H activation, proton 
transfer reactions and C-C bond formation amongst otherS.47-10  
For this work, a ruthenium (II) complex of [(DMAP)B(pyrazolyl) 3] was 
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Scheme 2.21. Synthetic approaches reported by Tocher for the synthesis of[Ru(,-p- 
MeC6H4) {-HB(pz)3)[PF6J. 48 
The ligand was added to a methanolic solution of dichloro(p-
cymene)ruthenium dimer and left stirring for an hour This was followed by a salt 
metathesis reaction with addition of NH4PF6 . The obtained yellow powder was 
crystallized from diethyl ether diffusion into a concentrated acetonitrile solution. The 
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Fig.2.14. Crystal structure of[[(DMAP)B(pz) 3/Ru(p-cyinene)Cl] PF6 2.38. 
(hydrogen atoms and hexafluorophosphate counter-ion were omiitedfor clarity). 
One chloride ligand is still coordinated to ruthenium and the ligand is ,c2-N,N 
coordinated. This was unexpected since the synthetic method used was the analogous 
to the one reported by Tocher and collaborators (Scheme 2.21) which provides the 
ic3- N,N,N coordinated ligand. The analysis of this product by 1H and 13C NMR 
showed the presence of two types of pyrazole signals in a 1:2 ratio, which was 
concordant with the structure found in the solid state. 
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Table 2.8. Selected angles () and bond lengths (A) for [{(DMAP)B(pz)3)Ru(p-
cymene)Cl] PF6 2.38. 
B-N DMAP(7) 1.569(4) Ru- 	(9) 2.159(3) 
B-N(2l) 1.521(4) Ru-CI 2.390(7) 
B-N 2(12) 1.531(4) Ru-N(11) 2.076(2) 
B-N p. (17) 1.540(4) Ru-N(16) 2.086(2) 
N(21)-N(22) 1.367(4) N(1 1)-Ru-N(16) 86.76(8) 
N(12)-N(1 1) 1.36 1(3) N(16)-Ru-Cl 84.92(6) 
N(16)-N(17) 1.370(3) N(11)-Ru-C1 84.82(6) 
Ru-C,,,,11 (4) 2.224(3) N(21)-B-N(17) 109.7(2) 
Ru- C m (5) 2.192(3) N(7)-BN(12) 105.9(2) 
Ru- C,-,.,,(6) 2.184(3) N(7)-B-N(21) 110.4(2) 
Ru- 	(7) 2.217(3) N(17)-B-N(12) 111.4(2) 
_Ru- C,.(8) 2.187(2)  
In this complex the [(DMAP)B(mt) 3] ligand binds the metal in a 
coordination mode with an average Ru-N distance of 2.08 A. The ruthenium is r 
bonded to the p-cymene ligand with an average Ru-C distance of 2.19 A and it is 
1.67 A separated from the arene centroid. The Ru-Cl distance is 2.39 A. The angle of 
the chelating ligand and the metal (N-Ru-N) is 84.87°. These distances and angles are 
very similar to the ones found in [Ru( 6-p-MeC6H4){ic2-HBz)31Cl] (average Ru-
C 2.20 A., Ru-Cl distance 2.39 A, N-Ru-N angle 84.8°) which was previously 
reported by Tocher 48 The average B-N distance of the three pyrazole N atoms to the 
boron center is 1.53 A and the B-N distance between DMAP's nitrogen coordinated 
to the boron is 1.57 A which is slightly longer than the other B-N bonds. 
In order to investigate the possible conversion of the ,?-NN coordination of 
the ligand to ,c3-N,N,N the complex was dissolved in acetonitrile and AgBF 4 was 
added and the formation of AgC1 was observed in solution (Scheme 2.22). 
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The solution was filtered and the remaining yellow solution was evaporated 
to dryness under vacuum. The 'H NMR spectrum of the resulting product showed 
three different signals for the pyrazole rings indicating that the ligand was not 
coordinated in a c3-N,N,N mode and/or there was a mixture of products resulting 
from complex decomposition. Attempted purification of this product by 
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(13F4 ) + AgCI 
2.38 	 2.39 
Scheme 2.22. Attempted synthesis of[{(DMAP)B(pz) 3)Ru(p-cymene)](PF6)(BF4) 
(hexafluorophosphate counter-ions are omittedfor clarity). 
The retention of the chloride ligand to the ruthenium centre in the structure of 
238 was responsible for the,? coordination of the tripodal ligand thus influencing 
the position of the uncoordinated pyrazole ligand. The attempt to recoordinate this 
pyrazole ring to the ruthenium failed since it required decoordination of the chloride 
and one of the pyrazole ring to form the ,c  coordinated complex 
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2.8. CONCLUSION 
The work presented in this chapter shows that it is possible to synthesize 
ligands of the type [(L)B(Mt)31 by substitution of dimethylamine in 
[(HNMe2)B(mt)3] when it is reacted with a neutral N-donors under reflux in toluene. 
The N-donors used in this work were mainly tertiary amines and iinines but also a 
primary amine, benzylamine was successfully used. The possibility to use primary 
amines to functionalize the boron broadens the range of N-donors that can be applied 
in the synthesis of new ligands. Hence, there are more possible ways to functionali.ze 
the boron of the Tin ligand derivatives with chiral groups. The synthesis of the ligand 
with a chiral primary amine, a-methylbenzylamine, is presented on Chapter IV. 
This synthetic route can also be applied to ligands with pyrazole instead of 
methimazole, although only two reactions were performed and more of the reactivity 
of these ligands requires further investigation. 
The evidence that the dimethylaniine in [(HNMe 2)B(mt)3] can be substituted 
with N-donors contradicts the previously proposed mechanism for the "one-pot" 
reactions with (dimethylamino)borane reported by Bailey and Perucha14' 25  In the 
light of this work, another mechanism for the formation of ligands of the type 
[(L)B(mt)3 ] is proposed. However, it was not possible to determine whether the 
process is a dissociative or a bimolecular substitution. This investigation will require 
further work in the reactivity of dimethylamino(trismethimazolyl)borate metal 
complexes with N-donors. 
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BORON-CENTRED TRIPODAL LIGANDS WITH HETEROCYCLES 
OTHER THAN METhIMAZOLE 
Boron-centred tripodal ligands with heterocycles other than methimazole 
3.1. INTRODUCTION 
Previously, the work towards the synthesis of analogues of 
tris(methimazolyl)borate ligands with boron functionalized with a neutral N-donor 
has been presented. Subsequently, the synthesis of these ligands with different 
sulphur and selenium donor heterocycle analogues of methimazole has been 
investigated. This work will be presented in this chapter. The heterocycles used for 
this work were 1 -methyl-benzimidazole-2-thione, 1 ,4,5-trimethyl-imidazole-2-thione 












Fig.3.1. Heterocycles usedfor the ligand synthesis. 
As some of these compounds were not readily available for purchase, their 
synthesis will also be discussed in this chapter. Dimethylamine and N-
methylimidazole were used to functionalize the boron forth position in these new 
ligands. 
3.2. BORON-CENTRED TRIPODAL LIGANDS WITH SOFT DONOR 
ATOMS 
The ubiquitous tris(pyrazolyl)borate ligand system can be derivatized in order 
to control the steric environment of the binding site. This derivatization can be done 
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by replacing the pyrazole rings by substituted pyrazole rings and/or by other 
heterocycles. 1,2 The substitution of the pyrazole by methimazole rings in this type of 
system gave rise to another generation of scorpionates or boron-centred tripodal 
ligands with soft donors. 
The tris(methima.zolyl)borate ligand system framework can be described as 
[E(L2D)3] (E = central tripod atom, L = linking  atom and D = donor atom) with many 
possibilities fbr variation by changing F, L and D (Fig.3.2.). 3 In this work only the 
ligand systems with boron as central tripodal atom, as [B(L 2D)3] with soft donor 
atoms will be considered. 
- Central Tn pod Atom 
L -Unking atom 












Fig.3.2. Coordination of a [E(L2D)3] ligand system to a metal centre (M) (two 
different views showing the bicyclo[3, 3, 3]cage). 
In these ligands the coordination of the three donor atoms to a metal forms 
C3 -symmetric complexes with a bicyclo[3,3,3]cage that presents chirality through the 
twisted conformation of the cage. 4 ' 5 Modification of the heterocycles that provide the 
donor atoms can be used to tune this system electronically and sterically. 
WC 









Boron-centred tripodal ligands with heterocycles other than methimazole 
3.2.1. Boron-centred tri podal lipands with sul phur donors 
As mentioned in Chapter 1, the Tm ligand has been used to model 
metalloenzyme sites , 6 since it can create a protective encapsulation for a metal 
centre. This metal protection can be achieved by substituting the methimazole N-
methyl group on the Tm ligand structure. To explore the biomimetic applications of 
this ligand system, many new ligands have been prepared with methimazole 
derivatives containing different functional groups (R) in the methima.zole ring 3-
position. The common abbreviation used for these analogues is TmR.  Some of these 
analogues are listed on Table 3.1 
Table 3.1. Some Tm ligand derivatives with methimazole analogues substituted in 
the third position. 
Substituent 	Abreviation 	Ref. 
Methyl 	R 	 Tm or TmMe 
o-Anisyl 	 Tm0M 	
10 
Xylene 	 Tm' 
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The metal protection in complexes with Tm ligand analogues depends on the 
orientation and the nature of the functional group in the methimazole 3-position. 
Vahrenkamp and co-workers have studied some zinc complexes with TmM,  Tnf 
IOIYI and Tm'' 1 and compared the orientation of the three different N-substituents of 
the thioimidazole relative to the B-Zn axis. A schematic view of this comparison is 
displayed in Fig.3.3. 
E  L 
C) 
 
Fig.3.3. Partial view of tripodal ligand arms bonded to zinc in three different 
complexes with: A) Tm'; B,) Tm T0M  and G,) Tin 0T 11 
According  to Fig. 3.3 it is possible to create more encapsulation of the metal if 
para-substituted aromatic thioimidazoles are used in the Tm backbone." The 
chirality of the metal complexes containing these Tm ligand analogues can also be 
influenced by variation of the nitrogen substituents of the methimazole. Since these 
ligands form a cage with helical rotation, the size and shape of these groups can 
create a hindrance that restrain the motion of this cage. Bailey and collaborators 
investigated a range of complexes and studied the possible racemisation processes 
and their energetic barriers.'' 13  This work will be discussed in more detail as an 
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introduction to Chapter IV, as this chapter is more focused on the modifications of 
the methimazole rings to obtain new ligands. 
It is also possible to synthesize analogues of the Tin ligand using heterocycles 
other than methimazole, but always keeping the sulphur donors atoms. Ojo and 
Regliski reported the synthesis of new soft tripodal ligands from the reaction of 
borohydride with different thiones.' 4 From the three imine-thiones used in their work 
(2-mercaptothiazoline, 2-mercaptobenzothiazoline and imidazolidmethione) only 
two reacted successfully with the borohydride to form new ligands (Scheme 3.l.)' 
C N >==s + NaBH4 / -H
21 
2-mercaptothiazoline 
pK 4.7. m.p. 105-107'C 
CN), 
 S 
+ NaBH4 E'J -H2, 
Methimazole 
pKa 4.7. m. p. 144-147 C 
C  -i;k C S >==s + NaBH4 -H2 IN 
2-mercapto.benzopthiazoline 
PKa 4.2, m p. 177-181C 
C
N
)=s  + NaBH 4 
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Scheme 3.1. Imine-thiones used by Ojo and Reglinski to synthesize the Tm ligands 
and two new boron centred-tripodal ligands with soft donors (NaTz and NaThz). ' 
The melting point and the pK.3 of the different heterocycles were determinant 
factors in the choice of the thiones used in Ojo and Reglinski's work. The 
unsuccessful synthesis with imidazolidinethione through a melt reaction showed that 
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in this case the pL of the heterocycle may not be a determinant factor in this 
synthetic route (Scheme 3.1). In these melt reactions the main cause of 
decomposition can be the overheating of the mixture. To avoid thermal 
decomposition during the synthesis, the melting point of the heterocycle has to be 
considered as an important factor when the thione is selected. 
Although, the pKa of different azoles is an important factor in the synthesis of 
neutral boron-centred tripodal ligands from B(NMe2)3. According to previous 
results, Bailey and Perucha established that the reaction of methimazole and other 
azoles with pKa below 3.0 (approximately) with tris(dimethylaxnino)borane 
generated the neutral tetrasubstituted species [(azole)B(azolyl) 3]. These azoles 
presented an acidic proton which allows the reaction with B(NMe2)3 and therefore 
the synthesis of new ligands with different heterocycles in place of methimazole.' 3 
In the next section of this chapter, the work with analogues of methimazole 
substituted in the 4th and 5th  position in order to develop the synthesis of new ligands 
will be presented. 
3.3. BORON-CENTRED TRIPODAL LIGANDS WITH SUBSTITUTED 
METHIMAZOLE ANALOGUES 
It was mentioned previously that the most common derivatizations made on 
the Tm ligand system were related to the substitution of the N-methyl group of the 
methimazole with different alkyl or aryl groups. However, it is also possible to use 
methimazole analogues substituted in the 4- and 5-positions. In this thesis, two 
analogues of methimazole were synthesized and used to obtain new boron-centred 
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tripodal ligands. This work will be presented in this section and the synthesis of these 
new ligands will be presented in presented and discussed on Section 3.4. 
The work with these heterocycles will be continued in Chapter IV where 
chiral neutral N-donors used to functionalize the boron's 0 position will be 
introduced. 
3.3.1. Carbon-substituted analogues of methimazole 
For this work two methimazole analogues substituted at the 4- and 5-
positions (Fig. 3.4) were used for the ligand synthesis. As in methimazole, these 
heterocycles present an acidic N-H proton which allows the transamination reaction 
with B(NMe2)3. 
H 
N >== S 
	
C,  N >== S 
1 -methyl-benzimidazole-2-thione 1 ,4,5-tnmethyl-imidazole-2-thione 
Fig.3.4. Methimazole analogues used to synthesize the ligands presented in this 
work 
From the reaction of these thioimidazoles with tris(dimethylamino)borane it 
is expected to obtain two ligands that, upon complexation, present a protected 
environment for the remaining axial site at boron as found for the anionic ligand 
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NaThz, containing the 2-mercaptobenzothiazoline donors, reported by Ojo and 
Reglinski (Scheme 3.1 and Fig.3.5). 
H 
Fig.3.5. Structure of the anionic Thz ligand coordinated to ihalium reported by Ojo 
and Reglinski.' 4 
In the structure of the complex displayed in Fig. 3.5, the orientation of the 
aromatic rings of the benzothiazoline in the Thz ligand creates a C 3-symmetric cavity 
around the hydride attached to the boron 
The 1 -methyl-benzimidazole-2-thione and the 1,4,5 -trimethyl-imidazole-2-
thione (Fig.3.4) can also be used to synthesize ligands with chiral N-donors in the 
boron 4th  position. In this case the chiral group coordinated to the boron will be 
located in the C 3-symmetric cavity thus increasing  the transfer of the chirality to the 
rest of the ligand. In the Chapter IV, the work done towards the synthesis of a new 
Boron-centred tripodal ligands with heterocycles other than methimazole 
chiral boron-centred tripodal ligand using 1,4,5-trimethylimidazole-2-thione which 
will be presented and discussed. 
3.3.2. Synthesis of 1-methvl-benzimidazole-24hione 
Several synthetic methods have been reported for the synthesis of i-methyl-
benzimidazole-2-thione. This compound can be synthesized by heating a mixture of 
l-methylbenzimidazole and sulphur at 2600C,15  or by reacting 1-methyl-2-
chlorobenzimidazole with sodium bisuiphite in sodium hydroxide solution. 16  There 
are also alternative synthetic routes starting from benzimidazole; the synthetic 
strategies to obtain l-methyl-benzimidazole-2-thione are displayed in Scheme 
3.7. 17,18 
/ 
(A) 	 + S 	
at26OC 









H 	1(cJ)- cI 	 H 
N Cr   N>= s 2. Et-,N n THF 	r.)c 	in 5% MeCOOUfMeOH10 	 Under reflux 3. KOH 
H 	4. Mel 	
Me 
I 
C  N C N 
Scheme 3.2. Synthetic routes to obtain 1-methyl-benz'imidazole-2-thione 3.19; 
References: (A),' 5 (B), ' 6(C),' 7(D).'8 
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The synthesis of 1-methyl-benzinidazole using 2-thiobenzimidazole as 
starting material, reported by Doerge and Cooray was undertaken (D of Scheme 
37)18 Via this method the methylation of 2-thiobenzimidazole is achieved after 
protecting the thione sulphur with a trityl group to avoid S- methylation. 
This method was successful, as the required benziniidazole was synthesized 
in gram-scale and high purity. However, it was found that if the tntyl protective 
group was not efficiently removed after methylation, the mixture of the desired 
benzimidazole and its protected derivative obtained as final product was difficult to 
separate. Although the separation of these compounds by recrystallization was 
possible, the reaction yield was substantially affected. These issues are related to an 
incomplete removal of the trityl group in the last step of this synthesis. After 
increasing the reaction time from 2h to 36 h to promote the completion of this last 
step and recrystallizing the product from acetonitrile instead of ethanol, it was 
possible to produce pure 1-methylbenzimidazole-2-thione in a 71% yield and 
proceed to the ligand synthesis. The 'H NMR analysis of the 1-
methylbenzimidazole-2-thione obtained was consistent with the reported analysis. 
3.3.3. Synthesis of I ,415-tnmethvlimidazole-2-thione 
The other methimazole analogue synthesized was 1,4,5-trimethylimidazole-2-
thione. The synthesis of this compound was reported by Kister, 19' 20 and it involves 
the condensation of 3-hydroxy-2-butanone and N-methylthiourea in hexanol at 
160°C for twelve hours. The water produced during this reaction can be removed by 
an azeotropic distillation and this product can be purified by preparative 
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chromatography and/or reciystallization. 20 This method was optimised in order to 
maximize the yield of this reaction (21%). The best result was obtained when this 
reaction was carried out in a solution of 4% hydrochloric acid in hexanol and heated 
to reflux for 16 hours (Scheme 3.3). 
0 	 S 




160°C 	 II >==s + 2H20 
3.3 
Scheme 3.3. Synthetic route to obtain 1,4,5-trimethylimidazole-2-thione 3•319 
The azeotropic removal of water was not necessary. The final crude product 
was recrystallized from petroleum ether and hexanes and obtained in 30% yield. The 
'H NMR analysis of this product was consistent with the literature data. 
3.4. LIGAND AND COMPLEX SYNTHESIS 
The methimazole analogues,were reacted with tns(dimethylamino)borane in 
toluene under reflux to afford the respective ligands (3.4 and 3.5) shown in Fig. 3.6 in 
respectively 66 and 54% yield. 
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Fig.3.6. Ligands synthesized with 1-methylbenzimidazol-2-thione 3.4 and 
1,4, 5-trimethylimidazole-2-thione 3.5. 
Both tripodal ligands were successfully synthesized and characterized by 'H 
and ' 3C NMR and positive ion FAB mass spectrometry. 
The 'H NUR spectrum of [(HNMe2)B(1,4,5-trimethylimidazolyl-2-thione)3] 
(3.4) showed three singlets at 2.84, 2.08 and 2.04 ppm assigned to the methyl groups 
of the 1,4,5-trimethylimidazolyl-2-thione groups. The dimethylamino group gives a 
singlet at 3.48 ppm for the six methyl protons and a broad signal appears at 10.47 
ppm for the N-H proton. The ' 3C NMR spectrum shows six signals for this ligand 
since the two CH3-C moieties of 1,4,5-trimethylimidazolyl-2-thione and the two 
methyl groups of HNMe2 appear at the same chemical shift. The presence of the 
ligand was confirmed by FAB mass spectrometry ([M+1] = 480) and elemental 
analysis. Further work with 1,4,5-trimethyl-imidazole-2-thione will be presented in 
Chapter IV. 
The 'H NMR spectrum of [(HNMe2)B(1-methyl-ben2imidazolyl-2-thione)3] 
(3.5) contained a clear aromatic multiplet in the region 7.19 to 7.13 ppm for the 
aromatic moiety of the thione heterocycle. The two equivalent methyl groups of the 
HNMe2 appeared at 3.75 ppm while the methyl groups of the benzimidazolyl moiety 
Boron-centred tripodal ligands with heterocycles other than methimazole 
of the ligand give another singlet at 3.80 ppm. The N-H proton produces a broad 
signal at 10.22 ppm. The ' 3C NMR exhibits nine signals; eight signals correspond to 
the three equivalent benzimidazole rings and one signal is assigned to the equivalent 
methyl groups of HNMe 2. The FAB mass spectrometry ([M+1] = 546) and 
elemental analysis confirmed the presence of the ligand. 
In order to study the donor properties of the ligand [(HNMe 2)B(1-methyl-
benzimidazolyl-2-thione)3] (3.5) it was coordinated to molybdenum tricarbonyl to 
form the complex [{ic 3-(HNMe2)B(1 -methyl-benzimidazolyl-2-thione)3}Mo(CO)3] 
(3.6). The complex was synthesized from a mixture of the ligand and MO(CO)6 in 











Fig.3.7. Complex of[('HIs/Me 2)B(1 -methyl -benzimidazolyl-2-thione)3] with 
molydenum tricarbonyl 3.6. 
The 'H NMR spectrum of 3.6 shows four sets of signals, as for the free 
ligand. In comparison to the proton signals of the ligand, this complex shows the 
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two methyl groups of HNMe2 shifted to slightly higher frequency (from 3.75 ppm to 
3.80 ppm). The same happens to the methyl groups of the thiobenzimidazole which 
shift from 3.80 ppm to 3.88 ppm after complexation. This deshielding is caused by 
electron density changes on the ligand upon coordination to the molybdenum. The 
aromatic signals of the thiobenzimidazole appear as a multiplet in the region 7.20 to 
7.10 ppm. Despite the deshielding of the methyl groups, the N-H proton of the 
dimethylamino group appears more shielded (from 10.22 ppm to 9.45 ppm). This 
may be related to ring-current effects due to the position of the aromatic moieties of 
the benzimidazole surrounding the HNMe2 group. The CO ligands of this complex 
provide a characteristic signal at 205.6 ppm in the ' 3C NMR spectrum. The FAB 
mass spectrometry ([M+1] = 726) the elemental analysis confirmed the presence of 
this complex The Infra-red analysis of 3.6 in hexane solution showed two absortions 
due to C-O stretching vibrations at 1979 and 1950 cm. A comparison of these C-0 
vibration energies with those observed in other Mo(C0)3 complexes with trisulphur 
donor ligands is provided on Table 3.2. 
Table 3.2. Infra-red C-O stretching frequencies of complex 3.6 and other tridentate 
sulphur donor molybdenum (0) tricarbonyl complexes. 
.Et 





CO 	 CO 
3.6 
U co(cm) 1899, 1784 	1930, 1820 1936, 1827 1979,1950 
Medium TIff CH202 CH2Cl2 Hexane 
Ref. 21.22 	-- This work 
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In order to do a better comparison of the donor strength of the tripodal 
sulphur donor molybdenum tricarbonyl complexes on Table 3.2., it only considered 
the energy of the A symmetry (higher energy) C-O vibration mode, where there is a 
simultaneous C-O stretching of the three carbonyl ligands. In these complexes, the 
energy of the C-O vibration is directly related to the electron density on the metal, 
and thus the donor properties of the various sulphur donor ligands. Higher electron 
density will result in greater electron density in the C-O ,r*  orbitals and thus lower the 
C-O stretching energy. 
Observing Table 3.2, the complex 3.6 gives the highest energy compared to 
the other complexes, which indicates that the ligand 3.6 is a weaker donor than the 
other ligands considered. However, this comparison does not take into account the 
sulphur hybridization in the different ligands. The sulphur in the thioimidazolyl 
ligands is sp2 hybridized and thus can potentially act as a ir-acceptor system, while 
the other ligands have sp3  hybridized sulphur atoms which have the potential to act 
as it-donors. 
It was established by Reglinski and Spicer that the donor properties of 
anionic Tm ligand system are affected when the methimazolyl moieties are replaced, 
or when a group is inserted on the bridgehead boron atom. 24 Complex 3.6 is a good 
example of this effect where the benzimidazole replaces Tm methimazole rings. This 
increases the electron density on the ligand and makes it a better donor when 
compared to a similar system as complex [{(HNMe2)B(mt)3}Mo(CO)3] (V C-0 = 1987 
cm') presented on Chapter U. 
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In this case the electronic and steric properties of these boron-centred tripodal 
ligands can change if the thioinudazoles are replaced by other heterocycles with 
sulphur donors, since these two properties are related. 24 
3.5. BORON-CENTRED TRIPODAL LIGANDS WITH OTHER DONOR 
ATOMS 
The electronic effects of the ligand on the metal centre are easy to observe 
when the donor atoms of the heterocycles are changed. Strongly donating ligand 
systems were reported using heterocycles bearing phosphorus, carbon and selenium 
atoms which were used as alternatives to the sulphur donor atoms of methimazole. 
The strong electron donating character of some tripodal ligands with [P3], [S3], [Se3] 
and [C3] donor sets can be compared by the N-O stretching frequency in the JR 
spectra of Ni(0) [LNiNO] complexes, which are displayed in Table 3.3. A decrease 
in the N-O stretching frequency indicates increased NO it-backbonding from the 
nickel due to a stronger electron donation from the tripodal ligand to the metal. 
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Table 3.3. N-O stretching frequencies for [LN1N0] complexes with boron-
centred tripodal liands with different donor atoms. 
COMPLEX REF.  
CAf 
H 





{ [Tm]NiNO} 1741 	26 
I., 
p 
{[PhB(CH2PPh2)3]NiNO} 1737 	27 
H 
{[HBImt ]NiNO} 1703 	28 
* Two frequencies observed 
Observing N-O stretching energies of the complexes on Table.3.3, it is 
possible measure the donor ability of these ligands in terms of different donor atoms 
as [C31>[P31>[S31>[Se31- 28  
The versatility of this boron centred tripodal ligand system allows the 
introduction of heterocycles that can hold two types of donor atoms. Bailey 
previously reported the synthesis of an ambidentate N 3/S3 tripodal ligand, the 
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hydridotris(thiooxotriazolyl)borate (Fig.3.8), from the melt reaction of sodium 




Fig.3.8. Structure of hydridotris(trioxotriazolyl) borate or Ti ligand reported by 
Bailey.' 
This system was explored to give rise to the Janus scorpionates which are 
systems with simultaneous and controlled soft ,c-S,S,S and hard ,c3-N.N,N 
coordination to a metal. This type of complex has been used in materials chemistry 






Fig.3.9. Representation of the binding behaviour of Janus scorpionale ligand 29 
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The Janus scorpionates profit from the hard nitrogen and the soft sulphur 
donor atoms to coordinate to a wide range of metals according to Pearson's Hard-
Soft Acid-Base concept. 30 
Generally, the derivatives of the Tm ligand are synthesized from melt 
reactions between sodium borohydride and a heterocycle similar to methimazole, as 
presented on Scheme 3.1. However, it is also possible to obtain these derivatives 
from the reaction of a heterocycle bearing a N-H acidic proton and 
tris(dimethylamino)borane. During their investigation of the synthesis of new ligands 
Bailey and Perucha observed that imazole derivatives with different donors 
successfully reacted with B(NMe2)3 in a "one-pot " reaction.13' 31  Perucha used 
imidazolinones to obtain a Tm derivative with oxygen donors (Scheme 34)31 
0 




3 H 	R 
- 	 I 
NMe2 	
- 	toluene 





—N I + 3HNMe2 
R 	 r. o)o 
R 
Scheme 3.4. Reaction of 1-R-imidazolin-2-one (1? = Ph, El) with 
tris(dimethylamino)borane and N-methylimidazole to afford new ligand with oxygen 
donors. 31 
The 1-R-imidazolin-2-one (R = Ph, Et) is an analogue of methimazole with 
oxygen donors. According to Perucha, this compound did not react with sodium 
borohydride in a melt reaction but its reaction with B(NMe 2)3 is successful. 3 ' 
Unfortunately, the coordination of these ligands to a metal was not successful due to 
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instability of the ligand [(N-methylimidazole)B(1-ethyl-imidazolyl-2-one)] or due to 
the low solubility in the solvent system used. 3 ' 
In order to continue the investigation of the synthesis of these types of ligands 
with different donors from tris(dimethylamino)borane, some work has been done 
using imidazoles bearing selenium atoms. In the next section of this thesis the 
synthetic work done with selenium analogues of methimazole towards the synthesis 
of a boron-centred tripodal ligand with selenium donor atoms will be presented 
3.6. SYNTHESIS OF BORON FUNCTIONALIZED LIGANDS WITH 
SELENIUM DONORS 
The derivatizations of the Ip and Tm ligand systems by changing the donor 
atoms have drawn the attention of many research groups. Since boron-centred tripod 
ligands can accommodate a diversity of donor atoms (carbon, nitrogen, phosphorus, 
oxygen and sulphur) it is very attractive to investigate new possible donors. 
Selenium is another chalcogen element with properties similar to sulphur and can be 
a good donor for this ligand system. 
Despite existing in many oxidation states (2, 2, 0, 4, 6), Se(H) is 
commonly used in organic chemistry due to its biological activity and catalytic 
applications of organoselenium compounds, as diselenides and selenides. 32-34  Since 
selenium atoms are larger than sulphur, these compounds present a longer Se-C bond 
(1.98 A) than the C-S bond (1.81 A) in organosulphur compounds. In comparison 
with sulphur, selenium is less electronegative and thus a stronger donor. 32 
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To synthesize an analogue of the Tm ligand with Se donors in place of S it is 
necessary to obtain a selenium analogue of methimazole. The main characteristic that 
makes the methimazole a good heterocycle for this ligand system is that it exists 
mainly in its thione form. However, in general selones are more stable than selenols, 
as the latter easily dimerize under oxidative conditions . 3 ' The use of a heterocycle 
with a selone functional group is therefore essential for a successful synthesis of new 
boron centred tripodal ligands. 
Metal complexes with selone ligands have been synthesized previously by 
Williams and Wazeer (Fig.3.9 and Fig.3.10). 36 ' Williams and co-workers reported 
the first complex with two 1,3-dimethylimidazole-2-selone ligands coordinated to 
cobalt(fl) (Fig.3.9). 41 
.. 
3.8 
Fig.3.9. Structure of dichlorobis[], 3-dimethylimidazole-2(3H)selone-Se]coball(7I) 
reported by Williams and co-workers. 4 ' 
Other complexes of Au(H), Ag(H) and Hg(H) with imidazolidine-2-selone 
and imidazole-2-selone as ligands can also be found in the published work by Ahmad 
and Wazeer. 3638 ' ° 
ffoU 
	
3.9 	 3.10 
Fig.3. 10. Structures of {chloro -1ris/N-m ethyl -2 (3H) -imidazolidine-2- 
seloneJmercury(II)Jchloride 	and dich!om-bis(N-isopropyl-imidazo/idine-2- 
selone)mercury(II) 3.10. 39 
3.6.1. Selenium analogue of methimazole: synthesis and liciands 
The first synthesis of the selenium analogue of methimazole, 1-methyl-
imidazole-2-selone, was presented and characterized by (luziec in 1994 in order to 
study its activity to inhibit the thyroid hormone synthesis. As for methimaz.ole, this 
seleno-imidazole also can exist in two tautomeric forms, selenol and selone, one 
more stable than the other. 42 According to Guziek, the synthesized selenium version 
of methimazole was very similar to the sulphur analogue, thus the product obtained 
was likely to be a selone. To continue this investigation on anti-thyroid inhibitors, 
Mugesh and co-workers improved Guziek's synthesis and proved that the previously 
reported selone was in fact a di-selenide species produced by oxidation. The 
formation of this dimer was an indication that the product synthesized was in the 
selenol rather than in the selone tautomeric form as this oxidative dimerization is 
very common amongst selenols. 35 Mugesh also reported that this dimerization can be 
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reversible by reacting the di-selenide with sodium borohydride to afford the 




N/>__Se_Se N huh > 1. BuLLFTHF at -78°C 	CNse 
, 	02 
2 Se 	 ___________ 
N 	3. H/HCI 
	
NH 	
NaBH4 	N 	 N 
/ 3.11 	 3.12 
Scheme 3.5. Synthesis of 1-methyl-imidazole-2-selene 3.11 and its dimer 3.12.
42-44 
 
From Mugesh's and Guziek's presented work it was not clear which 
tautomeric form of the selenium analogue of methimazole was more stable. 
Nevertheless, some work on the synthesis of this selenium analogue of methimazole 
was developed for this thesis and syntheses of some ligands were attempted. 
For this work, the selenium analogue of methimazole was synthesized from 
1-methylimidazole following the methodology represented in Scheme 3.5. However, 
only the di-selenide form of 1 -methyl-imidazole-2-selone could be isolated due to 
aerial oxidation. The fact that borohydride could be used to reduce this dimer back 
to the selone, and could also be used to synthesise the anionic Tm ligand led to the 
investigation of a different approach in order to synthesise the target boron-centred 
tripodal ligand with selenium donors. It was investigated whether the target ligand 
could be obtained from the melting reaction of the diselenide with an excess of 
NaBH4 (Scheme 3.6). 
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H 	 I 
3 	 se—Se +  2 NaBH4 	2 N_(/( 	 + 6K2 
3.12 	
H 	 $0 	 Se 
3.13 
Scheme 3.6. Attempted synthesis of hydrotris(1-methylimidazolyl-2-selone)boran-e 
3.11from the dimeric form of 1-methylimidazole-2-selone 3.12. 
This approach was unsuccessful since analysis of the solid product obtained 
did not reveal any traces of the desired ligand. 
While this work was being developed, a study on the stability of this selenium 
analogue of methimazole was reported by Parkin and collaborators, which helped to 
clarify the incongruous conclusions of Mugesh and Guziek on the stability of the 
selone and selenol tautomers. 45 
3.6.2. Selenol!selone tautomevism 
The structural study by Parkin and co-workers was focused on two systems of 
molecules, 1-R-2-hydroselenoimidazole/1-R-imidazole-2-selone, (R as methyl or 
mesityl groups; Fig.3. 11). 
C\:~= Se — C\-r- 
N
SeH] 
R = CH3Jj 
Fig.3.1 1. Selone/selenol tautomersism of (1-R-2-hydroselenoimidazole/1-R-
imidazole-2-selone) studied by Parkin and co-workers. 45 
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Parkin chose to synthesize a selenoimidazole substituted in the 1-position by 
a mesityl group due to its easy preparation, and to apply it to the synthesis of a 
selenium donor ligand analogue of TmM.  The insertion of a bulky mesityl group 
provides greater stability against rapid oxidation of this selenium compound. 
Parkin's study was based on characterization by NIMR and X-ray analysis of both 
mono and dimeric forms of the two systems 1-methyl-2-hydroselenoimidazole/1-
methyl-imidazole-2-selone and 1 -mesityl-2-hydroselenoimidazole/ 1 -mesityl-
imidazole-2-selone. 
The X-ray diffraction analysis of the selenium analogue of methimazole (R = 
Me) indicated the presence of a hydrogen atom attached to nitrogen, showing that the 
selone tautomer was crystallized. As for methimazole, the structure of these crystals 
is constituted by pairs of hydrogen bonded dimers (Fig.3. 12).' 47 
b) 
Fig.3.12. Methimazole (a) and its selenium analogue 	
47,48 
The interaction of the selenium atoms with the hydrogen were also found in 
the structure of the 1 -mesityl-imidazole-2-selone. 
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A short time after Parkin's research group published this structural study, 
Mugesh reported the crystal structure of 1-methyl-imidazole-2-selone and also 
concluded that the selone was the stable tautomer. 49 
3.6.3. Attempted lipand synthesis with I rnesitylimidazoIe-2-seIOfle 
Since the 1-mesityl-imidazole-2-selone was more stable towards oxidation 
than its methyl analogue, it was attempted to synthesize a boron-centred tripodal 
ligand functionalized in the 4 th position by N-methylimidazole. This ligand was 
targeted since previous work was developed with [(N-methylimidazole)B(mt)31 and a 
good comparison of the donor properties of the novel ligand could be readily 
observed. 
As l-mesitylimidazole is not a commercial product, it was synthesized as 
reported by Zhao and collaborators. 50  The synthetic route followed is represented in 
Scheme 3.7. 
0 
_______ 	 35% CH2O NH2 
+ 	
Meth.n 	
NH4CI, 85% PO,.-  RT 
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The target ligand was obtained from a one pot-reaction between 
tris(dimethylamino)borane, 1-mesitylimidazole-2-selone and N-methylimidazole in a 




NN 	+ 3 HNN 	 A I Toene B(NMe 	
+ \__j \__j _I? 
3.14 
3.15 
Scheme 3.8. Synthesis of [(N-methylimidazole)B( 1 -mesitylimidazolyl-2-selone)3]. 
The ligand formed, [(N-methylimidazole)B( 1 -mesitylimidazolyl-2-selone)3] 
(3.15), was analysed by 'H NMR and by positive ion (FAB) mass spectrometry. The 










Fig.3.13. Fab of [(N-methylimidazole)B(1-mesitilimidazole-2-SelOfle)31 with 
evidence of loss of selenium atoms. 
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The FAB spectrum showed the decomposition of the ligand via loss of the 
selenium atoms with formation of a species that could be the respective carbene 
species. A similar decomposition via loss of selenium on 1 -methylimidazole-2-
selone was also speculated by Hill and co-workers to explain the insertion of a third 
Se atom in the structure of a new diorganotriselenane ruthenium complex 
(Scheme.3.9). 5 ' 
 Cl 	CI 
2 
CN 
 >==Se + 	
-2 PPh3Ru 
PPh3 	 A' CI 
PPh3 N 	 Ph3P 
H 
3.10 /1 / CN~~ 
Se Se C> 
N 
	CI > — 
H 	 H 
Scheme 3.9. Synthesis of [Ru{0c 3- Se,N,N'-Se(mt9 2JCl2(PPh3)]rePOrted by Hill, 
showing a possible decomposition of the]-methylimidazole-2-selone via carbene 
formation. 5' 
For this work, the synthesis of these boron-centred tripodal ligands with 
selenium derivatives of methimazole started before the Parkin's research group 
reported the Tm ligand and its stability studies. 45' 52  Then, the importance of this 
project for this thesis was then limited due to lack of novelty. Therefore, it was 
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3.7. CONCLUSION 
Since the introduction of the Tm ligand, its derivatization has been studied 
extensively. This system is versatile and can easily be tuned electronically and 
sterically. In this chapter, two different thioimidazole analogues of methimazole 
substituted at the 4- and 5-positions (1-methyl-benzimidazole-2-thiOne and 1,4,5-
trimethyl-imidazole-2-thione) have been prepared in order to synthesize two new 
boron-centred tripodal ligands with sulphur donors: [(HNMe2)B(1,4,5-
trimethylimidazolyl-2-thione)3] (3.4) and [(HNMe2)B(1 -methyl-benzimidazolyl-2-
thione)3] (3.4). It is expected that these ligands present a protective environment 
around the boron bridgehead created by the methimazole substituents. Further 
investigation of the ligand [(L)B(1,4,5-trimethylimidazolyl-2-thiOfle)31 (L - chiral 
N-donor) will be presented in the next chapter. 
The ligand [(HNMe2)B(1methylbenzimidazolyl-2-thione)31 was coordinated 
to molybdenum tricarbonyl to afford the respective metal complex. The C-O 
stretching vibrations of this complex allowed the study of the donor properties of the 
ligand by comparison with other molybdenum tiicarbonyl complexes. It was then 
observed that this ligand is a better donor than the ligand [(HNMe 2)B(mt)3] presented 
in Chapter II, due to the electronic enrichment around the ligand promoted by the 
benzimidazole rings. 
In this chapter the work towards the synthesis of a boron-centred tripodal 
ligand system bearing selenium donor atoms was also presented. Work was done on 
the synthesis of selenium analogues of methimazole, but was abandoned due to its 
wide interest from other research groups despite its potential use for carbene 
chemistry. 
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CHAPTER IV 
CHIRAL SUBSTITUTED BORON-CENTRED TRIPODAL LIGANDS 
Chiral substituted boron-centred tripodal ligands 
4.1. INTRODUCTION 
The approach towards the synthesis of new boron-centred tripodal ligands 
with a chiral group on the boron bridgehead will be presented in this chapter. The 
work introduced in the previous chapters contributed to an understanding of the 
synthetic method adopted and the derivatization of this tripodal ligand system. The 
synthesis of a boron-centred tripodal ligand functionalized in the 
4th  position by a 
chiral, neutral N-donor such as (S)-(-)-a-methylbenzylamine will be presented and 
discussed. The different attempts undertaken to coordinate N-donors to the boron 
bridgehead will also be presented in this chapter. In order to introduce the work 
presented, an overview of the chirality of these ligands and their chiral complexes is 
provided, as well as the previous methodologies employed to obtain chiral Tm ligand 
derivatives. Finally, potential catalytic activity in asymmetric transfer hydrogenation 
using these chiral ligands will be discussed in the end of this chapter as future work. 
4.2. CHIRALITY OF TMR  LIGAND METAL COMPLEXES 
Metal complexes of the hydrotris(methimazolyl)borate (TM) ligand with x 3-
S,S,S coordination mode are C 3-symmetric and present a three-dimensional 
bicyclo [3,3,3 ]cage. This structure presents a type of atropisomerism by helical 
rotation about the B-M axis due to the angle strain within this cage. The 
interconversion between the two rotational enantiomers, LU and 666, can result from 
an associative or a dissociative process (Scheme 4.1). 1,2 
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The dissociative racemization process involves a low energy inversion of an 
eight-membered metallocycle formed after the de-coordination of one of the tripodal 
ligand aims from the metal centre (Scheme 4.1). After the inversion of the 
metallocycle, the tripodal arm re-coordinates to the metal centre to form the 
enantiomeric structure. This mechanism depends essentially on the dissociative 
energy between the metal and the donor atom which is related to the lability of the 














Inversion of 	/CN 






Scheme 4.1. Processes of interconvertion of the rotational enatiomers on Tm ligand 
metal complexes. 1 ' 
In the non-dissociative mechanism the enantiomers are interconverted by a 
conformational twist of the cage via a highly strained C 3 -symmetric transition state. 
The energy of the process is determined by the angle strain of the metal-ligand cage 
in this transition-state structure. 2 
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4.21. RacemizatiOn of Tm Ikiand metal complexes 
Bailey and co-workers reported some studies on the energy of racemization 
of a range of metal complexes containing Tm ligand analogues with diastereotopic 
protons, Tm"t  4.1 and Tm' 4.2 (Fig. 4.1), in four-coordinate complexes: 
[Tm"ZnCl], [Tm'ZnCl], [Tm" tCdCl], [Tm"tHgCl], [Tm"tCuPPh3], [TmEtAgPPh3]; 
and in six-coordinate complexes: [mItRu(pcymene]PF 
and [TmEtMn(CO)3]. 
$ 




Fig.4.1. Ligands used in the study of the barriers of C3 symmetric of complexes 
reported by Bailey and co-workers.' 
In these studies, the activation energy of the racemization process was 
calculated from the coalescence temperature measured by variable temperature NIvIR 
experiments for the complexes in donor solvents, such as dimethylsuiphoxide and 
acetomtrile, and in a non-donor solvents (tetrachloroethane and chloroform).' Fig.4.2 
displays the variable temperature 'H NUR spectra of [ZnTm" tCl] in deuterated 
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acetonitrile. The coalescence temperature is identified by the fst-exchange limit in 
which the methylene groups are no longer observed as diastereotopic. 
349 1 
T(X)I 
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Fig.4.2. VTNMR spectrum of the diastereotopic methylene proton signals of 
[ZnTmEtC1] in acetonitrile reported by Bailey and co-workers.' 
The activation energy of the racemisation process 	was determinated by 
Equation 4. 1, using the coalescence temperature (Tc) and the frequency of separation 
of the NMR signals in the slow exange limit (Av).' 
AG* = RTc [22.96 + In(Tc/Av)] 	 Equation 4.1 
The reported study revealed that the barrier of racemization for the four-
coordinate complexes falls between 55 and 77 kJ.mol' and was reduced by donor 
solvents. These low energies can be related to the substituition lability at d' ° metal 
ions. In the light of these observations, Bailey concluded that these complexes 
followed a dissociative mechanism for the racemization process. Scheme 4.2 shows 
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Scheme 4.2. Dissociative mechanism of racemization assisted by a donor solvent in 
a four coordinate complex.' 
This energetic barrier could not be determined experimentally for the six-
coordinate complexes, as the energy of the process was found to be higher than the 
limit of the method used (\'T NMR line shape analysis). Consequently, the 
mechanism of racemization in these complexes remains uncertain. However, the high 
energy of the process in these complexes (>100 kJ.moF'), and the lack of any solvent 
effects, indicate that a non-dissociative mechanism is followed as would be 
anticipated ftr these low-spin d 6 metal ions.' 
To complement this study, the energy between the C 3-symmetric (ground-
state) and the C3-symmetric (transition state) conformations for the non-dissociative 
mechanism in both [HB(C3H3N2S)3ZnCI] and [HB(C 3H3N2S)3Mn(CO)3] were also 
calculated ab initio by Bailey's research collaborators. The energy profile of this 
racemization mechanism, for the formation of two enantiomers is represented 
schematically in Fig.4.3. These DFT calculations estimated that this energy 
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difference was 121 kJmol' for the four-coordinate Zn(II) complex and 163 kJmoY' 





Lp~ L L LL 	 L 
reaction coordi 
Fig.4.3. Schematic energy profile of a non-dissociative mechanism of racemization 
for the formation of the enantiomers in C 3-symmetric complexes containing a 
bicyclo[3, 3, 3]cage. 
The racemization energy for the octahedral complexes studied by Bailey's 
group has been shown to be higher than 100 kJ.mol'. This indicates that the 
separation of the racemate is possible, however hitherto not accomplished. The 
understanding of the racemization mechanism in these different complexes is an 
important tool for the synthesis and isolation of single enantionric complexes, 
which is an objective of this thesis. 
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4.3. INTRODUCING CHIRALITY INTO THE TM LIGAND FRAMEWORK 
The introduction of chirality into the Tm ligand framework may enable the 
synthesis of a chiral ligand which, upon coordination, can generate a single 
diasteroisomeric complex. Chirality may be introduced into the structure of boron-
centred tripodal ligands at two different positions; it can be achieved by using chiral 
derivatives of methimazoles or by introducing a chiral group on the boron central 
tripodal atom. For this work only the latter approach was attempted. The synthetic 
methodologies employed previously by Bailey and Perucha to obtain a chiral ligand 
containing chiral groups on the methimazole N-atoms will first be discussed. 
4.3.1. Liqands with chiral methimazoles 
Bailey and Perucha reported the synthesis of a ligand containing 
enantiomerically pure a-methylbenzyl groups in place of N-methyl groups of the 





S + Me2N.... B.1 NMe2 + 	 MTolue 
N 	 F!JMe2 	 -3HNME a- 
4.3 
Scheme 4.3. Synthesis of[(N-methylimidazole)B(1(S)a-methylbeflzyli!flidaZOle-2- 
thione)3J via a one-pot reaction 3 
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This ligand was reacted with [Ru(p-cymene)C12]2 and NthPF6 to afford the 
respective Ru(H) arene complex with hexafluorophosphate counterions, [{(N-
methylimidazole)B( 1 (S)a-methylbenzylimidazole-2-thiofle)3 } Ru(p-cymene)] [PF 6 ]2 
(4.3). The structure of this complex is shown in Fig.4.4. 
Se 
4.3 
Fig.4.4. Structure of the Ai. diastereoisomer of[(('N_methylimidazole)B(l-(S)a- 
methylbenzylimidazole-2-Ihione)3)Ru(p-cYrflefle)1[PF6]2 (4.3) reported by Bailey. 3 ' 4 
The 'H NMR analysis of complex 4.3 showed only one pair of doublets for 
the diastereotopic protons of the p-cymene Pr methyl groups which indicates the 
presence of only one diastereotopic species. The crystal structure of this complex 
showed the presence of a single molecule per unit cell instead of an enantiomeric 
pair found in other achiral systems such as [{(N-methylimidazole)B(mt)3}Ru(P-
cymene)][PF6]2, confirming the presence of a single diastereoisomer. This complex 
presents a (W-S) configuration in a pseudo C3 symmetric environment. The (óoo-S) 
diastereisomer of this complex is not observed in the crystal. The conformations, ..UA 
and ôôà, have different energies and thus one is formed in preference during the 
synthesis of the complex. In this case the S-configuration of the a-methylbenzyl 
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groups favours the XAX form of the metal-ligand cage structure. The energetic profile 
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Fig.4.5. Schematic representation of the energetic profile for the formation of two 
energetically different diastereisomers through a non-dissociative mechanism of 
racemization. 
This demonstrates that it is possible to synthesise two diasterisomers with 
substantially different energies by incorporating chirality into the methimazole 
donors.' 
It was also observed in this complex that the Ru-S bonds lengths are longer 
than in Ru(H) complexes of other Tm analogues, indicating the steric protection at 
the metal binding  site induced by the chiral benzylamine groups on the 
methimazole. 3  This can limit the applicability of these complexes if metal reactivity 
is required, as in catalytic processes. 
131 
Chiral substituted boron-centred tripodal ligands 
4.3.2 Introducing chiralitv on the boron atom 
The insertion of chiral N-donors on the boron bridgehead of the 
tris(methimazolyl)borate framework is an alternative to the use of chiral 
methimazole analogues to synthesize single diastereomer complexes containing only 
the XXX or 86 metal-ligand cage. This approach was also used by Bailey and 
Perucha in order to obtain chiral ligands. Following their work on the synthesis of 
new ligands with tris(dimethylamino)borane, they sought to use chiral oxazolines to 
functionalize boron's bridgehead on analogues of Tin ligand. Their first attempt at 
the synthesis of a new chiral ligand was the reaction of (4R,5R)-4-methyl-5-phenyl-
2-oxazoline with tris(dimethylainino)borane and methimazole on a 1:1:3 ratio under 
reflux in toluene (Scheme 4•4•)•4 It was expected to obtain an analogue of [(N-
methylimidazole)B(mt)3] with the oxazoline replacing the N-methylimidazole. 3 
However, the analysis of the obtained product indicated the presence of a tetra-
coordinated borane with two methimazole rings, a dimethylamino and a formamide 
group (4.5). A cyclic structure formed via an intramolecular ring-opening reaction 
between the oxazoline and one methimazole sulphur atom could be the reason to 
explain the presence of a formamide group on the boron (Scheme 4•4)•3 
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Scheme 4.4. Reaction of(4R,5R)4methyl5phenyl-2-OXazOline with B(7VMe 2) 3 and 
meihimazole and the oxazoline ring-opening reaction products. 3 
To avoid the intramolecular oxazoline ring opening by the methimazole 
sulphur during the synthesis of new chiral ligands, Bailey co-vorkers tried to use 
other chiral oxazolines without a phenyl group at the 
5th position which can make the 
attached carbon more susceptible to a nucleophilic attack. The range of oxazolines 
used by Bailey and Perucha in their work is shown in Fig.4.6. 3 
0 	 N 	0 
Fig.4.6. Chiral oxazolines used by Bailey and Pencha in the attempted synthesis of 
new ligands. 3 
Despite using  other chiral oxazo lines to obtain a ligand, the outcome of the 
reactions was similar to the ring opening product. To investigate the effect of 
methimazole sulphur on the oxazoline ring opening, they performed a similar ligand 
synthesis replacing the methimazole by pyrazole rings. The product isolated 
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presented a tetrahedral borane with two pyrazole rings and an oxazo line attached 
always retaining the NMe2 group (Scheme 
4•5)•3 
NMe2 









Scheme 4.5. Reaction of (4R,5R)-4-methyl-5-phenyl-2-OXaZOlifle with B("e2)3 and 
pyrazole reported by Bailey . 3 
The retention of the dimethylamino group on the final product of both 
reactions can be related to the steric hindrance created by the other heterocycles 
which prevents the transaminat ion reaction with another heterocycle.' 
If the target chiral ligand was synthesized via substituition of HNMe 2 on 
[(HNMe2)B(mt)3] by the chiral oxazoline, by the method described in Chapter II, 
some of these problems could be avoided. This synthesis was not hitherto 
accomplished but can be considered as future work on this project. 
After the unsuccessful result with the oxazolines, Bailey and Perucha tried to 
functionalize the boron 4th  position in the Tin structure with (-)-tetramisole {(S)-(—)-
6-phenyl-2,3 ,5,6-tetrahydroimidazo[2, 1 -b]thiazole}. This chiral molecule was chosen 
for the ligand synthesis because of its basic pKa ( 8.17 in water)' which is in the 
range of the boron activating bases for the "one-pot "reactions. Then, the ligand [{(-)-
tetramisole}B(methimazolyl)3] was synthesized from the reaction of one equivalent 
of tris(dimethylamino)borane, three equivalents of methimazole and one equivalent 
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Scheme 4.6. Synthesis of {[(-) -tetramisole]B(methimazolyl)3}.4 
The ligand 4.8 was coordinated to [Ru(p-cymene)1 2 and the obtained chiral 
complex was characterized by NMR The 'H NMR of this complex showed the 






Fig.4.7. Diasteroisomers (S, A) and (SA) of the complex 
(tetramisole)B(methimazolyl)31 Ru(p-cyinene)]} 2 . 4 
The separation of the diasteoisomers of this complex was not possible despite 
attempts made by recrystallization and by chromatography. 4 The fact that both 
diatereoisomers of the complex are formed, albeit in unequal amounts, indicates that 
the interaction of the chirality of the tetramisole with the bicyclo[3,3,3] cage in this 
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complex is relatively weak and the energy difference between the two is small. This 
can be rationalized by the fact that the tetramisole phenyl ring can adopt a position 
where its interaction with the methimazolyl rings is minimal. 
The {[(-)-tetramisole]B(pyrazolYl)3} was also synthesized by Perucha 
(Scheme 4.7) and its structure was determined by X-ray crystallography (Fig.4.8). 4 
1'. I 
4.7 
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A I Touene 








Scheme 4.7. Synthesis of {[(-) -tetramisole]B(pyrazolyl)3).4 
4.9 
Fig.4.8. Crystal structure of {[(-)-Ietramisole]B(pyrazolyl)3). 4 
The crystal structure of the ligand 4.9 shows clearly that the tetramisole's 
phenyl ring is orientated perpendicularly to the C 3-axis of the ligand It is also 
assumed that the orientation of this phenyl ring is the same in ligand 4.8 and is 
maintained in the metal complex which explains the similar energies of the two 
diastereisomers. 
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4.4. SYNTHESIS OF BORON-CENTRED TRIPODAL LIGANDS 
FUNCTIONALIZED WITH CHIRAL MOLECULES 
4.4.1. Synthesis of boron centred tripodal lipands functionalized with (-
)-tetramisole 
In order to continue the work started by Perucha, some attempts at the 
synthesis of new chiral ligands were made. As observed in the previously 
synthesized ligands {[(-)-tetramisole]B(methimazolyl)3} and {[(-)-
tetramisole]B(pyrazolyl)3}, there is a weak interaction between the phenyl group of 
tetraniisole and the other heterocycles of the ligand. To increase this interaction and 
to synthesize a new chiral ligand, it was investigated whether the presence of methyl 
groups on the 4 th and 5 th  position of methimazole would increase the interaction 
between the tetramisole and the rest of the ligand. 
As the chiral heterocycle was only available as (-)-tetramisole hydrochloride 
it was obtained as the free-base as reported previously by Perucha and used for the 
ligand synthesis. 4 
The synthesis of a chiral ligand was carried out using 1,4,5-
trimethylimidazole-2-thione instead of methimazole or pyrazole. The synthetic 
approaches to this ligand are displayed in Scheme 4.8. 
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Scheme 4.8. Synthetic approaches to a new chiral boron-centred tripodal ligand 
using tetramisole tofunctionalize the boron 4th  position. 
The two synthetic methodologies adopted were: the "one-pot" reaction using 
tetramisole, tris(dimethylamino)borane and 1,4,5-trimethylimidazole-2-thione in a 
1:1:3 ratio, and the substitution of the dimethylamine in [(HNMe2)B(1 ,4,5-
trimethylimidazolyl-2-thione)3] by tetramisole. Both syntheses were set under 
toluene reflux for lOh or until the evolution of dimethylamine gas ceased. Despite 
the evolution of HNMe2 and the formation of a white precipitate in the reaction 
vessel, the product isolated from these reactions was only 1 ,4,5-trimethylimidazole-
2-thione. The 'H NMR and MS analysis of the recovered solid confirmed the 
presence of the modified methimazole and some impurities, however no traces of the 
(-)-tetramisole were found. 
A possible explanation for this is the low reactivity of the HNMe2 moiety due 
to the protective environment created by the methyl groups on the methimazole. This 
protected enclosure around the boron 0 position may prevent the coordination of the 
tetramisole in both syntheses. 
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4.4.2. Synthesis of boron-centred tripodal lipands functionalized with 1 
)-phenvlalanine derivatives 
In pursuance of new chiral molecules to functionalize the borane on the 
tripodal ligand some work was done with amino acid derivatives. 
Most a-amino acids are chiral and readily available. The presence of the a-
amino group which can coordinate to the boron was an attractive feature to this work. 
However, the presence of the -COOH group in these compounds could interfere in 
the ligand synthesis with tris(dimethylamino)borane as the oxygen of the -OH moiety 
could coordinate to the boron instead of the amine nitrogen. To avoid this problem, it 
was decided to use a-amino esters and a-phenylalanine methyl ester was chosen for 
this work The pI(3 of this amino ester is 7.11 (in water)6 which indicates that it 
should be able to coordinate to the borane through a "one-pot" reaction. 
A ligand synthesis was carried out using a-phenylalanine methyl ester, 
tris(dimethylamino)borane and methimazole in a 1:1:3 ratio, as shown on Scheme 
4.9. The reaction was left under reflux until HNMe2 evolution ceased (18h under 
reflux) and a white solid was recovered and analysed. The 'H NMR and MS of the 
product did not show the presence of the targeted ligand, but proved to be a mixture 
of products. None of these products could be isolated and identified. At this stage of 
the investigation, the ligand synthesis with the boron functionalized with primary 
amines was still in the beginning and since better results were obtained with tertiary 
amines (which are more basic) it was decided to carry on with the ligand synthesis 
using a dimethylamine analogue of the cx-phenylalanine methyl ester (Scheme 4.9). 
139 











R= H (4.11) or Me (4.12) 
Scheme 4.9. Attempts of tripodal-ligand syntheses with a-phenylalanine methyl ester 
and with its dimethylamine derivative. 
The dimethylamine derivative of the ct-phenylalanine methyl ester was 
synthesized via a reductive alkylation as reported by Wang and co-workers as shown 
in Scheme 4.10. 
0 	 0 
NH2 





Scheme 4.10. Synthesis of NN-dimethyl et-phenylalanine methyl ester. 
The ligand synthesis was attempted using the NN-dimethyl analogue of a-
phenylalanine methyl ester (4.14) in a "one-pot" reaction as shown in Scheme 4.9. 
The evolution of dimethylamme was observed during this synthesis; the reaction was 
heated under reflux for 20 h and a white solid was recovered. The 'H NIvIR spectrum 
of this material (Fig. 4.9) showed that the product obtained was a mixture and not the 
target chiral ligand. The presence of a broad signal due to an NH group in the 
spectrum may be an indication of the presence of [(HNMe 2)B(mt)3] or unreacted 
methimazole. The identification of the components of this mixture is difficult due to 
different methyl protons signals in the spectrum (Fig. 4.9). The MS of this compound 
does not show the expected molecular ion mass for the desired ligand (M: m/z = 
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557). The isolation and characterization of the components of this mixture was not 
undertaken as other synthetic approaches to insert chirality into the boron were 
attempted. 





110 	 10.0 	 9.0 	 LO 	 70 	
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Fig.4.9. 'HNMR of the crude product obtainedfrom the reaction of N,N-dimethyl 
analogue of ci-phenylalanine methyl ester, tris(dimethylamino)borane and 
methimazole on a 1:1:3 ratio. 
A possible cause for these unsuccessful results can be related to the cyclization of the 
methyl ester forming a boroxazoline by coordination of one amino ester oxygen atom 
to the boron (Fig.4. 10). 
/ 
Rz )N N 
L,0 op 
4.18 
R= H Me 
Fig.4.10. Possible structure of the boroxazoline formed during the ligand synthesis. 
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4.4.3. Synthesis of boron-centred tripodal ligands functionalized with - 
methvlbenzvlamifle 
Benzylamine was one of the N-donors used to substitute the dimethylamine 
in [(HNMe2)B(mt)3} as presented on Chapter H. This base was the first primary 
amine found to coordinate to the boron atom of tripodal ligand. The easy and readily 
available chiral analogues of this amine made it an attractive compound to be used in 
this work. (S)—a-methylbenzylamine was the chiral benzylamine analogue chosen 










Fig.4.11. Chiral ligands synthesisedfor this work. 
The synthesis of two ligands was carried out using the chiral (S)—a-
methylbenzylamine to coordinate the boron 
4th  position. The ligand [(S)-(-)-cc-
methylbenzylamine}B(mt)3] 4.19 (Fig.4. 11) was obtained via a "one-pot" reaction 
using methimazole, the chiral amine and tris(dimethylamino)borane in a 1:1:3 ratio 
in a toluene solution under reflux until the HNMe2 evolution ceased (after 48 h). 
After removing the toluene under vacuum and washing the remaining precipitate 
with diethyl ether, a white solid was recovered in 44% yield and analysed. The 'H 
NMR in deuterated chloroform of this product showed clearly the presence of the 
three methimazole rings which appear as a group of three signals: two doublets at 
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7.04 (three protons) and 6.68 ppm (three protons) for the six CH moieties, and a 
singlet at 3.42 ppm which corresponds to three methyl groups present in the ligand. 
In the same spectrum, the (S)—a-methylbenzylamine protons generated four different 
signals: a broad signal at 10.24 ppm assigned to the NH 2 group, a multiplet from 7.38 
to 7.21 ppm corresponding to the phenyl ring, the proton attached to the chiral 
carbon generated a characteristic quartet at 4.06 ppm, and a doublet at 1.30 ppm 
which was assigned to the methyl group of the chiral amine. The '3C NMR showed 
four signals for the three methimazolyl rings which confirm the equivalence of each 
ring on the ligand. The FAB MS ([M+l] = 472) and the CHN analysis also 
confirmed the presence of this ligand. 
The ligand 4.20 containing the 4,5-dimethylmethimazolyl donors was 
synthesized from a "one-pot" reaction similar to the one used to obtain 4.19. 
However, for this ligand synthesis the methimazole was replaced by its dimethylated 
derivative, 1,4,5-trimethylimidazole-2-thione, as displayed in Scheme 4.11. This 
















Scheme 4.11. Synthesis of [((S)-(-)- cx-methylbenzylamine)B(1, 4,5- 
trimethylimidazolyl-2-lhione)31 4.20. 
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The ligand 4.20 was recovered as a white solid in 31% yield by a similar 
procedure as employed for the synthesis of 4.19. The analysis of the product by 'H 
NMR showed the presence of the three dimethylated methimazole rings as three 
different singlets at 3.50, 3.47 and 2.02 ppm corresponding to nine protons each. The 
presence of (S)-cx-methylbenzylamine was also confirmed by the presence of similar 
signals as observed for the ligand 4.19. A comparison of both ligands signals shows a 
downfield shift of the chiral benzylamine signals for 4.20. From the spectrum it is 
possible to observe five different signals for the chiral benzylamine: a broad signal at 
11.54 ppm which corresponds to the NH2 protons, a multiplet between 7.32 and 7.27 
ppm which is assigned to the aromatic protons, the proton and the methyl group 
attached to the chiral carbon which generate respectively a quartet at 4.11 ppm and a 
doublet at 1.38 ppm. The ' 3C NMR showed five signals for the carbons in the 
dimethyl methimazolyl moiety indicating an equivalency between all the three 
heterocycles in the ligand 4.20. The successful formation of this ligand indicates that 
the methyl groups of 1,4,5-trimethylimidazole-2-thione do not fully block the 
coordination of donors to the boron. The presence of this ligand was also confirmed 
by FAB MS ([M+1] = 556) and the CHN analysis also confirmed the presence of 
this ligand. 
4.5. CHIRAL LIGAND TO METAL COORDINATION 
In order to study its donor properties, the ligand 4.20 was coordinated to 
molybdenum 	tricarbonyl. 	The 	[{(S)-(-)-cx-methylbenzylamine)B(1 ,4,5- 
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trimethylimidazolyl-2-tbiOfle)3}MO(CO)31 4.21 was synthesized by reacting the 
ligand 4.20 with [Mo(MeCN)3(CO)3] prepared from Mo(CO)6 in situ in acetonitrile 
at room temperature for 24 h. This reaction was followed by infra red spectroscopy 
until completion. The analysis by positive FAB mass spectrometry revealed the 
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4.21 
Fig.4.13. [{(S)-(-)-ct-methylben2ylamine)B(1, 4, 5-trimethylimidazolyl-2- 
thione) 3]Mo(CO)3] 4.21. 
The complex 4.21 was analyzed by infra-red spectroscopy and the observed 
C-O stretching frequencies were compared with the other two molybdenum 
complexes synthesized in this work. The C-O vibrations of the three complexes are 
displayed in Table 4.1. 
145 
Chiral substituted boron-centred tripodal ligands 
Table 4.1 Infra-red C-O stretching frequencies of the molybdenum complexes 




3.6 2.28 - 41 
u 	(cm) 1979,1950 1987, 1957 1952, 1957 
Medium Hexane Hexane Hexane 
From Table 4.1, it is clear that the complex 4.21 presents the lower C-O 
stretching energy which indicates a higher electron donation from the ligand to the 
metal. This indicates that the ligand 4.20 is a better donor than the other two ligands 
synthesized for this thesis. The donor properties of the ligand 4.20 are affected by the 
presence of the a-methylbenzylainine on the boron bridgehead and the methyl 
groups on the methimazole 4 th and 5 th  positions. In comparison to the other 
complexes, 4.21 presents a primary amine coordinated to the boron instead of a 
secondary amine as on the other two complexes which may affect the charge on the 
boron atom. 
The complex 4.21 was also analysed by 'H and ' 3C NMR spectroscopy, 
however some impurities were identified during  this analysis maybe caused by 
decomposition (Fig.4. 14 and Fig.4. 15). The proton NMR spectrum showed the 
presence of two sets of signals in 1:7 ratio approximately (Fig. 4.14). 
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Fig.4. 14. 'H NMR of[(('S)-(-)-a-methylbenzylamine)B(1 4, 5-trimethylimidazolyl-2- 
thione) 3}Mo(CO)3J (4.21) showing the two sets of signals in a 1:7 ratio. 
This observation was confirmed by the carbon NMR spectrum which clearly 
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Fig. 4.15. 13C AMR  of [{(S)-(-)-a-melhylbenzylamine)B(1, 4, 5-trirnethylimidazolyl-2- 
ihione) 3}Mo(CO) 314.21 showing the two sets of signals. 
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The presence of these two sets of signals indicates the presence of two 
diastereoisomers due to the complex bicyclo[3,3,3] cage twist. The 1:7 ratio of the 
two diastereoisomers synthesized shows that a small interaction between the chiral 
methylbenzylainine and the methyl groups in methiniazole 
4th and 5th  position which 
allows the twisting of the cage structure. This is a promising result to achieve the 
single diastereisomer synthesis of this system. The synthesis of a ligand analogue of 
[{(S)-(-)-(t-methylbenzylamine)B(l ,4,5-trimethylimidazolyl-2-thiOfle)3] using 1-
methylbenzimidazole-2-thione instead of methimazole can be considered as a future 
work for this project since the presence of the aromatic rings on the methimazole can 
interact more with the chiral group on the boron and therefore increase the energy 
difference between complex diastereoisomers. 
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4.6. CONCLUSION 
In this chapter, the work towards the synthesis of new boron-centred chiral 
tripodal ligands in order to obtain a single diastereoisomer of the respective metal 
complex was presented. For this purpose, it was attempted to improve the chiral 
ligand {[(-)-tetranhisole]B(methinlazolyl)3} by replacing the methimazole by its 
dimethylated analogue, 1,4,5-trimethylimidazole-2-thiOfle. Despite the two synthetic 
methodologies tried for the ligand synthesis, it was not possible to obtain the target 
ligand, possibly due to steric constraints between the methyl groups on the 
methimazole and the phenyl ring of the (-)-tetramisole. Thereafter, it was tried to 
functionalize the boron 4th position with the chiral phenylalanine ester and its 
dimethylamine derivative. This approach was not as successful and the aminoester 
may have undergone cyclization to form the respective boroxazoline. Finally, the 
synthesis of a chiral ligand was achieved by using (S)-(-)-cx-methylbenzylamine to 
coordinate to the boron bridgehead of the tripodal ligand. The chiral ligand, [(S)-(-)
a-methylbenzylamine)B( 1 ,4,5-trimethylimidazolyl-2-thione)3] was successfully 
synthesized and its coordination to molybdenum tricarbonyl showed to afford two 
diastereoisomeric complexes in a 1:7 ratio. The formation of two cliastereoisomers 
was surprising since it was expected a greater interaction between the chiral 
methylbenzylamine coordinated to the boron central atom and the methyl groups on 
the 0 and 5th  position of the methimazole. However, this is a very promising result 
and indicates that this system can still be improved in order to obtain a single 
diasteroisomeric complex with ruthenium or rhodium which can be tested as catalyst 
for asymmetric transfer hydrogenation. 
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4.7. CATALYTIC APPLICATIONS OF THIS CHIRAL SYSTEM 
The synthesis of a single diastereisomer of a complex with a chiral boron-
centred tripodal ligand was the aim of this work. Although, the synthesis of a single 
diasterisomer of a complex was not hitherto accomplished, it is important to relate 
this chiral system with its applicability. 
The idea behind this project is to explore the atropisomerism and the C3- 
symmetry present in the tris(methymazolyl)borate complexes and to apply it as an 
effective catalyst for asymmetric transfer hydrogenation. 
Several chiral systems displaying atropisomerism have applications in 
asymmetric catalysis. This type of chirality is present in binaphthyl derivatives, such 
as BINAP and BINOL ligands (Fig.4.16 and Fig.4.17), commonly used in catalysis, 
where two enantiomers are formed by restricted rotation around the C-C bond 
between the two naphthyl rings. 8, 9 The success of these ligand systems in 
enantioselective catalysis is usually related to two fold symmetry and their type of 
chirality, which inducts symmetric transformations •10 
(R)-BINAP 	 (S)-BINOL 
2,2'-bis(diphenylphosphino)-1 , I '-binaphthyl 	1 ,1'-binaphthyl-2-oI 
Fig.4.16. Structures of BINAP and B17VOL 8' 9 
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Fig.4. 17. Structure of (t 6-Benzene)-ch1oro-(2 ' 2 .bis(dipheny1phosphino)-1, I '- 
binaphthyl-P.P9-rutheniurn(W reported by Noyori." 
The two-fold symmetry is a common feature amongst the most successful 
catalysts used in asymmetric transfer hydrogenations. There are many advantages of 
the use of C 2-symmetry in catalysis, such as the possibility to reduce the formation of 
possible isomeric metal complexes and to minimize the number of different 
catalyst/substrate arrangements. This leads to a reduction of reaction pathways and 
intermediates which facilitates analysis of the ligand/substrate interaction, which 
may be crucial in the enantioselective process, and the kinetic studies of the catalytic 
reaction. 12 The successful chiral recognition in C 2-symmetric bidentate ligand 
systems is due to the formation of two identical situations upon rotation of 1800.  This 
is an advantage relative to C,-symmetric systems which can only form two different 
diastereoisomers. Besides this disparity, other ligands with different topologies and 
symmetry have also been employed for asymmetric catalysis. 
The increase of symmetry of a catalyst employed on asymmetric 
transformations can reduce the number of intermediate states in catalyzed reactions, 
as chirality is only compatible with proper rotational axis. This fact contributed for 
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the exploitation of complexes bearing C 3-symmetric ligands in asymmetric catalysis 
instead of the usual twofold symmetric ligands, as B1NAP, used in chiral 
transformations. 13  The homotopic sites present in a complex with a twofold bidentate 
ligand, or in a complex with a threefold symmetric tridentate ligand, depends on the 
geometry of the complexes. The favourable geometry of the complexes with C2- and 




2 homotopic sites 
A=B=C 
3 homotopic sites 
Fig. 4.18. Homotopic sites present on a tetrahedral complex with a bidentate 
ligand and of an octahedral complex with a tridentate ligand. 
An increase of the number of homotopic sites of the catalyst reduces the 
number of intermediate rotamers formed during the reaction and can maximize the 
probability of success of the chiral recognition during the catalytic process. 
13 
Although, it is important to establish that this is not a "universal rule" and 
experimentally the mechanism of a certain reaction can change when the symmetry 
of the ligand in the catalyst is different. 13 
An example of the effect of increasing the ligand symmetry in a certain 
catalyzed reaction was verified by Gade and co-workers while comparing the activity 
of copper (H) complexes with a threefold and a twofold oxazoline ligand system. 
Gade's studies were focused on an enantioselective Mannich reaction catalyzed by 
[(iPr-TRIZOX)Cu}(C104)2  and by [(iPr-BOX)Cu](C104)2 (Scheme 4.12). 
' 
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yield 84 % 
90% ee - (iPr-TRISOX] 
84 % ee - (IPr-BOX] 
Scheme 4.12. Enantioselective Mannich reaction of ethyl 2-methylacetoacetate with 
N-tosyl-ct-imino methyl ester catalyzed of by [(iPr-TRISOX)Cu](C104)2 and by [(iPr- 
BOX)CuJ(C10 4)2]. 14 
For this system, (3ade and collaborators observed that with 10 1/6 of catalyst 
the yield obtained was the same, however the enantioselectivity of the catalyst 
increased when the tripodal oxazoline ligand was employed (Scheme 4.12). ' 
In spite of the success of the TRISOX ligand and other C3-symmetric tripodal 
ligands in catalysis, 13 their potency to promote asymmetric transfer hydrogenation 
has not yet been assessed. 
The combination of atropisomerism and three-fold symmetry in the Tin 
ligand backbone makes it a good candidate as asymmetric transfer hydrogenation 
catalyst. It is expected that complexes of ruthenium with chiral pseudo-C3-symmetric 
ligands can catalyse enantioselective ketone hydrogenations following an inner-
sphere mechanism with the formation of a metal hydride as reported in reactions 
catalysed by Ru(PPh)3 Cl2 .' 5 
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Me 	 ,Me 
L,,, 
LIH 
:i: ,7!!, M,~), R' 
S - Solvent 
X - Halogen (Cl. Br, I) 
1 Catalyst Induction 
and olcoxide coordination 
2 Hydride transfer 
3 Coordinated ketone 
".- a' exchange 
\ Coordination of solvent 
molecule and 
asymmetric hydride transfer 
5 Coordinated alcohol 
exchange 
Fig.4.19. Catalytic cycle for asymmetric transfer hydrogenation catalysed by an 
octahedral complex with a tridentate ligand via metal-hydride for,nation.' 5 
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All the experiments were performed using Schienk techniques, under a nitrogen 
atmosphere, with glassware dried at 160°C. Solvents were distilled and dried by 
standard methods' or used directly from a Glass Contour solvent purification system. 
All chemicals were obtained from Sigma-Aldrich and used as received. 
Tris(dimethylamino)borane, 1 ,5-diazabicyclo[4. 3. 0]non-5-ene (DBN) and N-
methylimidazole were used as received and stored under nitrogen atmosphere. [Ru(p-
cymene)C12]2 was prepared according to the methods reported by Jensen 
.2  Mass 
spectrometry was recorded on two different spectrometers: Micromass Platform II 
(ES-MS) and Maspec II System. IR spectra were recorded from 4000 to 400 cm' 
with a JASCO FF-IR 410 instrument. NMR spectra were recorded on three different 
spectrometers operating at room temperature: Bruker ARX 250, Bruker DPX 360 
and Bruker DMX 500. 'H chemical shifts are reported in ppm relative to TMS (ö = 
0). Peak multiplicity is abbreviated: singlet, s; doublet, d; dd, doublet of doublets; 
broad, br; triplet, t; multiplet, m septet, sept; quartet, q. 
All ligand syntheses were followed by testing the evolution of dimethylamine gas 
from the reaction mixture with a simple pH paper test. Reaction times may differ if 
nitrogen is bubbled through the reaction vessel. 
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5.1.EXPERIMENTAL PART CHAPTER II 
I(dimethyIamine)B(PYIoIY1 2.8 
Tris(dimethylamino)borane (0.515 cry?, 2.90 mrnol) was added dropwise to a 
suspension of pyrazole (600 mg, 8.80 mmol) in 5 cm 3 of dry cyclohexane. This 
reaction is exothermic and dimethylamine gas evolution is immediate. The mixture 
was heated under refiux for 2 K The white solid formed was filtered, washed twice 
with 5 cm3  of cold diethyl ether and dried under vacuum. (560 mg, 751/o). 
'H NMR (250.1 MIHz, CDC13): ö,. 9.78 (1H, br), 6.66 (3H, m), 6.45 (3H, s), 3.58 
(15H, s). 
((dimethylamine)B(methimazolyl)31 2.1 14 
Tris(dimethylamino)borane (2.44 cm3, 13.4 mmol) was added to a suspension of 
methimazole (4.61g. 40.2 mmol) in 15 cm 3 toluene. This mixture was heated under 
reflux for 4 h. A white precipitate was formed after 1 K The solvent was removed 
under vacuum and the white powder was washed twice with 5 cm3 of diethyl ether, 
filtered and dried under vacuum (4.18 g, 79%). 
'H-NMR (250.1 MHz, CDC13): SH 7.70 (3H, d, 3J = 1.7 Hz), 7.51 (1H, s), 7.03 (3H, 





N-methylimidazole (0.093 cm3, 1.1 7mmol) and tris(dimethylamino)borane (0.205 
cm3, 1.17 mmol) were added to a suspension of methimazole (400 mg, 3.50 mmol) in 
10 cm3  of toluene. This mixture was heated under reflux for 4 h. After cooling  a 
white precipitate was observed. The precipitate was filtered by cannula and washed 
three times with 5 cm3 of diethyl ether (358 mg, 71 1/6). 
Method 2 
N-methylimidazole (0.0403 cm3, 0.506 mmol) was added to a suspension of 
[(dimethyla.mine)B(methimazolyl)3] (200 mg, 0.506 mmol) in 15 cm3 of toluene 
The mixture was heated under reflux for 3 K After lh, the clear solution became 
cloudy with a white precipitate. The white precipitate was filtered by cannula and 
washed three times with 5 cm 3 of diethyl ether. (134 mg, 75%) 
'H NMR (250.1 MHz, CDC13): SH 7.45 (11-L s), 7.07(1H, s), 6.69-6.64(6H, s), 3.70 





In 20 cm3  of toluene, 1,5-diazabicyclo[4.3.0]non-5-ene (0.200 cm3, 1.68 mmol), 
tris(dimethylanuno)borane (0.281 cm3, 1.68 mmol) and metbimazole (500 mg, 4.38 
mmol) were added together and heated to under refiux After 1 h a white precipitate 
had formed from the solution. The solution was heated for a further 3 h. The white 
solid was filtered via cannula and washed three times with 5 cm 3 of diethyl ether. 
The ligand was isolated in 78% yield (621 mg). 
Method 2 
1,5-diazabicyclo[4.3.0]non-5-ene (0.064 cm 3 , 0.506 mmol) was added to a 
suspension of 200 mg (0.506 mmol) [(dimethylamine)B(methimazolyl)3] in 15 cm 3 
of toluene. The mixture was heated under reflux for 5 h. After 1 h, the clear solution 
became cloudy with a white precipitate. The reaction was carried out for a further 4 
h. The white precipitate was filtered by cannula and washed three times with 5 cm3 
of diethyl ether (172 mg, 72%). 
C19H27BN8S3 (474.16): calcd.: C, 48.10; H, 5.74; N, 23.61; found: C, 47.60; H, 5.46; 
N, 23.36 %. MS (FAB): m/z = 474 (M); 'H NMR (500.1 MHz, CDC13): oH 6.71 
(3H, d, 3J = 2.5 Hz), 6.67 (3H, d, 3J = 2.2 Hz), 6.6-6.5 (4H, m), 3.6 (9H, s), 3.56-
3.49 (4H, m), 3.39-3.33 (2H, m), 2.05-1.9 (21L br); 13C-NMR (90.5 MHz DMSO-
d): öc  161.0 (C=S rn), 129.3 (Cq  DBN), 120.1 (CH in),  114.1 (CH !vçil),  46.9 (CH2 
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DBN), 43.9 (CH2 DEN), 42.9 (CH2 DNB),  34.9 (CH2 DBN), 30.7 (CH2 DBN),  24.1 (CI-3 
MTI), 18.3 (CH2 DBN). 
E(DMAP)B(metbim0IyI)31 2.20 
Method 1 
To a solution of 4-(dimethylamino)pyridine (148 mg, 1.3 mmol) in 20 cm' of toluene 
was added tris(dimethylamino)borane (0.232 cm 3, 1.3 mmol) and methimazole (455 
mg, 3.96 mmol). The reaction was heated under reflux. After 2 h a white precipitate 
was observed in the solution and the mixture was heated for a further 4 h. A white 
solid was recovered by filtration and washed three times with 5 cm3 of diethyl ether 
to yield 534 mg of product (87%). 
Method 2 
To a solution of 4-(dimethylamino)pyridine (61.7 mg, 0.506 mmol) in 15 cm 3 of 
toluene was added [dimethylamine)B(methimazolyl)] (200 mg, 0.506 mmol). The 
mixture was heated under reflux. After 2 h the solution became cloudy with a white 
precipitate. The reaction was heated for a further 2 h. A white precipitate was formed 
after cooling and it was isolated by filtration. It was washed three times with 5 cm 3 of 
diethyl ether to yield 181 mg (76%) of a white powder. 
'H NI4R (250.1 MHz, CDC13): öj, 8.23 (2H, dd, 3J= 1.6 Hz and 3J = 6.5 Hz), 6.65 
(314, d, 3J = 2.4 Hz), 6.61 (311, d, 3J = 2.3 Hz), 6.43 (211, dd, 3J = 1.6 Hz and 3J 





To a suspension of methimazole (300 mg, 2.63 mmol) in 15 cm 3 of toluene were 
added (0.153 cm3, 0.877 mmol) tns(dimethylainino)borane and benzylamine 
(0.0956 cm?, 0.877 mmol). The mixture was heated under reflux for 9 K A white 
precipitate was formed after 3 h. The powder was isolated by cannula filtration and 
washed three times with 5 cm 3 of diethyl ether (220 mg, 54%). 
Method 2 
To a suspension of [(dimethylamine)B(methimazolyl)3] (362 mg, 0.917 mmol) in 20 
cm3 of toluene was added benzylainine (0.100 cm 3, 0.917 mmol). The mixture was 
heated under reflux A white solid was observed after 1 h of reaction and the reaction 
was continued for a further 11 h. The powder was filtered and washed three times 
with 5 cm3 diethyl ether (167 mg, 40%). 
C19H24BN7S3 (457.4): calcd.: C, 49.89; H, 5.29; N, 21.43; found: C, 49.74; H, 5.56; 
N, 21.32 %. MS (FAB): m/z = 457.4 (M + 1); 'H NMR (360.1 MHz, CDC13): 511 
7.50-7.3 7 (5H, m), 6.71 (3H, d, 3J= 2.6 Hz), 6.67 (3H, d, 3J= 0.8 Hz), 6.35 (2H, s), 
3.89 (3H, s), 3.61 (9H, s); 13C NMR (90.5 MHz, CDC13): öc 162.5 (C=S Mn), 129.4 
(2CH BZA),  129.1 (2CH RZA),  128.7 (CH BZA),  127.5 (CH BZA), 121.16 (CH2 mm), 





To a suspention of 1,4-diazabicyclo[2.2.2]octane (81 mg, 0.725 mnxil) in 25 cm3 of 
toluene were added tris(dimethylamino)borane (0.255 cm 3, 1.46 mmol) and 
methimazole (500 mg, 4.35 mmol). The reaction was heated under reflux for 48 h. A 
white precipitate was observed after cooling the mixture. It was dried and washed 
with three times with 5 cm3  of diethyl ether to afford 276 mg (83%) of product. 
Method 2 
To a suspension of 1,4-diazabicyclo[2.2.2]octafle (56.6 mg, 0.506 mmol) in 15 cm 3 
toluene was added [(dimethylaniine)B(methimazOlYl)3] (400 mg, 1.01 mmol). The 
mixture was heated under reflux for 36 h. A white precipitate was observed after 
cooling the mixture. The solvent was removed under vacuum and the powder was 
washed with three portions of 5 cm3  of diethyl ether to afford 182 mg (78%) of 
product. 
C18H27BN8S3 (462.47): calcd.: C, 46.75; H, 5.88; N, 24.23; found: C, 46.19; H, 5.08; 
N, 23.94 %; MS (FAB): m/z = 463.4 (M + 1); 'H NMR (360.1 MHz, DMSO-d): öij 
6.82 (3H, br, CH), 6.65 (3H, d, 3J = 2.1 Hz), 3.33 (1211, s), 3.04 (911, s); 13C NMR 
(90.5 MHz, DMSO-d6): öc 161.7 (Cq im), 119.3 (CHim), 113.9 (CH,rn) 45.5 (CH2 




To a suspension of ruthenium (III) chloride hydrate (3.0 g, 0.014 nx)l) in 200 cm 3 
ethanol was added a-terpinene (15 cm3 , 0.092 mol). The mixture was heated under 
refiux for 6 h. The solvent was evaporated to half volume and the remaining solution 
was kept at -10°C for 18 h to allow the product to precipitate. The solid was filtered 
and washed with cold ethanol. The solvent was removed and 3.3 g (75%) of a red 
solid was obtained. 
'H NMR (250.1 MHz, CDC13): ö., 5.47 (4H, d, 3J = 6.0 Hz), 5.33 (414, d, 3J = 6.0 
Hz), 2.92 (2H, Sept, 3J = 7.2 Hz), 2.15 (6H, s), 1.28 (6H, d, 3J = 6.7 Hz). 
[{(1,5.diazabicycIoI4.3.O1non5ene)B(methimazoIyI)3}RU(P-CYmefle)I IPF 6I 2  2.25 
[Ru(p-cymene)C1 21 2 (64.6 mg, 0.105 mmol) was dissolved in 15 cm 3 of dried ethanol 
and stirred at room temperature for 45 minutes. The ligand [(1,5-
diazabicyclo[4.3 .0]non-5-ene)B(methimazolyl)31 (100 mg, 0.210 mmol) was added 
in small portions and the mixture stirred for 12 hat room temperature. Then, NH 4PF6 
(171 mg, 1.05 mmol) was added and the precipitation of an orange solid was 
observed. After filtration by cannula, the solid was washed three times with 7 cm 3 of 
ethanol and twice with 10 cm 3 of diethyl ether. After drying under vacuum, the 
complex was obtained with a yield of 76% (171 mg). Crystals suitable for X-ray 
crystallography were obtained by slow diffusion of diethyl ether in a concentrated 
solution of the complex in acetonitrile. 
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CH4jBFl2N8P2RUS3 (1000.1): calcd.: C, 34.89; H, 4.13; N, 11.21; found: C, 34.16; 
H, 4.02; N, 11.15%; MS (FAB 4 ): m/z = 501.9 [(M + 1)/2]; 'H NMR (250.1 MHz, 
CD3CN): ö, 7.15 (3H, d, 3J = 3.0 Hz), 6.77 (314, d, 3J 3.1 Hz,), 5.53-5.39 (411t m), 
3.91 (1H, sept, 3J = 6.7 Hz), 3.77-3.71 (41-L m), 3.67 (9H, s), 3.64-3.39 (4H, m), 
2.47-2.38ppm(2H. m), 2.18 pm (3K s), 1.30 ppm(2H, m), 1.17 ppm(6H,t, 3J7 
Hz); 13C NMR (125.7 MHz, (CH3)2C0): öc 172.2 (C q  DBN), 148.9 (Cq Mn), 124.4 
(CH Mu'l),  124.1(CH mu), 107.8 (C q p.cym), 103.5 (Cq  p..cym), 87.3 (2CH p-cym), 86.3 
(CH 85.3 (2CH 55.3 (CH2  DHN),  46.7 (CR3 DBN), 45.4 (CR3 DBN), 37.1 
(CR3 DBN), 36.9 (CH2 DBN),  32.0 (CR3 	), 23.5 (CR3 	21.3 (2CH3 	19.5 
(CH2 DBN);  "B NMR (115.5 MHz, DMSO-d6): 5B 4.15. 
Table 5.1 Crystallographic data and structure refinement details for 2.25 
Crystal description red block 	- - 
Empirical Formula C31 H4 B F 12 N9 P2 RU  S3 
M 1040.75 
T/K 150(2) 
Crystal system Monoclinic 











Reflexions measured 8811 
Rim 0.0674 
Data with Ifl>4fl) 7122 
Absortlon correction type multiscan 
Mm/max transmission 0.334 / 0.827 
- R 0.0452 
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[{(DMAP)B(methimaZOlyl)3IRU(pCYmefle)1 [PF6]2 2.26 
{Ru(p-cymene)Cl2]2 (153 mg, 0.025 mmol) was dissolved in 14 cm 3 of methanol and 
left stirring for 90 mm. [(DMAP)B(methimazolyl)3] (236 mg, 0.50 mmol) was added 
and a colour change from orange to red was observed. The reaction was stirred for 16 
h at room temperature and was heated for a further 4 h at 55-60 °C. NH 4PF6 (163 
mg, 1.00 mmol) was added to the complex and a red precipitate was formed 
immediately. The solid was dried and dissolved in 10 cm 3 of acetone. The red 
solution was filtered to remove the excess of hexafluorophosphate salt. The filtrate 
was taken to dryness and the remaining product was recrystallised from 
dichloromethane to obtain 497 mg (901/o) of a red solid. Crystals suitable for X-ray 
crystallography were obtained from slow evaporation of a concentrated solution of 
the complex in dichioromethane. 
C29H39BF 12N8P2RuS3 (998.68): calcd.: C, 34.91; H, 3.94; N, 11.23; found: C, 34.52; 
H, 3.89; N, 11.11 %; MS (FAB): m/z = 708.7 (M with loss of counter-ions); 'H 
NMR (250.1 MHz, DMSO-d6): ö,j 8.28 (2H, d, 3J = 7.8 Hz), 7.56 (3H, d, 3J = 2.4 
Hz), 6.98 (2H, d, 3J = 7.8 Hz), 6.94 (3H, d, 3J = 2.4 Hz), 5.64-5.76 (4H, m), 3.71 
(9H, s), 3.25 (6H, s), 2.91 (1H, sept, 3J= 6.8 Hz), 2.23 (3H, s), 1.21 (3H, s), 1.18 
(311, s); 13C NMR (90.1 MHz, DMSO-d6): Sc 162.6 (Cq MrI), 158.3 (Cq  DMAP), 145.7 
(CH DMAP), 108.9 (CH M1'l), 108.4 (Cq  p-cym), 103.1 (Cq p.cym), 86.8 (CH DMAP), 86.4 
(CH p..cym), 85.9 (CH 84.8 (CH p..cym), 41.2 (CH p-cym), 36.8 (CH3 DMAP), 32.0 
(CH3 m),  23.5 (CE!3 p. ym), 19.6 (CH3 p..cym). 
The refinement of the structure of 2.26 was not possible due to the loss of solvent 
which affected the quality of the obtained crystals. The R-factor found for the 
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refinement of this structure was above 30%. Apart from the atomic coordinates, no 
further crystallographic data was obtained, 
I(methimazolyl)3Ru(p-cymene)1 [PF 612 2.27 
A solution of [Ru(p-cymene)]C12]2 (330 mg, 0.5 mmol) in 23 cm 3 methanol was 
stirred for 90 min at room temperature. The ligand [(benzylamine)B(methimazolyl)3] 
(395 mg, 1.00 mmol) was added and a colour change from orange to dark red 
occurred. Then the mixture was stirred at room temperature for 16 h and heated for a 
further 4 h at 55-60 °C. Then NHPF6 (326 mg, 2.00 mmol) was added and an orange 
precipitate was formed. The solid was dried under vacuum and dissolved in 10 cm 3 
acetone. The red solution was filtered to remove the excess of hexafluorophosphate 
salt. The filtrate was dried and the remaining product was precipitated from a 
mixture of dichioromethane and hexane (4:1) to obtain 640 mg (70%) of a red/orange 
solid. Crystals suitable for X-ray crystallography were obtained by slow diffusion of 
diethyl ether in a concentrated solution of the complex in acetonitrile. 
(867.7): calcd.: C, 30.45; H, 3.72; N, 9.69; found: C, 30.08; H, 3.68; N,9.54 %; 
MS(FAB): m/z = 577.8 (MIt with loss of counter-ions); 'H NUR (250.1 MHz, 
CD3CN): 5H 10.70 (3H, br), 7.03 (6H, dd, 3J- 2.2 Hz and 3J=12.0 Hz), 7.01 (3H, d, 
3J= 2.2 Hz), 5.60 (2H, d, 3J = 6.3 Hz), 5.44 (2H, d, J= 6.3 Hz), 3.66 (911, s), 2.81 
(1H, sept, J= 6.9 Hz), 2.11 (3H, s), 1.26 (3H, s), 1.23 (3H,, s); ' 3C NMR (62.8 MHz, 
CDC13): Sc 154.0 (C q Mn), 123.4 (Cq p-cym), 118.0 (Cq p.cym), 108.4 (CH Ml'!), 105.7 




Table 5.2. Crystallographic data and structure refinement details for 2.26 
Crystal description Red rod 
Empirical Formula C22 H32 F 12 N6  P2 RU S3 
M 867.73 
T/K 150 
Crystal system Monoclinic 
Space group P121 /nl 
alA 15.1385(10) 







D I g cm73 1.794 
P / mnf4 0.880 
Reflexions measured 6574 
0.080 
Data with 	>4s(F1) 5071 
Semi-empirical from 
Absortion correction type equivalents 
Mm/max transmission 0.63/0.94 
R 0.0651  
I(dimethylamine)B(methim17o1y1)3Mo(CO)31 2.28 
[(dimethylamine)B(methimazolyl)3] (0.2 mg, 0.5 mmol) was dissolved in 15 cm3 of 
tetrahydrofuran and then MO(CO)6 (133 mg, 0.5 mmol) was added. The mixture was 
heated under reflux After 2 h the solution became yellow. The mixture was heated 
for a further 3 h. The solvent was removed under vacuum and the solid was washed 
three times with 5 cm3 of diethyl ether and dried under vacuum to afford 112 mg 
(38%) of an off-white powder. 
C 171425BMoN7O3S3 (578.4): calcd.: C, 35.30; H, 4.36; N, 16.95; found: C, 34.90; H, 
4.67; N, 17.12.%; MS(ES): m/z= 579 (M + 1); 'HNMR (360.1 MHz, CDCI3): 5H 
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9.75 (NH, br), 6.69 (3H, d, 3J = 2.2 Hz), 6.68 (31-L d, 3J = 2.2 Hz), 3.61 (9H, s), 3.68 
(6H,$); 13C NMR (90.5 MHz, CDC1 3 ): öc 207.4 (C = 0), 163.2 (C=S), 119.4 (CH 
vrrI), 114.0 (CH i.rri), 35.4 (CH3 rm),  25.2 (CH3); "B (115.5 MHz, CDC13): öB 5.98; 
IR (hexane): 1987, 1957 cm' (C 0). 
Attempted synthesis of [{(DM4P)B(methimazolyl)3JM0(CO)31 2.32 
[{(dimethylamine)B(methimazolyl)3}Mo(CO)3] (20 mg, 0.034 mmol) was dissolved 
in toluene and DMAP (4 mg, 0.34 mmol) was added. The mixture was heated under 
reflux for 1 h and evolution of dimethylamine gas was monitored by pH paper test. 
The mixture was cooled and left stirring at room temperature for 3 h. The solvent 
was removed under vacuum and the product was washed with 2 cm 3 of diethyl ether. 
The product analysis by "B magnetic resonance spectroscopy showed no boron 
signal and IR spectroscopy showed no bands for C 0 vibrations. 
[(DMAP)B(pyrazolyl)3J 2.33 
To a suspension of [(dimethylamine)B(pyrazolyl)3] (300 mg, 1.16 mmol) in 15 cm 3 
of toluene was added 4-(dimethylaniino)pyndine (143 mg, 1.16 mmol). The reaction 
was heated under refiux for 12 it A white powder was recovered by filtration. It was 
washed twice with 5 cm3 of diethyl ether and dried under vacuum. The ligand was 
obtained with 90% (350 mg) yield. 
C,6H,9BN8 (334.19): calcd.: C, 57.50; H, 5.73; N, 33.53; found: C, 57.01; H, 5.39; N, 
33.38 %; MS (FAB): m/z = 335.3 (M+ 1); 'H NIMR (360.1 MHz, CDC13): SH 8.31 
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(2H, d, 3J= 7.4 Hz), 7.74 (3H, d, 3J = 0.8 Hz), 7.12 (3H, d, 3J- 2.2 Hz), 6.56 (21-, d, 
3J= 7.5 Hz), 6.25 (31-t t, J = 1.7 Hz and 3J = 0.9 Hz), 3.16 (614, s); 13C NMR(90.5 
MHz, CD3CN): Sc 156.1 (Cq  DMAP), 145.4 (3CH 135.3 (3CH 129.1 (3CH 
DMAP), 106.6 (3CH ,), 105.7 (2CH DMAP),  39.9 (2CH3 DMAP). 
[(N-methylimidazole)B(pyrazolyl)31 2.34 
To a suspension of [(dimethylamine)B(pyrazolyl)3] (300 mg, 1.16 mmol) in 15 cm 3 
of toluene was added N-methylimidazole (0.0922 cm?, 1.16 mmol). The mixture was 
heated under refiux for 4 h. A white solid was recovered by filtration, washed three 
times with 5 cm3  of diethyl ether and dried under vacuum. The ligand was obtained 
in 88% yield (304 mg). 
'H NMR (360.1 MHz, CDC13): ö,., 8.58 (1H, s), 7.72 (3H, d, 3J = 1.7 Hz), 7.57 (1H, t, 
3J= 2.2 Hz and 3J= 3.1 Hz), 6.96 (3H, d, 3J = 2.2 Hz), 6.92 (1H, t, 3J = 1.7 Hz and 3J 
=1.3Hz),6.24(3H,t, 3J=1.7Hz and 3J=2.2Hz),3.77(1H,S). 
[{ic2-N,N (DMAP)B(pz)3}Ru(p-cymene)CI]PF6 2.38 
[Ru(p-cymene)C12]2 (110 mg, 0.0179 mmol) was dissolved in 10 cm 3 of methanol 
and stirred for 1 h. Then, [(DMAP)B(pz)3] (120 mg, 0.36 mmol) was added in small 
portions and a colour change of the mixture from orange to yellow was observed. 
The reaction was stirred for a further 24 h at room temperature. NH 4PF6 (60 mg, 0.37 
mmol) was added to the solution and a yellow precipitate was formed. The 
precipitate was dried and washed with ether to afford 120 mg (37%) of a yellow 
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solid. The product was crystallized by slow diffusion of diethyl ether into an 
acetonitrile solution to obtain crystals suitable for X-ray crystallography. 
CH33BC1F6NgPRu (749.9): calcd.: C, 41.64; H, 4.44; N, 14.94; found: C, 41.53; H, 
4.35; N,14.56 %; MS (FAB 4) m/z = 605.2 (M  complex without counter-ion); 'H 
NMR (360.1 MHz, DMSO-d6): 51, 8.18 (2H, d, 3J = 2.2 Hz), 7.82 (111, d, 3J = 1.3 
Hz),7.46(2H,d, 3J=2.6}z),7.08(1H,d,3J=2.1Hz),7.03(2H,d,3J7.8Hz), 
6.90 (2H, d, 3J = 7.4 Hz), 6.68 (21-L t, 3J = 2.2 Hz), 6.53 (1H, t, 3J = 1.7 Hz), 5.77 
(21-L d, 3J= 6.1 Hz), 4.92 (2H d, 3J= 6.1 Hz), 3.22 (6H, s), 2.66 (11L sept, 3J - 6.5 
Hz), 1.56 (3H, s), 1.76 (6H, d, 3J = 6.5 Hz); 13C NMR (90.5 MHz, DM50-d6): Sc 
160.9 (Cq  DMAP), 156.8 (2CH DMAP), 148.6 (Cq p..c)m), 142.3 (2CH pj, 138.2 (CH pz), 
133.6 (CH pz), 128.8 (2CH pz), 108.3 (2CH DMAP), 107.8 (2CH pz), 107.7 (CH 
pz), 102.6 (2CH,), 102.0 (2CH,,), 87.28 (Cqp ), 80.48 (CH p.cym) , 29.8 (CH3 
DMAP), 22.2 (CH3 17.5 (CH3 ,,.). 
Table 5.3. Crystallographic data and structure refmement details for 2.38 
Crystal description Orange block 
Empirical Formula C26 H33B F6 N8  P RU 
M 749.90 
TIK 150(2) 
Crystal system Monoclinic 




(r1 0 90.00 
fl!0 106.854(2) 
90.00 
v/A3 3095.20 (17) 
Z 4 
D g cm73 1.609 
plmm' 0.713 
Reflexions measured 6359 
Rha 0.0578 
Data with IF1>4G(Ifl) 5123 
Absortion correction type multiscan 
Mm/max transmission 0.7707 / 0.9168 
R 0.0347  
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Attempted synthesis of I{(DMAP)B(Pz)3)Ru(P-Cymefle)I(6)(4) 2.39 
[{(DMAP)B(pz)2}Ru(p-cymene)Cl]PF6 (60 mg, 0.08 mmol) was dissolved in 5 cm3 
of acetomtrile and silver tetrafluoroborate (23 mg, 0.12 mmol) was added. A 
precipitate of AgCl was formed after 10 min and the mixture was stirred for 30 mm. 
The precipitate was filtered off and the filtrate was concentrated to half volume and 
left to crystallise by slow diffusion of ether. Product analysis by NUR spectroscopy 
shows three more sets of signals for the pyrazole rings of the complex. This could be 
a mixture of products or decomposition of the complex. 
5.2. EXPERIMENTAL PART CHAPTER HI 
S-trityl-henzimidazole-2-thione 3.16 
Benzimidazole-2-thione (6.0 g, 40 mmol) was dissolved in 120 cm 3 tetrahydrofuran 
and triethylamine (5.2 g, 52 mmol) and triphenylmethyl chloride (11.16 g, 40 mmol) 
were added to the solution. The mixture was stirred at room temperature for 30 h. 
The NEt3 .HC1 precipitated and was filtered. The filtrate was concentrated and the 
solid obtained, S-trityl-benzimidazole-2-thione, was recrystallised from toluene and 




S-tntyl-benzimidazole-2-thiofle (14.6 g, 37 mmol) was dissolved in 160 cm 3 of 
freshly distilled acetone and ground potassium hydroxide (12.6 g, 226 mmol). This 
mixture was stirred for 40 mm, and then methyl iodide (9.3 g, 66 mmol) was added. 
After stirring for a further 3 h, 200 cm 3 of toluene were added and the mixture was 
extracted with 80 cm 3 of water and 80 cm3 of brine. The organic phase was dried 
over anhydrous sodium sulphate and dried under vacuum. The solid obtained was 
dissolved in 120 cm3 of a solution 5% (v/v) acetic acid in methanol and it was heated 
under reflux for 32 K The solvent was removed under vacuum and the crude product 
was dissolved in dichioromethane and extracted three times with 40 cm 3 of 10% 
(w/w) aqueous sodium bicarbonate solution. The organic phase was dried over 
anhydrous sodium sulphate, dried under vacuum and the solid obtained was 
recrystallized from acetonitrile. The crystals were washed with hexane to afford 4.3 g 
(71%) of a white solid. 
'H (250.1 MHz, CDC13): oH 9.57 (1H, br), 7.21 (4H, m), 3.78 (3H, s). 
1,4,5-trimethylimidazole-2-thione 337 
To a mixture of 3-hydroxybutanone (8.8 g, 0.1 mol) and N-methylthiourea (9.0 g, 0.1 
mol) in 50 cm3 of hexanol was added 2 cm3 of concentrated hydrochloric acid (37%). 
The reaction mixture was heated under reflux for 12 h. Then, it was cooled and 
placed in an ice bath. The mixture formed was filtered immediately and the 
precipitate was washed with two portions of hexane (15 cm) and three portions of 
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diethyl ether (25 cm). The product was then recrystallized from petroleum ether to 
afford 4.2 g (30%) of pure compound. 'H NMR (250.1 MHz, CDC13): 6H 10.95 (1H, 
br), 3.50 (3H, s), 2.08 (311, s), 2.05 (3H, s) 
I(HMe2)B(1,4,5methylimido1e-2-thi0)31 3.4 
To a suspension of 1,4,5-trimethylimidazole-2-thione (500 mg, 3.52 mmol) in 10 cm3 
of toluene was added tris(dimethylamino)borane (0.205 cm 3, 1.17 mmol). The 
mixture was heated to reflux for 12 h. The solvent was evaporated and the crude 
product was washed three times with 5 cm 3 of diethyl ether. The pure product was 
obtained as a white powder in 66 % (434 mg) yield. 
C20H34BN7S3 (479.5): calcd.: C, 50.09; H, 7.15; N, 20.45; found: C, 49.96; H, 7.13; 
N, 20.38 %; MS (FAB'): m/z = 480.4 (M + 1); 'H NMR (500.1 MHz, CDC13): SH 
10.47 (1H, br), 3.48 (6H, s), 2.84 (9H, s), 2.08 (911, s), 2.04 (9H, s); 13C NMR (125.7 
MHz, CDC13): Sc 157.9 (Cq), 121.5 (CH), 119.5 (CH), 39.3 (CH 3), 31.1 (2CH3), 8.9 
(2CH3). 
L(HNMe2)B(1methy1be11zm1doIe-2-thi0fle)31 3.5 
1-methylbenzimidazole-2-tbione (500 mg, 3.04 mmol) was dissolved in 15 cm 3 of 
xylene and tris(dimethylamino)borane (0.117 cm 3, 1.02 mmol) was added. The 
mixture was heated under reflux for 24 h, during which time the solution became 
cloudy. The mixture was cooled to room temperature and the solvent was removed 
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under vacuum. The white solid was washed twice with 5 cm' of diethyl ether and 
dried under vacuum to afford 300 mg (54%) of product. 
CH28BN7S3 (545.6): calcd.: C, 57.24; H, 5.17; N, 17.97; found: C, 57.05 H, 5.15; 
N, 17.91 %; MS(FAB'): m/z = 546 (M + 1); 'H NMR (360.1 MHz, CDC13): 6H 10.22 
(1H, br), 7.19-7.13 (12H, m), 3.80 (6H, s), 3.75 (6H, s); 13C NIVIR (90.5 MIHz, 
CDC13): & 169.9 (CS), 135.9 (C q), 127.9 (Cq), 124.9 (CH), 123.7 (CH), 110.8 (CH), 
109.8 (CH), 31.4 (CH3), 18.6 (2CR3). 
[{(HIMe2)B(1-methy1benzimidaZOIe-2-thiOfle)3}MO(CO)3I 3.6 
To a suspension of [(HNMe 2)B(1-methylbenzinIidazole-2-thiOfle)3] (200 mg, 0.360 
mmol) in 15 cm3  of tetrahydrofuran was added molybdenum hexacarbonyl (97.0 mg, 
0.360 mmol). The mixture was refluxed for 6 h and the reaction was monitored by JR 
spectroscopy. During the refiux the solution became pale green. The tetrahydrofuran 
was removed under vacuum and the product was dissolved in chloroform and 
impurities were filtered off. The filtrate was dried to afford 82 mg (31%) of a yellow 
solid. 
C29HBMoN7O3S3 (725.5): calcd.: C, 48.01; H, 3.89; N, 13.51; found: C, 47.87; H, 
3.86; N, 13.47%; MS (FAB 4): m/z- 726 (M+ 1); 'H NMR (360.1 MHz, CDC13): öji 
9.45 (1H, br), 7.20-7.10 (12H, m), 3.88 (9H, s), 3.80 (6H, s); 13C NMR (90.5 MHz, 
CDC13): Sc 205.6 (CO), 169.3 (CS), 132.3 (C q), 132.6 (Cq), 127.6 (CH), 124.7 (CH), 
110.1 (CE), 109.4 (CH), 30.7 (CH3), 15.1 (2CH3); "B NMR (119.1 MHz, CDC13): 
85 18.8. JR (hexane solution): 1982, 1950 cm -1 (C a 0). 
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5.3 .EXPERIMENTAL PART CHAPTER IV 
[((S)()cL-methy1benzyIamine)B(methimaZOIYl)31 4.19 
To a solution of (S)-(—)-a-methylbenzylainine (0.188 cm?, 1.45 mmol) in 15 cm 3 of 
toluene were added methimazole (500 mg, 4.36 mmol) and 
tris(dimethylamino)borane (0.253 cm3 , 1.45 mmol). The mixture was heated under 
reflux for 48 K Then, the toluene was removed under vacuum and the remaining 
solid was washed three times with 5 cm3 of diethyl ether. The product was obtained 
in 44% (305 mg) yield. 
C20H26BN7S3 (471.5): calcd.: C, 50.95; H, 5.56; N, 20.80; found: C, 57.51; H, 5.53; 
N, 19.98 %; MS (FAB): m/z = 472 (M + 1); 'H NMR (360.1 MHz, DMSO-d6): 511 
10.24 (2H, br), 7.38-7.21 (5H, m), 7.04 (3H, d, 3J = 2.1 Hz), 6.86 (3H, d, 3J = 2.4), 
4.06 (1H, q, 3J = 6.5), 3.42 (9H, s), 1.30 (3H, d, 3J = 6.5 Hz); 13C NMR (90.5 MHz, 
DMSO-d6): Oc 160.8 (CS), 128.1 (2CH MBZA), 126.4 (Cq  viZA), 125.8 (2CH MzA), 
124.9 (Cq  vffiZA), 119.6 (CH vfii),  114.2 (CH vrrI), 50.5 (CH azA),  33.5 (CH3 n), 
22.3 (CH3 MflZA). 
[((S)-(-)- cz-methylbenzylamine)B(1,4,5-trimethylimidaZOlyl2-thiOfle)31 4.20 
To a suspension of 1,4,5-trimethyl-imidazole-2-thione (600 mg, 4.22 mmol) in 15 
cm  of toluene were added tris(dimethylamino)borane (0.246 cm 3, 1.14 mmol) and 
(S)-(-)-a-methylbenzylamine (0.18 1 cm 3,1.14 mmol). The mixture was heated under 
reflux for 60 h. The solvent was removed under vacuum and the remaining solid was 
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washed twice with 5 cm3  of diethyl ether. The product was recovered as a white 
powder solid in 31% yield (240 mg). 
C261L8BN7S3 (555.6): calcd.: C, 56.20; H, 6.89; N, 17.65; found: C, 55.97 ; H, 6.86; 
N, 17.57 %; MS (FAB): m/z = 556 (M + 1); 'H NMR (360.1 MHz, CDC13): öii 
11.54 (2H, br), 7.32-7.27 (5H, m), 4.11 (1H, q, 3J= 6.5 Hz), 3.50 (9H, s), 3.47 (91-, 
s), 2.02 (9H, s), 1.37 (3H, d, 3J= 6.5 Hz); 13C NMR (125.7 MHz, CDC13): öc 157.9 
(CS), 144.9 (Cq  aromatic MBzA), 131.1 (CH zA), 130.2 (CH vIBZA),  125.9 (CH MBZA), 
125.1 (CH 122.9 (Cq), 119.6 (Cq), 31.2 (CH3), 11.9 (CH3 ?i.A),  8.9 (2CH3). 
4.21 
A suspension of molybdenum hexacarbonyl (40 mg, 0.151 mmol) in 20 cm 3 of 
acetonitrile was heated under reflux for 3 K The solution became yellow and was 
added via cannula to a schienk flask containing (S)-(-)-a-
methylbenzylamine)B( 1,4,5-trimethyl-imidazolyl-2-thione)3 (70 mg, 0.126 mmol). 
The solution was stirred at room temperature for 24 h. The resulting green solution 
obtained was evaporated under vacuum and the product was dissolved in a mixture 
chloroform/hexane (1:1) and filtered. The filtrate was dried under vacuum to obtain a 
15 mg (16%) of product. 
C 9H40BMoN703S3 (737.6): calcd.: C, 47.22; H, 5.47; N, 13.29; decomposition 
prevented satisfactory analysis; MS (FAB'): m/z = 737.3 (M4 ); 'H NMR (360.1 
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MHz, CDC13): oH 6.70-6.67 (5H, m), 3.74 (1H, q, 3J = 6.5 Hz), 3.61 (9H, s), 3.59 
(9H, s), 2.49 (3H, d, 3J = 6.0 Hz), 2.43 (2H, s), 1.25 (9H, s); ' 3C NMR (90.1 MHz, 
CDC13): & 205.3 (CO), 158.3 (CS), 136.4 (C q ammatic riizA), 129.5 (CH MBZA), 128.91 
(CHMjzA), 125.9 (CH,fl3zA), 125.7 (CHzA), 121.6 (CHMBZA), 120.6(C q), 119.4 
(Cq ), 31.8 (CH ?MA), 31.1 (CH3), 19.1 (CH3 fflzA), 8.02 (2CH3); "B NMR (119.1 
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